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Undoubtedly the pace at which we are living increases step by step on a daily basis. Since 
this is a gradual process in general, this may go unnoticed to some, but the implications on 
healthcare are not to be taken too lightly.
Interventional electrophysiology as a distinct entity is a relatively young discipline. It has gone 
through several groundbreaking changes in a short time span. Although the first measure-
ments of cellular currents date from the late 1800s, in general the birth of invasive clinical 
electrophysiology, associated with the use of programmed electrical cardiac stimulation 
combined with intracardiac activation mapping by the groups of Durrer and Coumel, is said 
to be no earlier than 1967. After having been used for several years as a diagnostic tool to 
evaluate the effect of anti-arrhythmic drugs, the therapeutic options of electrophysiology 
emerged in the early 1980s with the ‘shock’ ablation of the His bundle. At roughly the same 
time the pacing branch of electrophysiology experienced a comparable ‘shock’ with the 
introduction of the first implantable automatic defibrillator.
In the last decade, there has been a relentless innovation in the field of electrophysiology. 
The invasive electrophysiological armamentarium now consists of numerous diagnostic tools, 
multiple implantable devices aiming to pace, defibrillate or resynchronize the heart and a 
continuously growing number of manually and remotely navigated ablation catheters in 
various shapes and sizes.
In parallel to the aforementioned, the number of targeted arrhythmias expands. However, it is 
uncertain if our understanding of the underlying disease matures at the same velocity. Selection 
of patients suitable for an ablation or for device implantation, and timing of the intervention is 
crucial to achieve an optimal result. With regard to implantable defibrillators we need to opti-
mize criteria to select patients who benefit most from this therapy: cost-efficacy is reasonable 
in secondary prevention, but still a whole lot of work needs to be done in identifying victims 
at risk for sudden cardiac death in primary prevention. In respect to cardiac resynchronization 
therapy we are able to improve functional status in about three out of four patients, however, 
one out of four is labeled as being a non-responder. We are ignorant to the exact cause of 
this therapy failure: did we select the wrong patient, are the current devices insufficient or 
do we lack consensus about reprogramming using mechanical or electrical synchronicity. The 
same applies to ablation for several complex arrhythmias. Atrial fibrillation and ventricular 
tachycardia are two hot topics in electrophysiology that currently illustrate our limitations in 
fully understanding their pathophysiology. Both arrhythmias tend to respond better when 
treatment is installed in an early phase of disease progression. However, we do not know 
the precise implications of the structural, functional, electric, metabolic and neurohumoral 
remodeling that occurs in the presence of these arrhythmias. Success rates of ablation are 
indisputably influenced by these limitations: we are still left with fundamental questions about 
optimal timing of intervention, precise ablation targets and uniform ablation endpoints.
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Nevertheless, health care professionals tend to feel obliged to follow the new rhythm im-
posed by society. A swiftly increasing number of patients suffering from various arrhythmias 
in combination with regular cuts in financial resources by the Belgian government and a 
public opinion demanding a quick-fix treatment, form a potentially perilous combination.
Various questions need to be answered. When we strive to shorten procedural times, can we 
accept a trade-off in safety and efficacy? Is there still room for technologies that emphasize 
on safety without immediately shortening procedural times or increasing efficacy at the same 
time? How much effort should be made to first completely understand the pathophysiology 
of certain arrhythmias before developing treatment strategies that focus on swift and safe 
interventions?
Probably the true answer to these questions lies in a balanced approach combining different 
portions of speed, safety and success tailored to the needs of each single patient. In this 
thesis we aim to elucidate some determinants that could optimize our decision making using 
the currently available tools.
This thesis is composed of three parts each containing several chapters. The parts represent 
the past, present and future of catheter ablation. In each part we focus on techniques that 
were, are or could possibly be ‘game changers’ in the field of electrophysiology.
For starters, we take a look into the past comparing safety and efficiency of radiofrequency 
energy and cryothermal energy in treating atrioventricular nodal reentrant tachycardia. We 
try to find scientific evidence that justifies using one or the other energy form in certain 
circumstances. We also study basic principles of cryoenergy and learn how this knowledge 
can be of some help for less experienced users.
Secondly we evaluate some of the currently available novelties conceived to improve pulmo-
nary vein isolation. Do these ‘single shot ablation devices’ really serve their goal or do they 
come with new threats? Can we consider treating new subgroups of patients that formerly 
were not suitable for catheter ablation? And can some new tools change the way we always 
thought about cryoablation?
Finally we take a thorough look at remote magnetic navigation and its implications for future 
electrophysiology.
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Part I
Conventional AVNRT ablation: 
what do we learn from the past?
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Chapter 1
long-term follow-up after catheter ablation 
for AVNRT: a comparison of cryothermal 
and radiofrequency energy in a large series 
of patients
Bruno Schwagten MD, Paul Knops, Ing, Petter Janse, RN, Geert Kimman, MD, 
PhD, Yves Van Belle, MD, Tamas Szili-Torok, MD, PhD, Luc Jordaens MD, PhD, 
FESC
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ABSTRACT
Background: Radiofrequency (RF) catheter ablation for atrioventricular nodal re-entrant 
tachycardia (AVNRT) is highly successful but carries a risk for inadvertent atrioventricular 
block (AVB). Cryoablation has the potential to assess the safety of a site before the energy is 
applied. Aim: to evaluate the long term efficacy and safety of cryothermal ablation in a large 
series of patients and compare it to RF. Methods: All consecutive routinely performed AVNRT 
ablations from our centre between 1999 and 2007 were retrospectively analysed. Results: In 
total 274 patients were elegible: 150 cryoablations and 124 RF. Overall procedural success 
was 96% (262/274), and equal in both groups, but 9 patients were crossed to another arm. 
Mean fluoroscopy time was longer in the group treated with RF (27 ± 22 min vs. cryo 19 ± 
15 min; p=0.002). Mean procedure time was not different (RF 138 ± 71 min vs. cryo 146 ± 
60 min). A permanent pacemaker was necessary in 2 RF patients. The questionnaire revealed 
a high incidence of late arrhythmia related symptoms (48%), similar in both groups, with 
improved perceived quality of life. The number of redo procedures for AVNRT over 4,3 ± 2,5 
years follow-up was not statistically different (11% after cryo and 5% after RF). Conclusions: 
Our data confirm that cryo and RF ablation with 4 mm tip catheters for AVNRT are equally 
effective, even after long term follow up.
Key Words: arrhythmias; atrioventricular block; atrioventricular re-entrant tachycardia; cath-
eter ablation; cryoablation, radiofrequency
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INTRoduCTIoN
Catheter ablation is a successful and widely used approach for treatment of atrioventricular 
re-entrant tachycardia (AVNRT). (1,2) However, there is still debate about the choice of the 
most optimal energy. Radiofrequency (RF) catheter ablation is highly effective but carries 
the risk for creating inadvertent atrioventricular heart block (AVB). (3) Cryoablation (cryo) 
on the other hand can be performed very safely due to the possibility of `ice mapping` and 
`cryoadherence`. (4) We showed in the past in a randomised trial that both techniques had 
the same acute outcome. (5) However, conflicting data exist about the recurrence rate with 
this technique, ranging from 0 to more than 30%. (6-13) In this work, we evaluated not 
only the short term efficacy and safety of RF ablation and cryothermal ablation of AVNRT in 
a large series of patients, but also the long term outcome.
MeThodS
All catheter ablations performed at our centre from 24/02/1999 to 19/12/2007 were anal-
ysed. In all procedures the antiarrhythmic agents were discontinued for at least 5 half-lives 
before the procedure. The ablation protocols were unchanged during the whole inclusion 
period, and were supervised by the same electrophysiologist. However, the team consisted 
of several experienced electrophysiologists, with their own training and preferences. All 
procedures were performed under local anaesthesia, implemented with sedation. The fol-
lowing data were collected: energy used, acute success, number of applications, ablation 
time, fluoroscopy time, procedural time, acute and late complications and need for redo 
procedures. Procedural time was measured from the time of puncturing the vein until the 
time of removal of the sheaths from the groin, including the 30 minutes waiting period after 
a successful ablation. The patients included in two previously published studies were not a 
part of this retrospective analysis. (5,14)
Ablation procedure
One bipolar catheter, one quadripolar and one decapolar catheter were inserted to perform 
a standard electrophysiological study. The catheters were advanced into the heart and 
positioned respectively in the right ventricular apex, on the His bundle and in the coronary 
sinus. At baseline the AH and HV intervals were recorded on the catheter in the His posi-
tion, and with programmed electrical stimulation the presence of dual AV conduction was 
confirmed, defined as a AH jump of more than 50 ms. Subsequently tachycardia was induced 
by programmed electrical stimulation or by atrial burst pacing. If sustained tachycardia could 
not be induced, isoprenaline was used. Induction of AVNRT was performed at least 2 times 
before moving forward to ablation.
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Cryoablation:
Cryoablation was performed by using a Freezor 3 catheter with a 4 mm tip (Cryocath Tech-
nologies, Montreal, Canada) and a CCT2 CryoConsole (Cryocath Technologies, Montreal, 
Canada). At the site of interest, ice mapping was performed by cooling to -30°C for a 
maximum of 60 s. Fluoroscopy was applied until a stable temperature of -30°C was reached. 
During these 60 s, atrial extrastimulus testing was performed. Termination or non-inducibility 
of AVNRT or disappearance of an AH-jump was considered to be an identification of a poten-
tially successful ablation site. Ablation was subsequently performed using a freezing protocol 
by cooling to -75°C for a 6 min period to create a permanent lesion. If there was no clear 
AH-jump, and AVNRT was difficult to induce at baseline, prolongation of the anterograde 
AV refractory period during atrial extra stimulus testing during ice mapping was used to 
identify a target site. The endpoint was non-inducibility of AVNRT. This was tested after each 
application, and if non-inducible, repeated after a 30 min waiting period.
RF ablation:
RF catheter ablation was performed using a 4 mm, solid-tip, ablation catheter (Biosense-
Webster Inc, Diamond Bar, CA, USA or an EPT Blazer, Boston Scientific, San Jose, CA, USA) 
in a temperature controlled mode (maximum temperature 55°C, maximum duration 60 s, 
maximum 40 W) with the use of a Stockert RF generator (Biosense-Webster Inc, Diamond 
Bar, CA, USA). Ablation of the slow pathway was guided by a combination of intracardiac 
electrograms and anatomical landmarks. When an optimal balance of a small fractionated 
A and large V signals were seen, RF energy was applied starting at a low energy level. Each 
application was started with the power set at 10 W and, if AV conduction was preserved, 
the power was progressively increased to 40 W until a maximum of 55°C was reached or 
junctional rhythm appeared. Fluoroscopy was used throughout each application.
With both techniques, retrograde conduction was continuously monitored. The endpoint 
was non-inducibility of AVNRT. This was tested after each application, and if non-inducible, 
repeated after a 30 min waiting period.
Follow-up
Before hospital discharge, all patients received a 12-lead ECG recording and echocardio-
graphic examination. Three months after the procedure all patients were examined at the 
outpatient clinic and asked about recurrent palpitations. If longstanding palpitations occurred 
within the follow-up period, a new 24-hour holter monitor was performed or an effort was 
made to document the arrhythmia. Patients were then sent to their referring cardiologist, 
except when a redo procedure was necessary. For the purpose of this study, all patients were 
again personally approached by the investigators at the beginning of 2008 with a dedicated 
questionnaire, focusing on recurrence, duration and intensity of arrhythmias, antiarrhythmic 
drug use, cardioversion, readmission for cardiovascular reasons, for pacemaker implanta-
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tion or reablation, also for other arrhythmias. This questionnaire was also sent to patients 
included in former trials as the obtained results were supposed not to be dependent on acute 
procedural outcomes. (5,14).
Statistical analysis
Continuous variables were expressed as mean ± standard deviation, if normally distributed, 
or otherwise by median. The Students t-test or analysis of variance were used when appropri-
ate.
A Chi-square test with Yates correction was used for categorical data. The level of significance 
was set at p < 0.05. For efficacy and complications analysis, therapy as applied.
All statistics were performed using SPSS (16.0) for Windows (Chicago, Il, USA).
ReSulTS
Patient data
Of the 389 consecutive procedures performed at our centre between 24/02/1999 and 
19/12/2007, 81 were excluded as they were already part of other published studies.(5,14) Of 
the remaining 308 procedures, 16 were excluded because another arrhythmia was identified 
during the study before abalation, and 17 because of insufficient data (Figure 1). Patients 
Part 1 Chapter 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Patient flow chart. At the beginning, study patients were excluded, resulting in 308 
routine procedures. AVNRT: atrioventricular nodal re-entrant tachycardia; RF: 
radiofrequency. 
 
 
 
 
 
Figure 1. Patient flow chart. At the beginning, study patients were excluded, resulting in 308 routine 
procedures. AVNRT: atrioventricular nodal re-entrant tachycardia; RF: radiofrequency.
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in whom AVNRT was ablated along with another arrhythmia (atrial flutter or atrial tachy-
cardia) and redo procedures (28, of which 11 with cryo and 17 with RF) remained included. 
Eightyeight (32%) of 274 patients were male. The overall mean age was 51 ± 17 years, 50 ± 
17 in the cryo group vs. 52 ± 17 years in the RF group (NS).
Procedure and ablation data
The initial approach was cryoenergy for 150 and RF for 124 ablations (55% vs. 45%). The 
overall acute success rate was 95% (262 patients). Of these procedures 246 were a first 
ablation for AVNRT, and 28 were redo procedures. Only 10/274 patients (3.6%) would fail 
the ablation (5 in each group had procedural failure), but this implied a cross-over of 8 cryo 
patients to RF, and 1 RF to cryo. The acute failure rate for the final delivered energy modality 
was similar for both approaches (cryo 3% vs. RF 4%; NS). The median number of applica-
tions was less in the cryo group (2 vs. 6) (Table I). The mean ablation time was longer in the 
cryo patients (522 ± 384 s vs. 371 ± 621 s). The mean fluoroscopy time was shorter in the 
cryo group (19 ± 15 min vs. 27 ± 22 min), while the procedure time was not different (cryo 
146 ± 60 min vs. RF 138 ± 71 min). From the redo procedures, only one (cryo) failed acutely.
Table I. Procedural data (analysis including cross-overs)
patients reported a hospital readmission (Fig. 4). From the 35
arrhythmia-related admissions, 19 (54%) were after cryo, 16
(46%) after RF (NS). Two patients were admitted for
elective cardioversion (atrial fibrillation). Five patients
received a device for arrhythmia management. The two late
ICD's were implanted after anterior myocardial infarction
and after development of heart failure in a patient with non-
ischemic cardiomyopathy. Neither conduction disease nor
arrhythmias were recorded in these two patients. The three
late pacemaker indications were sinus node disease (one
from each group), and one second-degree AVB with
symptoms (RF group).
4 Discussion
The major finding of this study is that cryo and RF ablation
for AVNRT are equally effective techniques, also in the
long run. Cryoablation has a better safety profile.
4.1 Procedural efficacy
Both cryo and RF ablation are very successful techniques in
AVNRT ablation. Acute success was very high in previous
studies, and this is confirmed in our observations, which
were also achieved with a 4-mm catheter tip.[5–7] We
cannot completely explain the relatively high cross-over
rate, but we suspect that physician preference played a role
in this. Use of a 6-mm cryocatheter tip might improve the
success rate, compared to a 4-mm tip, when applying on the
right spot, but also might diminish the potential of ice
mapping, as it yields larger lesions, and therefore might
Table 2 Reported arrhythmia pattern and duration (numbers) before
and after ablation as answered in the questionnaire
Cryoablation (N = 115) RF (N = 120)
Arrhythmia pattern Before After Before After
None 1 63 1 63
Sporadic 9 29 12 33
Monthly 40 15 43 12
Weekly 40 7 35 8
Daily 25 1 29 4
Arrhythmia duration Before After Before After
None 0 77 1 70
Seconds 2 18 3 23
Minutes 30 14 32 17
Hours 72 6 75 9
Days 11 0 9 1
The pattern and duration before and after ablation are different (p <
0.0001); no differences are observed after ablation between the two
treatment modalities
N number; RF radiofrequency ablation
Fig. 2 Reported arrhythmia pattern and duration in the questionnaire
(N = 235) after ablation (percentages) with cryoenergy (left) and RF
(right). There are no differences in both parameters for the two
approaches
Cryoablation RF ablation p value
Nr (final approach) 143 131
Application number (mean ± SD); median 2 ± 22 9 ± 86 <0.001
Ablation time (mean ± SD); s 522 ± 384 317 ± 621 <0.001
Fluoroscopy time (mean ± SD); min 19 ± 15 27 ± 22 <0.002
Procedural time (mean ± SD); min 146 ± 60 138 ± 71 NS
Acute success (nr) 138/143 126/131 NS
Temporary AVB (nr) 6 7 NS
Permanent AVB 0 2 NA
First procedure/Redo 132/11 114/17 NA
Table 1 Procedural data
(analysis including cross-overs)
Analysis taking into account all
patients as theywere finally treated
AVB atrioventricular block; NA
not applicable; nr number; NS
not significant; RF radiofre-
quency; SD standard deviation
58 J Interv Card Electrophysiol (2011) 30:55–61
Analysis taking into account all patients as they were finally treated. AVB: atrio-ventricular block; NA: 
not applicable; nr: nu ber; NS: not significant; RF: radiofrequency. SD: standard deviation
Acute complications
Thirteen patients had temporary AVB (6 cryo vs. 7 RF, including one cross-over patient; NS). 
Two patients had pericardial effusion needing acute intervention (both in the RF group).
Further, two patients in the RF group received a permanent PM because of third degree 
atrioventricular block with narrow QRS complexes, without recovery before discharge.
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long term follow-up data
After a mean follow up of 4.3 ± 2.5 years, 20 of the 246 patients (8%) treated for the first 
time in this series did undergo a redo ablation. The number of redo AVNRT procedures 
divided by the number of first procedures was not statistically different for both groups 
(14/132 for cryo vs. 6/114 for RF). During 3 redo procedures the arrhythmia proved to be a 
left sided concealed accessory pathway.
Questionnaire
The overall response rate to the questionnaire was 235/389 (61%). Of all patients respond-
ing to the questionnaire, 49% initially underwent cryo and 51% RF ablation (NS). There was 
only one patient from the cross-over group to RF , and she is included in the RF group.
Arrhythmia related symptoms were reported in 55/115 (47.8%) in the cryo group versus 
57/120 (47.5%) in the RF group (NS). Table II displays the distribution of the arrhythmia pat-
tern and the reported duration of the arrhythmias as reported in the questionnaire. Whereas 
the majority of the patients initially reported monthly or weekly occurrence of palpitations 
with a typical duration of hours, rather than minutes, this changed to no palpitations or 
sporadic occurrence, sometimes lasting only seconds after the procedure (figure 2). No dif-
ferences were seen between the groups. The perceived quality of life improved in 102/115 
patients (89%) in the cryo vs 106/120 (88%) in the RF group (NS) (Figure 3); 12/115 patients 
(10%) in the cryo vs 12/120 (10%) in the RF group (NS) observed no difference in their 
Table II. Reported arrhythmia pattern and duration (numbers) before and after ablation as answered in 
the questionnaire
patients reported a hospital readmission (Fig. 4). From the 35
arrhythmia-related admi ions, 19 (54%) were after cryo, 16
(46%) after RF (NS). Two patients were admitted for
elective cardioversion (atrial fibrillation). Five patients
received a device for arrhythmia management. The two late
ICD's were implanted after anterior myocardial infarction
and after development of heart failure in a patient with non-
ischemic cardiomyopathy. Neither conduction disease nor
arrhyth ias were recorded in these two patients. The three
late pacemaker indications were sinus no e diseas (one
from each gr up), and one second-degree AVB with
symptoms (RF group).
4 Discussion
The major finding of this study is that cryo and RF ablation
for AVNRT are equally effective techniques, also in the
long run. Cryoablation has a better safety profile.
4.1 Procedural efficacy
Both cryo and RF ablation are very successful techniques in
AVNRT ablation. Acute success was very high in previous
studies, and this is confirmed in our observations, which
were also achieved with a 4-mm catheter tip.[5–7] We
cannot completely explain the relatively high cross-over
rate, but we suspect that physician preference played a role
in this. Use of a 6-mm cryocatheter tip might improve the
success r te, co p red to a 4-mm tip, when applying on the
right spot, but also might diminish the potential of ice
mapping, as it yields larger lesions, and therefore might
able 2 Reported arrhythmia pattern and duration (numbers) before
and after ablat on as answered in the questionnaire
Cryoablation (N = 115) RF (N = 120)
Arrhythmia pattern Before After Before After
None 1 63 1 63
Sporadic 9 29 12 33
Monthly 40 15 43 12
Weekly 40 7 35 8
Daily 25 1 29 4
Arrhythmia duration Before After Before After
None 0 77 1 70
Seconds 2 18 3 23
Minutes 30 14 32 17
Hours 72 6 75 9
Days 11 0 9 1
The pattern and duration before and after ablation are different (p <
0.0001); no differences are observed after ablation between the two
treatment modalities
N number; RF radiofrequency ablation
Fig. 2 Reported arrhythmia pattern and duration in the questionnaire
(N = 235) after ablation (percentages) with cryoenergy (left) and RF
(right). There are no differences in both parameters for the two
approaches
Cryoablation RF ablation p value
Nr (final approach) 143 131
Application number (mean ± SD); median 2 ± 22 9 ± 86 <0.001
Ablation time (mean ± SD); s 522 ± 384 317 ± 621 <0.001
Fluoroscopy time (mean ± SD); min 19 ± 15 27 ± 22 <0.002
Procedural time (mean ± SD); min 146 ± 60 138 ± 71 NS
Acute success (nr) 138/143 126/131 NS
Temporary AVB (nr) 6 7 NS
Permanent AVB 0 2 NA
First procedure/Redo 132/11 114/17 NA
Table 1 Procedural data
(analysis including cross-overs)
Analysis taking into account all
patients as theywere finally treated
AVB atrioventricular block; NA
not applicable; nr number; NS
not significant; RF radiofre-
quency; SD standard deviation
58 J Interv Card Electrophysiol (2011) 30:55–61
The patter  and duration before and after ablation are different (p<0.0001); no differences are 
observed after ablation between the two treatment modalities. N: number; RF: radiofrequency 
ablation.
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Figure 3. Percentage of patients indicating an improvement, no difference or deterioration in 
their quality of life before and after the cryoablation (cryo) or radiofrequency (RF) ablation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Percentage of patients indicating an improvement, no difference or deterioration in their 
quality of life before and after the cryoablat on (cryo) or radiofrequency (RF) ablation.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Reported arrhythmia pattern and duration in the questionnaire (N=235) after 
ablation (percentages) with cryoenergy (left) and RF (right). There are no differences in both 
parameters for the two approaches. 
 
 
 
Figure 2. Reported arrhythmia pattern and duration in the questionnaire (N=235) after ablation 
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quality of life; only 1/115 in the cryo and 2/120 in the RF group (NS) indicated a deterioration 
in perceived quality of life.
From the 235 responses, 66 (28%) patients reported a hospital readmission (Figure 4). 
From the 35 arrhythmia related admissions 19 (54%) were after cryo, 16 (46%) after RF 
(NS). Two patients were admitted for elective cardioversion (atrial fibrillation). Five patients 
received a device for arrhythmia management. The 2 late ICD’s were implanted after anterior 
myocardial infarction and after development of heart failure in a patient with non-ischemic 
cardiomyopathy. No conduction disease, nor arrhythmias were recorded in these 2 patients.
The 3 late pacemaker indications were sinus node disease (one from each group), and one 
second degree AVB with symptoms (RF group).
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Figure 4. Hospital admissions according to the questionnaire. AVB, atrioventricular block; 
PM, pacemaker; SSS, sick sinus syndrome; ICD, implantable cardioverter defibrillator 
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dISCuSSIoN
The major finding of this study is that cryo and RF ablation for AVNRT are equally effective 
techniques, also in the long run. Cryoablation has a better safety profile.
Procedural efficacy
Both cryo and RF ablation are very successful techniques in AVNRT ablation. Acute success 
was very high in previous studies, and this is confirmed in our observations, which were also 
achieved with a 4 mm catheter tip.(5,6,7) We cannot completely explain the relatively high 
cross-over rate, but we suspect that physician preference played a role in this. Use of a 6 mm 
cryocatheter tip might improve the success rate, compared to a 4 mm tip, when applying on 
the right spot, but also might diminish the potential of ice mapping, as it yields larger lesions, 
and therefore might result in false positive conduction damage, so that no applications are 
given.(8-13)
The technique of RF ablation is well known: anatomical and electrical landmarks guide the 
procedure aimed to eliminate the slow pathway. The procedure is associated with some 
difficulties as the RF catheter tip moves during ablation due to changes in heart rhythm, 
respiratory movements and potential patient movements. For these reasons and also because 
of potential anatomic variations, damage to the fast pathway can occur in the triangle of 
Koch which is very small in comparison to a relatively large RF lesion. The need for careful 
imaging during RF ablation, which is not necessary during cryoablation, explains the shorter 
fluoroscopy time in our hands, confirming the data from other studies. (5,6,10)
Safety
The major potential advantage of cryoablation is its safety in preserving normal atrioventricu-
lar conduction. The ablation lesions formed by cryomapping probably always are reversible. 
Block during mapping at minus 30ºC, is a warning that no application should be given at this 
site.(4) However, even with short freezes at minus 75ºC on the compact AV node or on the 
His, the conduction seems to recover spontaneously almost always after waiting a short time. 
(8) With both the cryo and RF approach temporary heart block occurred in a similar amount. 
Further, we have seen unexpected temporary AVB occurring during real cryoablation, after 
cryomapping without blocking, but have never met inadvertent persisting heart block after 
such a procedure.(5) In contrast, in spite of a well trained group of electrophysiologists, we 
observed two times complete AVB requiring permanent pacing in the RF group, and detected 
one additional late conduction problem after RF.
Symptoms versus success
Although cryo and RF have very high acute and long-term success rates, a significant amount 
of patients still have some arrhythmia related complaints as shown by the questionnaire.
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Nevertheless, most patients indicate an improvement in quality of life after the ablation. It 
is well known that palpitations after AVNRT ablation often bear no relationship with the 
original arrhythmia: some patient complain of sinus tachycardia, atrial premature beats, 
ventricular premature beats or have an associated arrhythmia. (3,15) Moreover, after AVNRT 
ablation atrial flutter might become present, or ectopic atrial tachycardia may arise due to 
the scarring.(3) It also has to be said when interpreting these results that atrial or ventricular 
premature beats, which often initiate AVNRT, are not treated by ablation of the slow path-
way and may continue to provoke symptoms in both groups. An association with ventricular 
outflow tachycardia has been described, and is not uncommon. (16-18) Finally, it is known 
that in the long run, supraventricular tachycardia is associated with the development of atrial 
flutter or fibrillation. This indicates that judging the success of the AVNRT procedure merely 
by relying on symptoms is inefficient and can lead to incorrect conclusions. (15)
late recurrence
Our study suggests that cryo and RF have a similar early and late failure rate, as reflected 
by the amount of redo procedures, even after a mean follow-up of over more than 4 years. 
When cryo is used on an intelligent way (i.e. with conventional pacemapping at -30ºC), its 
success rate is equal to RF ablation in AVNRT (even when using a 4 mm tip). We always use 
pacing during cryomapping to prove that the AH-jump disappears, to see non-inducibility 
of AVNRT, or when cryomapping is performed during tachycardia, to witness termination of 
the AVNRT. Only after fulfilling at least one of the afore mentioned criteria we proceed to 
cryoablation.
limitations
The major limitation of this study is its retrospective design. However, the early results are in 
line with all former trials trying to compare cryo with RF in a randomized fashion, (including 
our own study) or in a retrospective way. (5-13) Further, the high cross over rate created 
a discrepancy between the number intended to be treated with one approach, and the 
number really treated with one or another approach. However, this minor shift in numbers 
was taken into account in the interpretation of the data, so that the finally used energy 
modality took the benefit and the disadvantage.
The value of the questionnaire can be debated, as no standardized instrument to measure 
quality of life was used, and as no questionnaire was taken before the ablation. (19) On the 
other hand, patients indicated a perception of a better quality of life, indicating that some 
positive change occurred in a large majority after the treatment.
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CoNCluSIoN
The overall success rate is very high and similar for both techniques. There is more need for 
fluoroscopy in the RF group, but procedures are equal in duration. There was no need to 
implant any pacemaker after cryoablation. Our data confirm that cryo and RF ablation for
AVNRT are equally efficient, even after long term follow up, but still are associated with a 
high hospital admission rate during follow-up.
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Cryoablation: how to improve results in 
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ABSTRACT
Ablation for atrioventricular nodal reentry tachycardia is very effective, with a potential 
for damage to the normal conduction system. Cryoablation is an alternative, as it allows 
cryomapping, which permits assessment of slow pathway elimination at innocent freezing 
temperatures, avoiding permanent damage to the normal conduction system. It is associated 
with shorter radiation times and the absence of heart block in all published data. We discuss 
in this overview different approaches of cryoenergy delivery (focusing on spot catheter abla-
tion), and how lesion formation is influenced by catheter tip size, application duration, and 
freezing rate. Some advantages of cryoenergy are explained. Whether these features also 
apply for an approach with a cryoballoon, e.g. for atrial fibrillation is unclear.
Key words: Arrhythmia, Atrial fibrillation, Atrioventricular nodal reentrant tachycardia, Cath-
eter ablation, Cryoenergy, Radiofrequency
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INTRoduCTIoN
In the past decade, a significant amount of basic and clinical research has been conducted 
regarding the use of cryoablation. The different clinical trials leave no doubt on the advanta-
geous safety profile of this ablation technique, with not a single permanent heart block 
reported till now for atrioventricular nodal reentrant tachycardia (AVNRT).1 – 4 This has lead 
to the use of cryoablation as the technique of choice in medical or health care environments 
where safety is the primary concern, e.g. in pediatric patients, or when ablation is performed 
close to normal conduction system.5 Still, some debate remains about the long-term efficacy 
of cryoablation. Table 1 shows the average success rate and the long-term outcome of stud-
ies analysing cryoablation versus radiofrequency (RF) in AVNRT. Acute success is similar, but 
it cannot be denied that slightly more recurrences are observed with cryotherapy.1,2,5 – 10 
However, it is possible that cryoablation procedures can be improved. Issues such as catheter 
tip size, application duration, and the temperature constant will be discussed in this paper. 
In Table 2, we show procedure and radiation times as reported by investigators, directly 
comparing cryoenergy, and RF, clearly demonstrating that less fluoroscopy is needed with 
AVNRT, with a similar procedure time as for RF.
Table 1 Acute procedural and long-term outcome data in studies comparing cryothermy vs. 
radiofrequency
At 1 month, the lesion is composed of dense fibrosis.14 In
summary, cryolesions are formed by consecutive freezing, inflam-
mation, and fibrosis, leading to tissue with intact extracellular
matrix. The advantage of preservation the endothelium is a
decreased risk of thromboembolism.11 A theoretical advantage
could be that cryolesions are less proarrhythmic as the lesion is
more homogeneous.
At this moment, cryoenergy is applied at the epicardium by sur-
geons and by spot, and balloon catheters by the cardiologist. It is
evident that these methods will result in different ways of lesion
formation. Most of what we will address in this review will be
based on data from spot catheters, as used for AVNRT.
Cryomapping
One of the major advantages of cryoablation is the possibility of
cryomapping, a feature which was initially introduced by
Dubuc.15 After cryoadhesion at 2308C, freezing is continued at
this temperature, to evaluate the clinical effect of the application,
and to proof that no collateral damage is present. Some authors
reported that temporary AV block may happen, even after such
cautious approach.16,17 Nevertheless, this should not lead to per-
sisting block. Even fast freezing till 2708C on the target site was
applied to perform cryomapping, and did not lead to permanent
block in the hand of other investigators.6 However, it has to be
pointed out that this ‘aggressive’ approach was associated with a
lower procedural success than for other groups, with substantially
more recurrences (Table 1). One of the reasons might be that
the ‘stunned’ area becomes larger, and that real (i.e. long-term)
success becomes more difficult to predict. More moderate
attempts, using 2408C resulted as well in local damage.18
Catheter tip size
Catheter tip size can be a very important determinant of pro-
cedural success. Nowadays, 4, 6, and 8 mm tip catheters are avail-
able. In everyday practice, the 4 and 6 mm tip catheters are used
most frequently for treating AVNRT, although the 8 mm tip cath-
eter can be very useful in other areas as ventricular tachycardia,
Wolff–Parkinson–White (WPW), and atrial flutter.19 The 4 and
6 mm tip catheters create a lesion size, which is smaller than the
lesions of the 8 mm tip.12 The difference seems to be mostly
dependent on the angle of the catheter tip in relation to the
surface.20 Moreover, when comparing the 4 and 6 mm tip cath-
eters in AVNRT in clinical practice (Table 3), there seems to be
a difference in efficacy in favour of the 6 mm tip catheters: acute
success is similar in both groups, but there is a higher recurrence
rate in the 4 mm tip group.21,22
Apart from the lesion size and depth, lesion quality or degree of
tissue damage created by cryoablation is influenced by the selected
catheter tip size and by the tissue contact reached during the abla-
tion, as shown in the recent experimental paper of Atienza et al.23
Application duration
It was shown in several experimental settings that lesion depth is
determined by the duration of freezing. During the first minute a
stable temperature gradient is reached, and a plateau phase is
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Table 1 Acute procedural and long-term outcome data in studies comparing cryothermy vs. radiofrequency
Authors Patient nr Acute success (%) Recurrences (%)
Cryo RF Cryo RF Cryo RF
Kimman et al.1 30 33 93 91 10 9
Zrenner et al.2 100 100 97 98 8 1
Gupta et al.6 71 71 85 97 19.8 5.6
Collins et al.5 57 60 95 100 8 2
Avari et al.7 38 42 97 95 2 2
Chan et al.8 80 80 97.5 95 9 1.3
Schwagten et al.9 144 130 97 95 7.5 6.5
Opel et al.10 123 149 83 93 11 3
Total 643 665 93 96 10 4.2
Cryo, cryothermy; RF, radiofrequency
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Comparison of procedural parameters in
studies using cryothermy vs. radiofrequency
Authors Procedure time
(min)
Fluoroscopy
time (min)
Cryo RF Cryo RF
Kimman et al.1 142,5 144 29 35
Zrenner et al.2 140 112 12 14
Gupta et al.6 96 90 17 13
Collins et al.5 146 112 20 21
Avari et al.7 176 174 19 21
Chan et al.8 150 159 19 26
Schwagten et al.9 149 152 22 29
Opel et al.10 90 90 16 14
Cryo, cryothermy; RF, radiofrequency.
Medians are in bold, italic; means are in a regular font.
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leSIoN FoRMATIoN
The creation of a permanent cryolesion is characterized by three phases: (i) the freeze/thaw 
phase, (ii) the haemorrhagic and inflammatory phase, and (iii) the replacement of this acute 
lesion by fibrosis.11 In the first phase, intracellular a d extracellular ice crystals are f rmed 
with variable size. Ice crystals formed more closely to the catheter tip are intra- nd extracel-
lular, in contrast to more peripheral ice crystals, which tend to appear only in the extracel-
lular space. During the thawing phase, mitochondria develop irreversible damage due to 
increased membrane permeability. These changes a e less marked towards the periphe y.12 
Bruno BW.indd   41 05-Jan-12   17:36:04 PM
42 Chapter 2
The second phase, occurring within the first 48 h, is characterized by the development of 
haemorrhage, oedema, and inflammation.12,13 After 1 week, a sharply demarcated lesion 
is formed.12 The final phase of lesion formation takes place within 2–4 weeks. At this time, 
the lesion consists of dense collagen and is infiltrated by fatty tissue. At its border many 
small blood vessels are found. At 1 month, the lesion is composed of dense fibrosis.14 In 
summary, cryolesions are formed by consecutive freezing, inflammation, and fibrosis, leading 
to tissue with intact extracellular matrix. The advantage of preservation the endothelium is 
a decreased risk of thromboembolism.11 A theoretical advantage could be that cryolesions 
are less proarrhythmic as the lesion is more homogeneous. At this moment, cryoenergy is 
applied at the epicardium by surgeons and by spot, and balloon catheters by the cardiologist. 
It is evident that these methods will result in different ways of lesion formation. Most of what 
we will address in this review will be based on data from spot catheters, as used for AVNRT.
CRyoMAPPING
One of the major advantages of cryoablation is the possibility of cryomapping, a feature 
which was initially introduced by Dubuc.15 After cryoadhesion at -30°C, freezing is contin-
ued at this temperature, to evaluate the clinical effect of the application, and to proof that no 
collateral damage is present. Some authors reported that temporary AV block may happen, 
even after such cautious approach.16,17 Nevertheless, this should not lead to persisting 
block. Even fast freezing till -70°C on the target site was applied to perform cryomapping, 
and did not lead to permanent block in the hand of other investigators.6 However, it has 
to be pointed out that this ‘aggressive’ approach was associated with a lower procedural 
Table 2 Comparison of procedural parameters in studies using cryothermy vs. radiofrequency
At 1 month, the lesion is composed of dense fibrosis.14 In
summary, cryolesions are formed by consecutive freezing, inflam-
mation, and fibrosis, leading to tissue with intact extracellular
matrix. The advantage of preservation the endothelium is a
decreased risk of thromboembolism.11 A theoretical advantage
could e that cryolesions are less proarrhythmic as the le ion is
more homogen ous.
At this moment, cryoenergy is applied at the epicardium by sur-
geons and by spot, and balloon catheters by the cardiologist. It is
evident that these methods will result in different ways of lesion
formation. Most of what we will address in this review will be
based on data from spot catheters, as used for AVNRT.
Cryomapping
One of the major advantages of cryoablation is the possibility of
cryomapping, a feature which was initially introduced by
Dubuc.15 After cryoadhesion at 2308C, freezing is continued at
this temperature, to evaluate the clinical effect of the application,
and to proof that no collateral damage is present. Some authors
reported that temporary AV block may happen, even after such
cautious approach.16,17 Nevertheless, this should not lead to per-
sisting block. Even fast freezing till 2708C on the target site was
applied to perform cryomapping, and did not lead to permanent
block in the hand of other investigators.6 However, it has to be
pointed out that this ‘aggressive’ approach was associated with a
lower procedural success than for other groups, with substantially
more recurrences (Table 1). One of the reasons might be that
the ‘stunned’ area becomes larger, and that real (i.e. long-term)
success becomes more difficult to predict. More moderate
attempts, using 2408C resulted as well in local damage.18
Catheter tip size
Catheter tip size can be a very important determinant of pro-
cedural success. Nowadays, 4, 6, and 8 mm tip catheters are avail-
able. In everyday practice, the 4 and 6 mm tip catheters are used
most frequently for treating AVNRT, although the 8 mm tip cath-
eter can be very useful in other areas as ventricular tachycardia,
Wolff–Parkinson–White (WPW), and atrial flutter.19 The 4 and
6 mm tip catheters create a lesion size, which is smaller than the
lesions of the 8 mm tip.12 The difference seems to be mostly
dependent on the angle of the catheter tip in relation to the
surface.20 Moreover, when comparing the 4 and 6 mm tip cath-
eters in AVNRT in clinical practice (Table 3), there seems to be
a difference in efficacy in favour of the 6 mm tip catheters: acute
success is similar in both groups, but there is a higher recurrence
rate in t e 4 mm tip group.21,22
Apart from the lesion size and depth, lesion quality or degree of
tissue damage created by cryoablation is influenced by the selected
catheter tip size and by the tissue contact reached during the abla-
tion, as shown in the recent experimental paper of Atienza et al.23
Application duration
It was shown in several experimental settings that lesion depth is
determined by the duration of freezing. During the first minute a
stable temperature gradient is reached, and a plateau phase is
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Table 1 Acute procedural and long-term outcome data in studies comparing cryothermy vs. radiofrequency
Authors Patient nr Acute success (%) Recurrences (%)
Cryo RF Cryo RF Cryo RF
Kimman et al.1 30 33 93 91 10 9
Zrenner et al.2 100 100 97 98 8 1
Gupta et al.6 71 71 85 97 19.8 5.6
Collins et al.5 57 60 95 100 8 2
Avari et al.7 38 42 97 95 2 2
Chan et al.8 80 80 97.5 95 9 1.3
Schwagten et al.9 144 130 97 95 7.5 6.5
Opel et al.10 123 149 83 93 11 3
Total 643 665 93 96 10 4.2
Cryo, cryothermy; RF, radiofrequency
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Table 2 Comparison of procedural parameters in
studies using cryothermy vs. r diofrequency
Authors Procedure time
(min)
Fluoroscopy
time (min)
Cryo RF Cryo RF
Kimman et al.1 142,5 144 29 35
Zrenner et al.2 140 112 12 14
Gupta et al.6 96 90 17 13
Collins et al.5 146 112 20 21
Avari et al.7 176 174 19 21
Chan et al.8 150 159 19 26
Schwagten et al.9 149 152 22 29
Opel et al.10 90 90 16 14
Cryo, cryothermy; RF, radiofrequency.
Medians are in bold, italic; means are in a regular font.
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success than for other groups, with substantially more recurrences (Table 1). One of the 
reasons might be that the ‘stunned’ area becomes larger, and that real (i.e. long-term) suc-
cess becomes more difficult to predict. More moderate attempts, using -40°C resulted as 
well in local damage.18
CATheTeR TIP SIze
Catheter tip size can be a very important determinant of procedural success. Nowadays, 4, 6, 
and 8 mm tip catheters are available. In everyday practice, the 4 and 6 mm tip catheters are 
used most frequently for treating AVNRT, although the 8 mm tip catheter can be very useful 
in other areas as ventricular tachycardia, Wolff–Parkinson–White (WPW), and atrial flutter.19 
The 4 and 6 mm tip catheters create a lesion size, which is smaller than the lesions of the 8 
mm tip.12 The difference seems to be mostly dependent on the angle of the catheter tip in 
relation to the surface.20 Moreover, when comparing the 4 and 6 mm tip catheters in AVNRT 
in clinical practice (Table 3), there seems to be a difference in efficacy in favor of the 6 mm 
tip catheters: acute success is similar in both groups, but there is a higher recurrence rate in 
the 4 mm tip group.21,22 Apart from the lesion size and depth, lesion quality or degree of 
tissue damage created by cryoablation is influenced by the selected catheter tip size and by 
the tissue contact reached during the ablation, as shown in the recent experimental paper 
of Atienza et al.23
Table 3 Comparison of procedural and outcome data in studies comparing 4 and 6 mm tips for slow 
pathway ablation
achieved at 5–6 min.11,13,21 This is reflected in most clinical set-
tings, where cryoenergy is applied for 4–5 min.
A recent experimental paper describing the electrophysiologic
and histologic changes in correlation to the duration of the cryoap-
plication using an 8 mm tip catheter on the compact AV node in pigs
showed that recovery of AV nodal functionwas less likely if the appli-
cation lasted longer.23 They observed that isolated viable cells sur-
rounded by necrotic tissue in the compact AV node were
associated with acute AV conduction recovery. Moreover, they wit-
nessed a variation in the degree of myolytic changes between the
animals with and without persistent AV block at 1 week.
Some suggestions have beenmade to improve lesion formation by
applying a double freezing cycle (freezing–thawing–freezing).24 First,
a freezing phase of 4 min is applied. Then the catheter rewarms and
immediately a new freezing cycle is performed at exactly the same
site for 2 min. Data in hepatocellular ablation show that repetitive
freeze–thaw cycles create larger lesions than those obtained by
longer freezing at a certain temperature.25 The rate and extentof con-
duction of the cold front increases with repetitive exposure, what
suggests a progressive increase in thermal conductivity of tissue.
Although poorly understood, this could be related to basic cellular
structure changes and/or modification of local microperfusion.26 So
far, no cardiovascular data exist to support the routine use of this
technique, which was tested in hepatic disorders.
Temperature time constant
Several suggestions have already beenmade to improve the quality of
the lesion. Fast freezing, with a steep decrease in temperature is
more effective than a slow progression to the target temperatures.27
It was demonstrated in a group of WPW patients that successful ice
mapping attempts were characterized by a short time-constant. This
parameter reflects the time interval between the onset of ice
mapping and the steady-state mapping temperature of 2308C.
Catheter adhesion
The formation of ice during ablation at the tip of the catheter
causes the catheter to adhere to the adjacent tissue
(cryoadherence). This allows pacing manoeuvres in the atrium
and the ventricle during ablation without the risk of catheter dis-
lodgement, what is very useful to show persistence or absence
of slow pathway conduction. Moreover, ablation can be performed
during tachycardia without a risk of dislodging the catheter when
normal rhythm is restored. Also, small patient movements and
even deep breaths do not affect ablation catheter position during
ablation. Unlike the ‘brush lesions’ formed by radiofrequency abla-
tion, cryoablation creates very focal lesions. This is similar to
lesions as described with magnetic navigation.28
Recurrence
It is not impossible that some of the recurrences are due to recon-
duction, a phenomenon which is well known in the pulmonary
veins, where reconnection is often detected, and almost always
when a patient is restudied because of recurrences.29 Asympto-
matic reconduction is also seen in a recent study on cryoablation
of the cavotricuspid isthmus in 23% of cases during restudy after
several weeks.30 This might be a reason to strictly adhere to
some observation time after ablation, and to ascertain that there
is no more slow pathway conduction after this time.
Conclusion
In conclusion, cryoablation is a safe and effective approach for
AVNRT, but care should be taken to use it in a way with full under-
standing of its possibilities and limitations, otherwise it could lead
to disappointing results.
This means that cryomapping should be performed to demon-
strate that the catheter is over the slow pathway, which is imposs-
ible with RF techniques. Further, application times should be long
enough to create full lesions. A 6 mm tip is probably better than
the 4 mm tip, which still may have a place in some pediatric indi-
cations. Energy sources should allow very fast freezing to
improve penetration of the cold in the tissue. Finally, waiting
times should be respected, as recovery within a short time may
indicate that more applications are necessary. In this way, cryoabla-
tion is an elegant technique, with few important side effects. The
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Comparison of procedural and outcome data in studies comparing 4 and 6 mm tips for slow pathway ablation
Authors Nr of cryoablation
patients
Study design Acute
success
Follow-up
(months)
Recurrences Temporary
AV block
(first, second,
third)
Complete,
permanent
AV block
De Sisti et al.17 8 (4 mm) SC, cohort, prospective,
4 and 6 mm
4/8 18a 4/4 NR (21/69) 0
61 (8 mm) 56/61 20/59 0
Sandilands et al.21 59 (4 mm) SC, cohort, prospective,
4 vs 6 mm
54/59 18a 12/54 NR (13/160) 0
101 (6 mm) 95/101 7/95 0
Rivard et al. (2007)31 152 (4 mm) SC, 2 cohort, retrospective,
4 vs 6 mm
139/152 6 22/139 6/152 0
137 (6 mm) 123/137 4.7 10/123 12/137 0
NR, not reported; SC, single centre.
aSubgroup not specified.
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APPlICATIoN duRATIoN
It was shown in several experimental settings that lesion depth is determined by the duration 
of freezing. During the first minute a stable temperature gradient is reached, and a plateau 
phase is chieved at 5–6 min.11, 3,21 This is reflected in most clinical settings, where cryoen-
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ergy is applied for 4–5 min. A recent experimental paper describing the electrophysiologic 
and histologic changes in correlation to the duration of the cryoapplication using an 8 mm tip 
catheter on the compact AV node in pigs showed that recovery of AV nodal function was less 
likely if the application lasted longer.23 They observed that isolated viable cells surrounded by 
necrotic tissue in the compact AV node were associated with acute AV conduction recovery. 
Moreover, they witnessed a variation in the degree of myolytic changes between the animals 
with and without persistent AV block at 1 week. Some suggestions have been made to 
improve lesion formation by applying a double freezing cycle (freezing–thawing–freezing).24 
First, a freezing phase of 4 min is applied. Then the catheter rewarms and immediately a 
new freezing cycle is performed at exactly the same site for 2 min. Data in hepatocellular 
ablation show that repetitive freeze–thaw cycles create larger lesions than those obtained by 
longer freezing at a certain temperature.25 The rate and extent of conduction of the cold 
front increases with repetitive exposure, what suggests a progressive increase in thermal 
conductivity of tissue. Although poorly understood, this could be related to basic cellular 
structure changes and/or modification of local microperfusion.26 So far, no cardiovascular 
data exist to support the routine use of this technique, which was tested in hepatic disorders.
TeMPeRATuRe TIMe CoNSTANT
Several suggestions have already been made to improve the quality of the lesion. Fast freez-
ing, with a steep decrease in temperature is more effective than a slow progression to the 
target temperatures.27 It was demonstrated in a group of WPW patients that successful ice 
mapping attempts were characterized by a short time-constant. This parameter reflects the 
time interval between the onset of ice mapping and the steady-state mapping temperature 
of -30°C.
CATheTeR AdheSIoN
The formation of ice during ablation at the tip of the catheter causes the catheter to adhere 
to the adjacent tissue(cryoadherence). This allows pacing manoeuvres in the atrium and 
the ventricle during ablation without the risk of catheter dislodgement, what is very useful 
to show persistence or absence of slow pathway conduction. Moreover, ablation can be 
performed during tachycardia without a risk of dislodging the catheter when normal rhythm 
is restored. Also, small patient movements and even deep breaths do not affect ablation 
catheter position during ablation. Unlike the ‘brush lesions’ formed by radiofrequency 
ablation, cryoablation creates very focal lesions. This is similar to lesions as described with 
magnetic navigation.28
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ReCuRReNCe
It is not impossible that some of the recurrences are due to reconduction, a phenomenon 
which is well known in the pulmonary veins, where reconnection is often detected, and 
almost always when a patient is restudied because of recurrences.29 Asymptomatic recon-
duction is also seen in a recent study on cryoablation of the cavotricuspid isthmus in 23% 
of cases during restudy after several weeks.30 This might be a reason to strictly adhere to 
some observation time after ablation, and to ascertain that there is no more slow pathway 
conduction after this time.
CoNCluSIoN
In conclusion, cryoablation is a safe and effective approach for AVNRT, but care should be 
taken to use it in a way with full understanding of its possibilities and limitations, otherwise 
it could lead to disappointing results. This means that cryomapping should be performed 
to demonstrate that the catheter is over the slow pathway, which is impossible with RF 
techniques. Further, application times should be long enough to create full lesions. A 6 mm 
tip is probably better than the 4 mm tip, which still may have a place in some pediatric indica-
tions. Energy sources should allow very fast freezing to improve penetration of the cold in the 
tissue. Finally, waiting times should be respected, as recovery within a short time may indicate 
that more applications are necessary. In this way, cryoablation is an elegant technique, with 
few important side effects. The complete absence of AV nodal conduction defects in AVNRT, 
should make it a strategy of first choice. The small excess number of patients requiring a sec-
ond approach makes the extra amount of radiation and catheterization related complications 
of a second procedure acceptable, due to the absence of the main RF related complication. 
Further studies should be undertaken to improve the long-term outcome, as the value of 
freeze–thaw–freeze cycles and different application times; more flexible catheters, e.g. steer-
able with robotics or magnetic navigation (and without pull wires) could make the procedure 
even more safe.
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Chapter 1
Pulmonary vein stenosis after pulmonary 
vein ablation catheter–guided pulmonary 
vein isolation
Yves De Greef, MD, Bruno Schwagten, MD, Gilles De Keulenaer, MD, PhD, Dirk 
Stockman, MD
Key words: Atrial fibrillation; Pulmonary vein ablation catheter; Pulmonary vein stenosis
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INTRoduCTIoN
We report the case of a patient with severe pulmonary vein (PV) stenosis of the left superior 
PV 5 months after PV isolation using a pulmonary vein ablation catheter (PVAC; Medtronic, 
Inc., Minneapolis, MN, USA).
CASe RePoRT
The patient was a 44-year-old man with highly symptomatic paroxysmal atrial fibrillation 
(AF). The paroxysms of AF had started 6 years earlier and initially had been treated with Class 
IC and Class III antiarrhythmic drugs. He was referred for invasive treatment due to persistent 
symptomatic AF paroxysms despite medical therapy and after he developed severe side ef-
fects of amiodarone treatment (photosensitivity and thyroid dysfunction). No evidence of 
underlying cardiac disease was noted. Left atrial (LA) diameter on transthoracic echocardio-
graphic parasternal long-axis view was 44 mm. Contrast-enhanced computed tomography 
(40 slices, Philips, Eindhoven, The Netherlands) was performed the day before ablation.
PV ABlATIoN PRoCeduRe
The ablation procedure was performed with the patient under general anesthesia. A 6Fr 
decapolar catheter was inserted in the coronary sinus for pacing purposes. Immediately prior 
to transseptal puncture, an intravenous loading dose of 10,000 international units of heparin 
was given. Target activated clotting time throughout the procedure was maintained above 
350 seconds. A 9.6Fr deflectable sheath (Channel sheath, Bard Electrophysiology, Lowell, 
MA) was positioned in the LA after a single transseptal puncture was performed using a 
modified Brockenbrough technique under transesophageal echocardiography, fluoroscopy, 
and pressure guidance. A multielectrode temperature probe (Esotherm Plus, Fiab, Florence, 
Italy) was used to monitor the luminal esophageal temperature and to delineate the ana-
tomic position of the esophagus throughout the procedure. Selective PV angiography was 
performed for each PV and was used as a “template” during the ablation to anatomically 
delineate the PV ostia. The ablation procedure consisted of PV isolation of each PV using the 
PVAC catheter. Prior to radiofrequency (RF) application, template bipolar electrograms and 
corresponding fluoroscopic PVAC positions were carefully annotated in the Bard acquisition 
system, during both sinus rhythm and coronary sinus pacing (Figure 1). The ostia of the PVs 
were sequentially targeted with RF energy at all or at selected electrode pairs (60°C, 4:1 or 
2:1, 60 seconds). Appropriate positioning of the PVAC catheter at the ostia was ensured by 
local electrogram interpretation and by comparing the position of the PVAC catheter with 
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the presumed LA–PV ostium seen on the selective PV angiogram. Between applications, 
remapping with the PVAC catheter at the same template position within the PV to check 
for PV isolation was repeatedly performed. Ablation was stopped when PV isolation was 
confirmed (Figure 1). The patterns of RF delivery for each PV are detailed in Table 1. Total 
procedure time was 180 minutes, with total RF time of 22 minutes.
inferior PV (Figure 2).1 The patient’s condition improved
significantly during treatment with antibiotics.
Maximal cardiorespiratory exercise test performed prior
to discharge showed slightly impaired VO2max (27 mL/kg/
min, 76% of predicted value), near-normal maximal oxygen
pulse (16.4 L/min, 80% of predicted value), and normal
breathing reserve at peak exercise (20%). Based on these
results, PV angioplasty and stenting were no perf rmed.
The patient is scheduled for a follow-up visit 1 month after
discharge. In addition to clinical evaluation, cardiorespira-
tory exercise test and transesophageal echocardiography
will be performed at that time. In case of persistent func-
tional impairment, recurrent pneumonia, and/or progressive
elevation of left superior PV peak flow velocities (with risk
for progression to total occlusion), PV angioplasty and
dilation will be planned.
Discussion
PV stenosis occurs in 1% to 3% of patients after catheter
ablation for AF.2,3 Although frequently asymptomatic, it
can be associated with severe respiratory symptoms.
Since the development of three-dimensional mapping
systems and the currently more extraostial ablation
strategies, the reported incidence of PV stenosis is de-
creasing.2,3 However, point-by-point catheter ablation
procedures still remain complex, eliciting the need for
“single-shot” devices to make AF ablation a more
straightforward procedure. The PVAC catheter, a multi-
el ctrode over-the wire catheter using duty-cycled bipo-
lar and unipolar nonirrigated RF energy, has recently
provided promising results. Boersma et al4 studied the
clinical outcome of PVAC ablation in patients with par-
oxysmal AF and found freedom from fibrillation (without
antiarrhythmic drugs) in 83% of patients after 6 months.
They found no evidence of PV stenosis on magnetic
resonance imaging or angiography performed during a
redo procedure in 11 patients.4
This is the first report of significant PV stenosis after
PVAC ablation, which can represent a potential serious
drawback of the technique. Due to its over-the wire design,
the PVAC catheter can easily be torqued in and out of the
PVs, inevitably harboring the tendency to again more
closely approach the PV ostium. This approach may in-
crease the risk for PV stenosis, especially when delineation
of the PV ostia by a single “template” selective PV angio-
gram is not sufficiently accurate. Furthermore, PVAC abla-
tion is performed in a circular fashion at multiple electrodes
simultaneously. A circumferential cicatrization close to the
Figure 1 Pulmonary vein ablation catheter (PVAC)–guided ablation of the left superior pulmonary vein (LSPV). The PVAC catheter is circumferentially
placed within the LSPV for mapping and validation of PV isolation (middle). A decapolar catheter positioned in the coronary sinus and a multielectrode
esophageal temperature probe also can be observed. A selective PV angiogram is shown in the inset. Surface ECG leads I and V1 and bipolar electrogram
recordings before and after PVAC-guided ablation of the distal coronary sinus CS) and the PVAC catheter positioned within the LSPV are shown (left and
right). At baseline, far-field (FF) and pulmonary vein potentials (PVP) can be clearly differentiated by distal CS pacing (left). After PVAC-guided ablation,
remapping with the PVAC catheter at the same template position revealed only residual far-field potentials, thus confirming PV isolation.
Table 1 Pattern of energy delivery with PVAC for each
pulmonary vein
PVAC energy modus 4:1 modus 2:1 modus
Left superior pulmonary vein 0 8
Left inferior pulmonary vein 0 3
Right superior pulmonary vein 3 2
Right inferior pulmonary vein 4 2
PVAC  pulmonary vein ablation catheter.
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Figure 1 Pulmonary vein ablation catheter (PVAC)–guided ablation of the left superior pulmonary 
vein (LSPV). The PVAC catheter is circumferentially placed within the LSPV for mapping and validation 
of PV isolation (middle). A decapolar catheter positioned in the coronary sinus and a multielectrode 
esophageal temperature probe also can be observed. A selective PV angiogram is shown in the inset. 
Surface ECG leads I and V1 and bipolar electrogram recordings before and after PVAC-guided ablation 
of the distal coronary sinus CS) and the PVAC catheter positioned within the LSPV are shown (left and 
right). At baseline, far-field (FF) and pulmonary vein potentials (PVP) can be clearly differentiated by 
distal CS pacing (left). After PVAC-guided ablation, remapping with the PVAC catheter at the same 
template position revealed only residual far-field potentials, thus confirming PV isolation.
Table 1 Pat er  of energy delivery with PVAC for each pulmonary vein
inferior PV (Figure 2).1 The patient’s condition improved
significantly during treatment with antibiotics.
Maximal cardiorespiratory exercise test performed prior
to discharge showed slightly impaired VO2max (27 mL/kg/
min, 76% of pr dicted v lue), near-normal maximal oxyge
pulse (16.4 L/min, 80% of predict d value), and ormal
breathing reserve at peak exercise (20%). Based on these
results, PV angioplasty and stenting were not performed.
The p ti nt is scheduled for a follow-up visit 1 month after
discharge. In addition to clinical evaluation, cardiorespira-
tory exercise t st and transesophageal echo rdiogr phy
will be p rformed at that time. In case of persist nt func-
tional impairm nt, recurrent pneumon a, and/or progressive
elevation of left superior PV peak flow velocities (with risk
for progression to total occlusion), PV angioplasty and
dilation will be planned.
Discussion
PV sten sis ccurs in 1% to 3% of patients after catheter
ablati n for AF.2,3 Although frequently asymptomatic, it
can be associated with severe respiratory symptoms.
Since the development of three-dimensional mapping
systems and the currently more extraostial ablation
strategies, the reported incidence of PV stenosis is de-
creasing.2,3 However, point-by-point catheter ablation
procedures still remain complex, eliciting the need for
“single-shot” devices to make AF ablation a more
straightforward procedure. The PVAC catheter, a multi-
electrode over-the wire catheter using duty-cycled bipo-
lar and unipolar nonirrigated RF energy, has recently
provided promising results. Boersma et al4 studied the
clinical outcome of PVAC ablation in patients with par-
oxysmal AF and found freedom from fibrillation (without
antiarrhythmic drugs) in 83% of patients after 6 months.
They found no evidence of PV stenosis on magnetic
resonance imaging or angiography performed during a
redo procedure in 11 patients.4
This is the first report of significant PV stenosis after
PVAC ablation, which can represent a potential serious
drawback of the technique. Due to its over-the wire design,
the PVAC catheter c n easily be torqued in and out of the
PVs, inevitably harboring the tendency to again more
closely approach the PV ostium. This approach may in-
cr ase the risk for PV tenosis, especially when delineation
of the PV ostia by a single “template” selective PV angio-
gram is not sufficiently accurate. Furthermore, PVAC abla-
tion is performed in a circular fashion at multiple electrodes
simultaneously. A circumferential cicatrization close to the
Figure 1 Pulmonary vein ablation catheter (PVAC)–guided ablation of the left superior pulmonary vein (LSPV). The PVAC catheter is circumferentially
placed within the LSPV for mapping and validation of PV isolation (middle). A decapolar catheter positioned in the coronary sinus and a multielectrode
esophageal temperature probe also can be observed. A selective PV angiogram is shown in the inset. Surface ECG leads I and V1 and bipolar electrogram
recordings before and after PVAC-guided ablation of the distal coronary sinus CS) and the PVAC catheter positioned within the LSPV are shown (left and
right). At baseline, far-field (FF) and pulmonary vein potentials (PVP) can be clearly differentiated by distal CS pacing (left). After PVAC-guided ablation,
remapping with the PVAC catheter at the same template position revealed only residual far-field potentials, thus confirming PV isolation.
Table 1 Pattern of energy delivery with PVAC for each
pulmonary vein
PVAC energy modus 4:1 modus 2:1 modus
Left superior pulmonary vein 0 8
Left inferior pulmonary vein 0 3
Right superior pulmonary vein 3 2
Right inferi r pulmonary vein 4 2
PVAC  pulmonary vein ablation catheter.
1307De Greef et al PV Stenosis After PV Ablation Catheter–Guided PV Isolation
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ClINICAl eVoluTIoN PoSTABlATIoN ANd dIAGNoSIS oF PV STeNoSIS
One month after the ablation procedure, the patient was free of AF paroxysms, with only 
residual symptomatic extrasystole recorded on 24-hour Holter monitoring. Treatment with 
antiarrhythmic drugs (except for beta-blockers) was interrupted, and a follow-up visit was 
scheduled for 6 months postablation. During the follow-up period, the patient developed 
progressive symptoms of exercise intolerance and fatigue. Five months after ablation, he was 
hospitalized with a 3-day history of pleuritic chest pain, shortness of breath, and fever. He 
was diagnosed with left lower and upper lobe pneumonia and severe secondary hypoxemia. 
Computed tomographic scan showed severely obstructed flow of contrast in the left superior 
PV with a “stop” image shortly postostially, suggesting severe PV stenosis. This diagnosis 
was confirmed by transesophageal echocardiography, which showed turbulent flow and 
high peak flow velocities (>2 m/s, normal 0.2 cm/s to 1 m/s) in the left superior PV (Figure 2). 
Normal laminar flow with low peak flow velocities was recorded in the left inferior PV (Figure 
2).1 The patient’s condition improved significantly during treatment with antibiotics.
Maximal cardiorespiratory exercise test performed prior to discharge showed slightly im-
paired VO2max (27 mL/kg/min, 76% of predicted value), near-normal maximal oxygen pulse 
(16.4 L/min, 80% of predicted value), and normal breathing reserve at peak exercise (>20%). 
PV ostium may lead to ostial PV stenosis during the sub-
sequent healing process.
Upon careful review of the bipolar electrograms re-
corded for this patient prior to each PVAC ablation of the
left superior PV, combined atrial far-field (circumferentially
present) and PV potentials were always observed. No single
application was performed on solitary local residual PV
electrograms without any far-field signals.
We believe, therefore, that all standard precautions to
prevent PV stenosis were taken. The most likely explana-
tions for PV stenosis in this patient are related to the meth-
odology-based inaccuracy of ostial delineation with sole
reliance on selective PV angiography and the high number
of RF applications to the left superior PV with dominant use
of a 2:1 ablation modus.
Of interest, the results reported by Boersma et al4 were
established by energy delivery in a 4:1 modus only. Recent
developments with the technique make energy applications
in a 2:1 modus possible with the theoretical advantage of
burning deeper lesions to enhance efficacy and limit the
total number of applications.
Limiting the total number and/or the number of 2:1
modus applications, avoiding ablations too close to the PV
ostium, and improved imaging modalities to accurately de-
lineate the PV ostia are potential ways to minimize the risk
of PV stenosis.
Conclusion
This case report underscores the need to better evaluate the
risk for PV stenosis after use of the PVAC catheter and to
compare the incidence of PV stenosis with that observed
after use of other RF ablation catheters.
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Figure 2 Transesophageal echocardiographic images of the left superior pulmonary vein (LSPV) (right) and left inferior pulmonary vein (LIPV) (left).
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Figure 2 Transes phageal echocardiographic images of the left superior pulmon ry v in (LSPV) (right) 
and left inferior pulmonary vein (LIPV) (left). Turbulent flow with high peak flow velocities (2 m/s, 
normal 0.2 cm/s to 1 m/s) is present in the LSPV compared to laminar flow with normal peak flow
velocities in the LIPV.
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Based on these results, PV angioplasty and stenting were not performed. The patient is 
scheduled for a follow-up visit 1 month after discharge. In addition to clinical evaluation, car-
diorespiratory exercise test and transesophageal echocardiography will be performed at that 
time. In case of persistent functional impairment, recurrent pneumonia, and/or progressive 
elevation of left superior PV peak flow velocities (with risk for progression to total occlusion), 
PV angioplasty and dilation will be planned.
dISCuSSIoN
PV stenosis occurs in 1% to 3% of patients after catheter ablation for AF.2,3 Although fre-
quently asymptomatic, it can be associated with severe respiratory symptoms. Since the de-
velopment of three-dimensional mapping systems and the currently more extraostial ablation 
strategies, the reported incidence of PV stenosis is decreasing. 2,3 However, point-by-point 
catheter ablation procedures still remain complex, eliciting the need for “single-shot” devices 
to make AF ablation a more straightforward procedure. The PVAC catheter, a multielectrode 
over-the wire catheter using duty-cycled bipolar and unipolar nonirrigated RF energy, has 
recently provided promising results. Boersma et al4 studied the clinical outcome of PVAC 
ablation in patients with paroxysmal AF and found freedom from fibrillation (without antiar-
rhythmic drugs) in 83% of patients after 6 months. They found no evidence of PV stenosis 
on magnetic resonance imaging or angiography performed during a redo procedure in 11 
patients.4 This is the first report of significant PV stenosis after PVAC ablation, which can 
represent a potential serious drawback of the technique. Due to its over-the wire design, the 
PVAC catheter can easily be torqued in and out of the PVs, inevitably harboring the tendency 
to again more closely approach the PV ostium. This approach may increase the risk for PV 
stenosis, especially when delineation of the PV ostia by a single “template” selective PV 
angiogram is not sufficiently accurate. Furthermore, PVAC ablation is performed in a circular 
fashion at multiple electrodes simultaneously. A circumferential cicatrization close to the PV 
ostium may lead to ostial PV stenosis during the subsequent healing process. Upon careful 
review of the bipolar electrograms recorded for this patient prior to each PVAC ablation of 
the left superior PV, combined atrial far-field circumferentially present) and PV potentials 
were always observed. No single application was performed on solitary local residual PV elec-
trograms without any far-field signals. We believe, therefore, that all standard precautions to 
prevent PV stenosis were taken. The most likely explanations for PV stenosis in this patient 
are related to the methodology-based inaccuracy of ostial delineation with sole reliance on 
selective PV angiography and the high number of RF applications to the left superior PV with 
dominant use of a 2:1 ablation modus.
Of interest, the results reported by Boersma et al4 were established by energy delivery in a 
4:1 modus only. Recent developments with the technique make energy applications in a 2:1 
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modus possible with the theoretical advantage of burning deeper lesions to enhance efficacy 
and limit the total number of applications. Limiting the total number and/or the number 
of 2:1 modus applications, avoiding ablations too close to the PV ostium, and improved 
imaging modalities to accurately delineate the PV ostia are potential ways to minimize the 
risk of PV stenosis.
CoNCluSIoN
This case report underscores the need to better evaluate the risk for PV stenosis after use of 
the PVAC catheter and to compare the incidence of PV stenosis with that observed after use 
of other RF ablation catheters.
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Cryoballoon ablation for paroxysmal atrial 
fibrillation: a comparison of two age groups
B. Schwagten, MD, P. Janse, RN, R. Bhagwandien, MD, N.M.S. de Groot, MD, 
PhD, T. Szili-Torok, MD, PhD, Y. Van Belle, MD, L. Jordaens, MD, PhD, FESC
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ABSTRACT
In elderly patients with atrial fibrillation (AF) the role of the substrate becomes more impor-
tant and it can be questioned whether pulmonary vein isolation is as efficient as in younger 
patients. We evaluated the safety, feasibility and success rate of a cryoballoon ablation in an 
elderly population, and compared it to the younger patients.
A series of 241 patients with a subgroup of 52 patients aged ≥ 65 years was therefore 
analysed. Procedure, fluoroscopy time and hospital stay were similar in the 2 groups. There 
was a similar serious adverse event rate (4,5%). However, vascular complications occurred 
more frequently in the elderly (15% versus 5%). If the patients under intubation and general 
anaesthesia were considered (74 of the total group), the higher age group had significantly 
more serious adverse events (SAE), vascular and other adverse events (AE). In the older 
patient group, AF burden was reduced in the first 3 months from 15% to 3%; the Holter at 
3 months showed AF in 11% as compared to 29% before the procedure. This was similar 
in both groups. AF free survival was similar for both groups with an event free survival of 
>60%, with only one procedure. After a mean follow-up of 884±414 days, a redo because 
of reconduction was performed in a similar number of patients in both groups (22%).
We conclude that the use of the cryoballoon is feasible in treating paroxysmal atrial fibrillation 
in elderly people, however special attention should be paid to possible vascular complications.
Key words: aging, anaesthesia, atrial fibrillation, complications, cryoablation, pulmonary vein 
isolation
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INTRoduCTIoN
The prevalence of atrial fibrillation (AF) is high in the elderly and increases with time.1 Pulmo-
nary vein isolation (PVI) has become a useful rhythm control strategy in patients with lone AF, 
and aims to address the triggers of this arrhythmia.2 In older patients, the substrate becomes 
more important, and it can be questioned whether PVI alone is sufficient, as in elderly 
patients the disease is often more advanced, with more dilation of the atria, and probably 
more fibrosis.3 Especially for older patients, who are prone to more vascular complications, a 
technique is needed that combines safety and an acceptable success rate.4 We evaluated the 
safety, feasibility and success rate of cryoablation with a double lumen cryoballoon, which 
is introduced through a quite thick venous sheath to treat paroxysmal or short-standing 
persistent AF in an elderly population, and compared it to the younger patients.
MeThodS
After exclusion of our initial study group, which served as learning curve, we studied all 
consecutive patients treated with a first PVI, done with a cryoballoon, between November 
1st, 2006 and December 1st 2010, with at least 3 months of follow-up till March 1st, 2011.5 
This resulted in a series of 241 patients, and allowed analysis of 52 patients aged ≥ 65 years, 
and 189 patients < 65 years (table 1).
Table 1. Demographics and procedure parameters
Total < 65 yrs ≥ 65 yrs P
Number of patients 241 189 52
Age (years) 56 ± 10 53 ± 9 69 ± 3 < 0,001
Male/Female 169/72 136/53 33/19 NS
Number transmitted events 124/218 (%) 95/172 (55%) 29/46 (63%) NS
Holter with AF (baseline) 86/228 (38%) 71/175 (41%) 15/52 (29%) 0,041
 Continuous AF 26/86 (30%) 21/71 (30%) 5/15 (33%) NS
Balloon size
 23 mm 18 (7%) 14 (7%) 4 (8%) NS
 28 mm 223 (93%) 175 (93%) 48 (92%) NS
Additional touch up 77 (32%) 64(34%) 13 (25%) NS
Simultaneous Cavotricuspid flutter ablation 46 (19%) 39 (21%) 7 (13%) NS
General Anesthaesia 72 57 (30%) 15 (29%) NS
Procedure time (min) 193 ± 64 192 ± 63 196 ± 67 NS
Fluoroscopy time (min) 46 ± 32 47 ± 34 44 ± 23 NS
Hospital stay (days) 3,98 ± 1,99 3,96 ± 2,08 4,02 ± 1,6 NS
 stay ≥ 4 days 111 (46%) 85 (45%) 26(50%) NS
AF: atrial fibrillation
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Procedure
Details of the procedure have already been described in a previous paper.5
data collection and definitions
The patients had a baseline ECG and 24-hour Holter recording, repeated at 3-months and 
at one year after the procedure. Whenever necessary, unsolicited ECG`s were taken. All 
patients underwent daily transtelephonic Holter monitoring during one month before the 
ablation and during 3 months after the ablation. The number of days an arrhythmic event 
was transmitted, in relation to all transmitted recordings was used to calculate the burden 
of AF, symptomatic AF and other events.6 Procedure duration, success rate, early and late 
recurrence of AF, fluoroscopy time and short and long term complications were prospectively 
registered. Vascular complications were groin haematomas, AV fistula and false aneurysms. 
All other potential procedure related complications (other adverse events – AE`s) were 
entered in a registry, and analysed by two of the authors, and kept for analysis when the 
relation to the procedure was possible, or when the hospital stay was prolonged. For hospital 
admission duration a partial day was considered as a day. Serious adverse events (SAE`s) were 
cardiac tamponade (requiring puncture or surgery), stroke, infarction, and cardiogenic shock.
Statistical methods
The Fisher exact test was used for the contingency tables. Non-parametric test were used 
when appropriate. SPSS was used for the Kaplan Meier survival curves. The Kaplan Meier 
curves were constructed for the total group and for both age groups, including all recurrence 
data obtained with all techniques, excluding the blanking period of 3 months, but included 
the 3 months Holter.
ReSulTS:
Inclusion
Demographics
The mean age of all patients was 56 ± 10 years, the majority was male. Demographic data 
are shown in table 1. Before ablation 124/218 patients transtelephonically transmitted AF, 
29/46 in the older group, and 95/172 in the younger group (figure 1). Median AF burden 
was 21% and similar in both groups (15% with IQR from 0-38% in the older, and 6% with 
IQR from 0-29% in the younger group). At baseline, 38% showed AF during the Holter, 
continuous in 39% of these.
AF was more often documented in the younger age group: 41% vs 29% in the older group 
(p=0.041).
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Procedure
Procedural data
These are shown in table 1. Intubation with general anaesthesia was performed in 72 (30%) 
of the patients, the same proportion for both age groups. PVI was achieved in all patients. A 
touch-up with a spot catheter was required in 77 patients (32%); simultaneous cavotricuspid 
isthmus ablation was performed in 46 patients (19%). This was similar for both groups. 
Total procedure time (193 ± 64 min for all) did not differ in both groups, neither did total 
fluoroscopy time (46 ± 32 min for all). The average admission duration in hospital was 3,98 
± 1,99 days, and was also similar in both groups. The admission duration is shown in detail 
Part 2 Chapter 2 
 
 
 
Figure 1. Percentage of patients showing AF at the base-line evaluation. Holter AF means 
paroxysmal, Holter CAF means continuous AF. TT: transtelephonic events. 
 
 
 
 
 
Figure 1. Percentage of patients showing AF at the bas -line val ation. Holter AF means paroxysmal, 
Holter CAF means continuous AF. TT: transtelephonic events.
 
Figure 2. Hospital admission duration in both age groups. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Hospital admission duration in both age groups.
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in figure 2, for both groups. A total number of 111 patients stayed ≥4 days in the hospital 
(similar for both groups).
Complications
The major and minor complications are shown in table 2. There was no incidence of stroke 
(CVA and TIA) in both groups; nobody died. There was one tamponade in the higher age 
group, and 6 in the other group (NS). There were 4 other SAE`s: 2 peri-procedural infarctions 
(one in each group, once due to air embolism, once as a complication of retroperitoneal 
bleeding leading to hypovolaemia). One other retroperitoneal bleeding, and one cardiogenic 
shock due to aggravated mitral dysfunction after balloon insertion in the left atrium were 
noted as well. All these events were resolved without sequelae.
Table 2. Complications
All < 65 yrs ≥ 65 yrs p
Number of patients 241 189 52
Stroke 0 0 0
Cardiac tamponade 7 6 1
Other SAE 4 2 2
Total SAE 11 (4,5%) 8 (4,2%) 3 (5,8%) NS
Haematoma (groin) 13 7 6
AV fistula/ Aneurysm 4 2 2
Vascular AE 17 (7%) 9 (4,8%) 8 (15%) 0,0138
Phrenic nerve paralysis (transient) 9 5 4
Other adverse events 8 5 3
Total other AE 17 (7%) 10 (5%) 7 (13%) 0,0002
AE: adverse events; SAE: serious adverse events
Vascular complications (17) happened more frequently in the older group, where groin prob-
lems were present in 15% (p<0,05). Other adverse events (17) included transient phrenic 
nerve paralysis (PNP), similar in both age groups, ST segment changes suggestive for ischemia 
(1), hemoptysis (3), cystitis (1), a general allergic reaction (1), pacemaker lead damage (1), 
and leg oedema due to thrombosis (1). When all these events were counted, the elderly 
group had more complications (p<0,0002).
Anesthesia
There was a tendency to longer hospital duration in the higher age group if intubation and 
general anaesthesia (GA) was used (p=0,052). Moreover, if the patients under intubation and 
GA were considered, the higher age group had more serious or vascular AE`s and other AE`s 
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(table 3). Similarily, a tendency towards more serious or vascular complications was present 
in the older group if anaesthesia was used (6/11 were under anaesthesia with intubation), 
while only 3/17 complications occurred in the younger under the same conditions (p=0,052).
Follow-up
Table 4 shows the follow up. The mean follow-up was 884 ± 414 days. Follow-up duration 
was shorter in the older group. Figure 3 shows a summary of the documented AF recurrences 
with the various follow up methods.
Table 4. Follow-up
< 65 yrs ≥ 65 yrs p
Number of patients 241 189 52
Duration (days) 884 ± 414 924 ± 441 741 ± 414 <0,01
Event recording
 Number transmitting AF (months 1-3) 109/215 (51%) 82/167 (49%) 27/48(56%) NS
 Number transmitting > 1 AF event (months 1-3) 84/215 (39%) 62/167 (37%) 22/48 (45%) 0,069
 Median burden (IQR) 1% (0-19) 0% (0-9) 3% (0-10) NS
Holter with AF (3 months) 20/201 (10%) 15/156 (9,6%) 5/45 (11%) NS
 Continous AF 4 4 0
Holter with AF (1 year) 16/155 13/119 (11%) 3/36 (8%) NS
 Continous AF 7 6 1
Unsolicited ECG`s
 Incidental recording < 90 days 36 27 (14%) 9 (17%) NS
 Incidental recording > 90 days 43 35 (18,5%) 8 (15%) NS
Clinical failure 69 58 (31%) 11 (21%) NS
Redo 52 45 (24%) 7 (13%) 0,043
AF: atrial fibrillation; IQR: interquartile range
Table 3. General anaesthesia with intubation
All < 65 yrs ≥ 65 yrs p
Number of patients 74 59 15
Hospital stay (days) 4 ± 1,61 4 ± 1,76 4 ± 0,85 NS
 stay ≥ 4 days 37(50%) 27 (46%) 11(73%) 0,052
Serious adverse / vascular events 8 (11%) 3 (5%) 6 (40%) 0,002
Other adverse events 7(9,5%) 3(5%) 4(27%) 0,028
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Event recording
A total number of 215 patients transmitted daily events in the first 3 months. In the elderly, 
27/48 transmitted AF, including 5 with only one episode; in the younger group, 82/167 
transmitted AF, including 20 with only one episode. There was a tendency to have more AF 
transmissions in the elderly. Over the first 3 months median AF burden was 1% (IQR 0-19) 
with no difference between both groups (3%, with IQR from 0-10% in the older, and 0% 
with IQR from 0-9% in the younger).
Holter recordings
After the ablation, at month 3, without any further intervention, the number of patients 
with AF was reduced to 20/200, still including 4 continuous patients. Both age groups had 
a similar incidence of AF on the Holter, which was done at an average of 91 ± 16 days after 
the ablation. A redo was performed in 33 patients after the first control Holter.
A second control Holter was performed in 155 of the patients without a redo at a mean of 
277±148 days after the procedure, with 16 showing AF (7 continuous).
AF on scheduled and unsolicited ECG`s – In the so-called blanking period of the first 3 
months, 42 patients (17%) showed AF on a 12 lead ECG (12 from the older, 30 of the 
younger group). This occurred as well in 52 patients after month 3 (21%), 10 in the older 
and 42 in the younger group. These proportions were not different.
Clinical failure and redo procedures
All data and the clinical judgement at follow up, including the advice of the referring cardi-
ologists determined whether clinical success was achieved after day 90. Clinical failure was 
 
 
 
Figure 3. Percentage of patients showing atrial fibrillation (AF) on the 3 months Holter, or at 
a 12 lead ECG after 3 months. Holter AF: all AF; CAF: continuous AF. 
 
 
 
 
Figure 3. Percentage of patients showing atrial fibrillation (AF) on the 3 months Holter, or at a 12 lead 
ECG after 3 months. Holter AF: all AF; CAF: continuous AF.
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considered to be present in 84 patients (35%): 15/52 patients in the older group (29%), and 
69/189 patients in the younger group (37%). This was not statistically different (p=0,079).
The Kaplan Meier curves (figure 4) were constructed for the total group and for both age 
groups. There was no significant difference in AF free survival. Redo procedures were per-
formed in 54 (23%) of all patients. This was in 2 young patients because of atrial tachycardia, 
without reconduction. Reconduction was observed in 2 other cases restudied for atrial tachy-
cardia and in 15 in whom the reason for the redo was atrial flutter. This implies that 52 cases 
underwent redo, with PV reconduction. This happened in 7/52 patients in the older (13%), 
and 45/189 patients in the younger group (24%). There were more redo procedures in the 
younger age group with documented reconduction (p=0,043).
dISCuSSIoN
The nice observation in this study is that the outcome in the elderly was similar as in the 
younger patients. The number of clinical failures even tended to be lower. There were less 
redo procedures scheduled in the patients above 65 years, but it is not clear whether this was 
biased because we were reluctant to offer them a redo.
 
 
 
Figure 4. Kaplan-Meier curve showing event (atrial fibrillation) free survival; at the right for 
both age groups. 
 
 
 
 
 
 
 
Figure 4. Kaplan-Meier curve showing event (atrial fibrillation) free survival; at the right for both age 
groups.
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However the high number of complications was impressive. While the general number was 
acceptable (4,5%), the total number in the older age group became too high with 5,8%. 
This was not as was shown in similar studies.7,8,9 Further the number of vascular events might 
have been due to the use of the thick sheath, and was also more prominent in the elderly. An 
excess of complications was observed when patients were treated under general anesthesia. 
This is not surprising, as patients who are awake can be very informative when complica-
tions should be prevented with insertion and positioning of catheters. Indeed regarding the 
latter, the opportunity of performing a PVI under conscious sedation is one of the possible 
advantages of this single shot ablation device. Except from the phrenic nerve stimulation to 
prevent phrenic nerve palsy, cryoablation is performed without any pain or discomfort for the 
mildly sedated patient, except maybe from the insertion of the catheters in the groin. Using 
a Doppler echo might be a way to facilitate to obtain vascular access and could even reduce 
vascular problems in the elderly.
Furthermore, not having any clinical stroke in this specific population of frail patients with a 
high risk of thromboembolic events can be considered as a major advantage for the cryobal-
loon technique. Unfortunately, no data on silent cerebral events were available.
A possible limitation for the interpretation of the results is that all procedures were performed 
by experienced Cryoballoon users.
CoNCluSIoNS
Our data suggest that the use of the cryoballoon is feasible in treating paroxysmal atrial 
fibrillation in elderly people. These data also suggest that more attention should be paid 
to avoidance of vascular complications if one decides to invasively treat elderly patients. 
Moreover, our data encourage the use of conscious sedation specifically when performing a 
PVI using the cryoballoon in older patients.
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INTRoduCTIoN
Pulmonary vein isolation (PVI) has established itself as a standard therapy for paroxysmal 
atrial fibrillation (AF) (1). Still, the most widely performed procedure of point-by-point dis-
taltip ablation using a 3D mapping system and a circular catheter to validate PVI, remains a 
complex, elaborative and time consuming procedure. This explains the many efforts being 
made over the recent years to simplify and shorten PVI procedures without compromising 
the efficacy nor the safety. The Cryoballoon (Ablation Frontiers, Medtronic, Inc., MN, USA) is 
a recently introduced ‘single shot ablation tool’ to facilitate PVI. Initial studies on efficacy and 
safety of this device are encouraging in patients with paroxysmal AF (2-4). However, several 
controversies remain such as the need for an additional circular mapping catheter to validate
PVI and the lack of on-line PV recording during freezes. One of the most recent develop-
ments in this field is the Achieve circular mapping catheter (Ablation Frontiers,
Medtronic, Inc., MN, USA). We describe an apparent case in which this tool is used in con-
junction with the cryo-balloon.
Key words: Atrial fibrillation; Cryoablation; Achieve; Pulmonary vein isolation; Catheter abla-
tion
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CASe deSCRIPTIoN
A 59-year old male was scheduled to undergo PVI at our center. He had been suffering 
from paroxysmal AF for over 2 years. The paroxysms of AF were becoming more frequent 
despite treatment with class Ic anti-arrhythmic drugs in combination with a low dose of beta-
blocking agent. There were no significant co-morbidities: patient did not suffer from arterial 
hypertension, there was no underlying structural or functional heart disease (ejection frac-
tion on echocardiography was 75%). Coronary angiography performed in 2008 showed no 
significant coronary atheromatosis. A recent blood sample showed normal thyroid function, 
normal blood count, normal renal function, no signs of infection and no other abnormalities.
The left atrial diameter measured 43mm (PS-LAX, Vivid 7, GE Healthcare, UK). Based on a 
3-D reconstruction of the left atrium using a CT scan of the heart after contrast injection, 
patient was selected to have a Cryoballoon procedure: the image of the left atrium showed 
four separate pulmonary veins without a common ostium.
ABlATIoN PRoCeduRe
The procedure was performed under general anaesthesia. Immediately prior to transseptal 
puncture, an intravenous loading dose of 10,000 international units of heparin was given.
Target activated clotting time throughout the procedure was maintained above 350 seconds.
The femoral vein was punctured twice: first a decapolar diagnostic catheter (Bard Elec-
trophysiology, Lowell, MA, USA) was introduced through the vein and was positioned in 
the coronary sinus, subsequently a single transseptal puncture was performed under TEE 
guidance using a transseptal needle (BKR1, St Jude Medical, MN, USA) and a 14 Fr steer-
able sheath (FlexCath, Ablation Frontiers, Medtronic, Inc., MN, USA). An angiogram was 
made of all four pulmonary veins and was stored into the system (Figure 1). The presence of 
pulmonary vein potentials before ablation was confirmed using a decapolar steerable and 
adjustable lasso catheter (Inquiry Optima, St Jude Medical, MN, USA) (Figure 1).
Additionally exit pacing using the lasso catheter was successfully performed from all pulmo-
nary veins.
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Figure 1. Selective positioning of the lasso catheter in the four pulmonary veins: LSPV (left superior pulmonary vein), LIPV 
(left inferior pulmonary vein), RSPV (right superior pulmonary vein) and RIPV (right inferior pulmonary vein). Together with 
the corresponding angiograms of the four pulmonary veins. All fluoroscopic images are taken in antero-posterior projection. 
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Figure 1. Selective positioning of the lasso catheter in the four pulmonary veins: LSPV (left superior 
pulmonary vein), LIPV (left inferior pulmonary vein), RSPV (right superior pulmonary vein) and RIPV 
(right inferior pulmonary vein). Together with the corresponding angiograms of the four pulmonary 
veins. All fluoroscopic i ages are taken in antero-posterior projection.
The AChIeVe CIRCulAR MAPPING CATheTeR
The Achieve circular mapping catheter was introduced through the Cryoballoon system. This 
wire is conceived to combine both the properties of a wire for positioning of the Cryoballoon 
at the antrum of the pulmonary veins and the possibility of continuously checking the pres-
ence of pulmonary vein potentials throughout the ablation (Figure 2).
Cryoablation was started in the left superior pulmonary vein. Since this vein had a relatively 
late branching, it was possible to position the Achieve circular mapping catheter in the body 
of the pulmonary vein before its division into side-branches (Figure 2). The Cryoballoon was 
inflated thus occluding the left superior pulmonary vein at its ostium and cryoablation was 
started. Distinct sharp pulmonary vein potentials from the left superior pulmonary vein were 
clearly visible on the Achieve circular mapping catheter at the start of cryoablation (Figure 
3). The temperature sensor on the proximal part of the Cryoballoon reached a minimal 
temperature of minus 45 degrees. During the first minute of cryoablation, the pulmonary 
vein potentials on the Achieve circular mapping catheter gradually delayed and eventually 
disappeared after 30 seconds (Figure 3). The cryoablation was continued for 300 seconds.
The pulmonary vein potentials did not reappear afterwards. A second cryoablation of 300 
seconds was carried out in the same pulmonary vein. Subsequently the Achieve circular 
mapping catheter was positioned in the left inferior pulmonary vein and large pulmonary 
vein potentials were registered. Again the Cryoballoon was inflated and complete occlusion 
of the inferior pulmonary vein was realized. Cryoablation was started and gradual delay and 
disappearance of the pulmonary vein signals was seen after 105 seconds. The ablation was 
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completed after 300 seconds and also in this vein a second cryoablation was performed. In 
both right pulmonary veins similar ablations were performed. During ablation in the right 
pulmonary veins, phrenic nerve stimulation was performed from the tip of decapolar diag-
nostic catheter (which was repositioned in the right atrium) to prevent occurrence of phrenic 
nerve paralysis. At the end of the procedure all four pulmonary veins were checked with the 
lasso catheter during sinus rhythm and during pacing from the distal coronary sinus catheter 
(Figure 3). Elimination of all pulmonary vein potentials was confirmed in all pulmonary veins. 
Additionally exit pacing was performed from all pulmonary veins. This showed exit block 
in all veins. Catheters were removed from the heart, sheaths extracted from the groin and 
the patient was awakened. No complications occurred during the procedure. The patient 
 
Figure 2. Selective positioning of the Cryoballoon over the Achieve circular 
mapping catheter in the four pulmonary veins while injecting contrast agent 
through the tip of the Cryoballoon: panel A: RSPV (right superior pulmonary 
vein), panel B: LSPV (left superior pulmonary vein), panel C: RIPV (right 
inferior pulmonary vein) and panel D: LIPV (left inferior pulmonary vein). 
Central image: the inflated Cryoballoon with the circular mapping end of the 
Achieve wire emerging fro  its tip. 
Page 9 of 10 PACE - manuscript for review
Figure 2. Selective positioning of the Cryoballoon over the Achieve circular mapping catheter in the 
four pulmonary veins while injecting contrast agent through the tip of the Cryoballoon: panel A: RSPV 
(right superior pulmonary vein), panel B: LSPV (left superior pulmonary vein), panel C: RIPV (right 
inferior pulmonary vein) and panel D: LIPV (left inferior pulmonary vein). Central image: the inflated 
Cryoballoon with the circular mapping end of the Achieve wire emerging from its tip.
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was discharged on the following day after a control echocardiography revealed no signs of 
pericardial fluid.
 
Figure 3. Panel A to F: Gradual delay and finally disappearance of pulmonary vein potentials (white arrow) on 
the Achieve circular mapping catheter in the LIPV (left inferior pulmonary vein) during the first 30 seconds of 
Cryoballoon ablation.  Panel G to J: Recordings on the lasso catheter in the LIPV before (panel G and H) and 
after (panel I and J) ablation, without (panel G and I) and with (panel H and J) pacing from the distal CS 
catheter. 
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Figure 3. Panel A to F: Gradual delay and finally disappearance of pulmonary vein potentials (white 
arrow) on the Achieve circular mapping catheter in the LIPV (left inferior pulmonary vein) during the 
first 30 seconds of Cryoballoon ablation. Panel G to J: Recordings on the lasso catheter in the LIPV 
before (panel G and H) a d after (pa el I and J) ablation, without (panel G and I) and with (panel H 
and J) pacing from the distal CS catheter.
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dISCuSSIoN
The Achieve circular mapping catheter seems to be a useful additional tool in PVI procedures 
using the Cryoballoon. Especially in pulmonary veins with late branching, delay and disap-
pearance of pulmonary vein potentials can be monitored during cryoablation. However, in 
pulmonary veins with early branching local pulmonary veins potentials are hard to monitor 
during ablation as the Achive wire is advanced into the branches of the veins by the relatively 
long tip of the Cryoballoon. If the findings on the Achieve circular mapping catheter prove 
to be consistent in randomized trials in comparison to the mapping capabilities of the lasso 
catheter, this could speed up procedures. Moreover it could make procedures safer as this 
could obviate the need for a second transseptal puncture or render the need for switch-
ing of the Cryoballoon for the lasso catheter superfluous. Another peculiar finding with 
the Achieve circular mapping catheter was the definitive disappearance of pulmonary vein 
potentials only 30 seconds after the start of the ablation in some pulmonary veins. This raises 
some questions about the need for continuing the ablation for 300 seconds, a duration 
which was based on experimental findings about cryoablation that show reaching of a stable 
temperature gradient during the first minute and a plateau phase at 5 to 6 minutes(5,6). Of 
course, this needs to be studied in large randomized trials before it can be put into practice.
CoNCluSIoN
In conclusion, this technique demonstrates the possibility of on-line PV recording with the 
Achieve circular mapping catheter during cryoablation. This allows physicians to assess the 
timing of PV disconnection during ablation and could potentially obviate the need for a 
diagnostic circular catheter. Therefore these advantages offered by the Achieve circular map-
ping catheter have the potential to change the way we nowadays use the Cryoballoon to 
isolate the pulmonary veins.
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Chapter 1
A randomized comparison of transseptal 
and transaortic approach in ablation 
of left-sided accessory pathways using 
magnetic navigation
Bruno Schwagten, MD, Luc Jordaens, PhD, Maximo Rivero-Ayerza, PhD, Yves Van 
Belle, MD, Paul Knops, MD, Andrew Thornton, PhD, Tamas Szili-Torok, PhD
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ABSTRACT
Objectives: Radiofrequency catheter ablation of left-sided accessory pathways (AP) can be 
performed either by transseptal (TS) or transaortic (TA) approach. When performed manually, 
these techniques were found to be equally effective. The aim of this prospective randomized 
study was to compare these approaches using the magnetic navigation system (MNS) (Niobe, 
Stereotaxis, St. Louis, MO, USA). Methods: Twenty-two consecutive patients were random-
ized to undergo ablation of a left-sided AP by either a TS or a TA approach. MNS was used 
in all patients for catheter navigation and eventual ablation, after standard electrophysiology 
study confirmed the presence of left-sided APs. Crossover was allowed after failure of the 
initial approach. Success rate, procedure, fluoroscopy and ablation times were compared. 
Results: 10/11 procedures (91%) were successful in the TS group. The patient crossed over to 
the TA approach remained unsuccessful. A successful elimination of the AP was obtained in 
9/11 (82%) of the TA procedures. Of the 2 patients who crossed over to a TS procedure in the 
same session, one was successful and one remained unsuccessful. Total procedure time did 
not differ in both groups (87,1 ± 30,8 vs 90,9 ± 26,5 min). When total procedure and patient 
fluoroscopy times were divided into electrophysiology study time, time to first application, 
to successful application and time to perform TS puncture or to retrogradely cross the aortic 
valve, only the last measurement differed significantly for both groups (p<0.01). Ablation 
times were comparable in both groups. No major complications occurred. Conclusions: Our 
data show that TS and TA approaches are equal in success rate and total procedure, patient 
fluoroscopy and ablation time when using the MNS for left sided AP ablation. However, 
crossing the aortic valve is faster than completing a transseptal puncture.
Key Words: Ablation, new technology, SVT/WPW
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INTRoduCTIoN
Radiofrequency (RF) catheter ablation remains the first line of therapy for patients with 
symptomatic Wolff-Parkinson-White (WPW) syndrome and for selected patients with asymp-
tomatic WPW syndrome.(1) Historically, the initial approach for catheter ablation of left sided 
accessory pathways (AP) used the retrograde, transaortic route.(2,3) The TS approach was 
later introduced for ablation with a high success rate and few complications. (4,5) However, 
surveys showed that AP ablation had a 2.1% complication rate both caused by the need 
for retrograde arterial left heart catheterisation and the transseptal puncture. (6) Results ob-
tained from previously published retrospective and nonrandomized papers comparing these 
two manual approaches showed that both techniques had a comparable efficacy. RF ablation 
using the magnetic navigation system (MNS) (Niobe, Stereotaxis, St. Louis, MO, USA) has 
showed several advantages compared to manual ablation in more complex arrhythmias.(7-8) 
This study is the first prospective randomized open-label trial comparing the TS and the TA 
approach for RF ablation of left sided AP using the MNS.
MeThodS
Patients
Twenty-two consecutive patients with WPW syndrome and pre-excitation on a rest ECG 
indicative of a left sided AP (9) were randomized to undergo RF ablation by either a TS or 
TA approach. MNS was used in all patients for catheter navigation and eventual ablation, 
after a standard electrophysiology study confirmed the presence of left-sided APs. Crossover 
was allowed after failure of the initial approach. Success rate, complications and procedure, 
fluoroscopy and ablation times were compared. All anti-arrhythmic drugs were discontinued 
for the duration of 5 half-lives. All patients signed informed consent.
Procedural information
In the TS group the right and left femoral vein were punctured. A decapolar coronary 
sinus catheter, a quadripolar right ventricular catheter and a quadripolar His catheter were 
introduced. Subsequently, an intracardiac echocardiographic catheter (ICE) was positioned 
in the right atrium to visualize the membranous part of the interatrial septum. A trans-
septal 8.5F sheath (SL1, St Jude Medical, Minneapolis, Minn) was inserted into the left 
atrium by means of a transseptal puncture or through a patent foramen ovale. Transseptal 
puncture was performed using fluoroscopic landmarks and ICE for guidance. As soon as 
echocardiographic contrast material appeared in the left atrium on ICE, successful trans-
septal puncture was confirmed. The transseptal sheath was then advanced and the dilator 
and needle were withdrawn. Finally the magnetic guided catheter (Celsius RMT 4mm, 
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Biosense-Webster, Diamond Bar, CA, USA) was positioned on the atrial side of the mitral 
annulus using the MNS.
In the TA group both the right femoral vein and artery were punctured. A decapolar coronary 
sinus catheter, a quadripolar right ventricular catheter and a quadripolar His catheter were 
introduced through the right femoral vein. Subsequently the magnetic guided catheter 
(Celsius RMT 4mm, Biosense-Webster, Diamond Bar, CA, USA) was introduced through the 
right femoral artery. Under fluoroscopic guidance the ablation catheter was advanced to the 
aortic root. With the aid of the MNS the magnetic vector was aimed at the apex of the left 
ventricle. The ablation catheter tip was advanced until the aortic valve was crossed. If it did 
not cross the aortic valve immediately, we further advanced the ablation catheter causing 
it to bend on the aortic valve, continuously making sure that the catheter tip did not enter 
a coronary artery. In the meantime the magnetic vector was changed to a position aiming 
in the complete opposite direction of the apex of the left ventricle. The catheter tip was 
then pointing in a cranial direction. We reduced the magnetic field and slowly retracted the 
ablation catheter a few centimeters causing it to drop into the left ventricle. If the ablation 
catheter still did not enter the left ventricle, the previous steps were repeated. After access to 
the left ventricle was achieved, the ablation catheter was positioned on the ventricular side 
of the mitral annulus using the MNS.
Magnetic navigation system
As previously described (10) the MNS consists of two permanent magnets situated on either 
side of the patient, which are computer-controlled via a workstation (Navigant, Stereotaxis, 
St. Louis, MO, USA) to allow for changes in the orientation of a stable magnetic field within 
the chest of the patient. A combined field strength of 0.08 Tesla is produced in navigation 
mode. As navigation is best performed with a fixed table position, this must be optimized prior 
to the start of magnetic navigation. When the magnets are positioned next to the patient, 
only limited angulation of the C-arm is possible (~28° in the right and left anterior oblique 
angulations with the magnets in the AP position and this can be increased by 15 degrees in 
either direction by tilting the magnets to either RAO or LAO). From the control room remote 
catheter advancement and retraction was performed using a catheter advancer system (Car-
diodriveTM, Stereotaxis, St. Louis, MO, USA), positioned on the high anterior thigh. Remote 
control of the fluoroscopy system was also performed from the control room. The mapping 
and ablation catheters are equipped with three small permanent magnets within the distal tip 
segment that align themselves with the direction of the externally controlled magnetic field, 
allowing effective catheter orientation. By changing the orientation of the outer magnets 
relative to each other, the orientation of the magnetic field changes and thereby leads to 
deflection of the catheter. After the magnets are brought in next to the patient, the physician 
is free to leave the room and performs the rest of the procedure from the control room. A 
nurse stays with the patient to monitor vital signs and administer drugs when required.
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Ablation
Radiofrequency catheter ablation was performed with the 4-mm, solid-tip, three-magnet 
ablation catheter (Celcius RMT 4mm, Biosense-Webster Inc, Diamond Bar, CA, USA) in a 
temperature controlled mode (maximum temperature 55°C, maximum duration 60 seconds, 
maximum 40 W) with the use of a Stockert (Biosense-Webster Inc, Diamond Bar, CA, USA) 
radiofrequency (RF) generator. The target site for ablation was identified using standard 
electrophysiologic techniques: early local ventricular activation relative to the onset of a delta 
wave on surface electrocardiogram, continuous atrioventricular activity and a possible AP po-
tential.(11,12) RF delivery was terminated within 10 seconds if conduction over the AP failed 
to block. If successful ablation of the accessory pathway was achieved, a waiting period 
of 30 minutes was initiated during which anterograde and retrograde accessory pathway 
conduction block was tested. If no reconduction occurred during this period, the procedure 
was considered successful. Antiarrhythmic drugs were discontinued and the patient received 
aspirin for a period of 4 weeks.
Statistical analysis
Continuous variables were expressed as mean ± standard deviation. The Student t test was 
used to compare the two groups for continuous variables. All tests were two-tailed. The level 
of significance was set at p < 0.05.
ReSulTS
Patient data
The patient group consisted of sixteen male and six female patients. Mean age was 42 ± 
17 years. Fourteen patients had proven tachycardia, six patients presented with atrial fibril-
lation and rapid ventricular response through the accessory pathway, one patient had a 
near syncope and one was asymptomatic but had a short refractory period of the accessory 
pathway during exercise testing. Fourteen patients had an overt delta wave on surface ECG. 
Pathway location according to conventional and anatomic terminology is given in table I and 
was as follows: 16 left lateral, three left posteroseptal, one left posterolateral and two left 
posterior accessory pathways. (13)
Procedure and ablation data
Half of the patients were randomized to the TS group and half to the TA group. Ten (91%) 
out of the 11 procedures were successful in the TS group. The failing one crossed over to the 
TA approach but remained unsuccessful. Of the 11 TA procedures, 9 (82%) resulted in a suc-
cessful elimination of the AP. Of the two patients who crossed over to a TS procedure in the 
same session, one was successful and one remained unsuccessful. Total procedure time did 
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not differ in both groups (87,1 ± 30,8 vs 90,9 ± 26,5 min). When total procedure time was 
divided into electrophysiology study time (26,5 ± 14,5 vs 20,8 ± 18,3 min), time to first ap-
plication (53,7 ± 18,3 vs 59,6 ± 18,2 min), time to successful application (76,7 ± 24,7 vs 78,1 
± 28,6 min) and time to perform transseptal puncture or time to retrogradely cross the aortic 
valve, only the last parameter differed significantly (23,8 ± 19,2 vs 4,4 ± 3,6 min, p<0.01) 
(Table II). Total fluoroscopy times did not show a statistical significant difference between the 
two groups (14,4 ± 4,7 vs 15,5 ± 9,4 min). When total fluoroscopy time was divided into 
electrophysiology study fluoroscopy time (3,9 ± 2,5 vs 4,6 ± 3,2 min), fluoroscopy time to 
first application (11,2 ± 7,3 vs 11,8 ± 4,0 min), fluoroscopy time to successful application 
(13,8 ± 8,2 vs 13,6 ± 4,6 min) and fluoroscopy time to perform transseptal puncture or time 
to retrogradely cross the aortic valve, again, only the last parameter differed significantly (9,8 
± 4,8 vs 3,9 ± 2,7 min, p<0.01). Ablation times were comparable in both groups: 192 ± 107 
Table I. Distribution of left sided pathway location according to the conventional and the anatomical 
terminology. Total number of pathways and number of pathways ablated by retrograde or transseptal 
approach.
Pathway location
Conventional 
terminology
Anatomical 
terminology
Number Retrograde approach Transseptal approach
Lateral Anterior 16 7 9
Posteroseptal Inferoparaseptal 3 2 1
Posterolateral Inferoposterior 1 0 1
Posterior Inferior 2 2 0
Table II. Comparison of fluoroscopy and procedural times in the retrograde and the transseptal 
approach. Time for EP study and time to go transseptal or to cross the aortic valve are absolute 
times, the time to first RF, to first successful RF, to final successful RF and total time are presented in a 
cumulative fashion.
Fluoroscopy time Procedural time
Retrograde 
approach
Transseptal 
approach
p Retrograde 
approach
Transseptal 
approach
p
Time for EP study 3.9 ± 2.5 4.6 ± 3.2 ns 26.5 ± 14.5 20.8 ± 18.3 ns
Time to go 
transseptal or to 
cross aortic valve
3.9 ± 2.7 9.8 ± 4.8 0.002 4.4 ± 3.6 23.8 ± 19.2 0.004
Time to first RF 11.2 ± 7.3 11.8 ± 4.0 ns 53.7 ± 18.3 59.6 ± 18.2 ns
Time to first 
successful RF
13.8 ± 8.2 13.6 ± 4.6 ns 74.5 ± 21.7 72.0 ± 16.5 ns
Time to final 
successful RF
13.8 ± 8.2 14.3 ± 4.7 ns 76.7 ± 24.7 78.1 ± 28.6 ns
Total time 15.5 ± 9.4 14.4 ± 4.7 ns 90.9 ± 26.5 87.1 ± 30.8 ns
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vs 163 ± 101 seconds. The median number of RF applications in the successful procedures 
was 4. Time to block of the accessory pathway did not differ significantly in both groups: 5.3 
± 4.6 vs 5.4 ± 4.3 seconds. No major complications occurred.
dISCuSSIoN
The aim of this study was to evaluate if the navigation capabilities of the MNS would alter 
our approach in catheter ablation of left sided accessory pathways. The major finding is that 
success rate is high in both groups and does not differ significantly. However, performing the 
transseptal puncture takes longer than retrogradely crossing the aortic valve and causes a 
higher radiation burden for patient and operator.
TA versus TS approach
Catheter ablation of left sided accessory pathways can be done either by a retrograde TA or 
a TS approach. When performed manually, both techniques seem to have a comparable effi-
cacy. On the other hand, different reports also showed some inconsistent findings regarding 
procedural and fluoroscopy time.(5,6,14,15) The most recently published randomized paper 
favoured the TS approach because of decreased procedural duration, radiation exposure 
and RF lesions.(16) However, nowadays some operators continue to prefer the TA approach 
because it is simpler and faster (17) and the TS approach is reserved only for patients who 
have a difficult arterial access or for cases in which the TA approach fails. One patient in this 
study failed in both the TA and TS approach using the magnetic navigation catheter. Figure 
1 depicts the fluoroscopic images and corresponding tracings. Despite optimal continuous 
atrial and ventricular electrograms , ablation was unsuccessful. An attempt using a manually 
steered RF catheter transseptally positioned on the mitral annulus also was not successful. 
Finally the accessory pathway was successfully ablated from the coronary sinus using a 
manually steered RF catheter. In terms of success rate, this randomized prospective trial 
did not show any difference between the two groups. Only three patients crossed over, 
one from the TS to the TA approach but remained unsuccessful, two from TA to TS: one 
of which remained unsuccessful. Very importantly, no complications occurred with either 
technique.
Radiation exposure
One of the key advantages of the MNS is the reduction in radiation exposure for the opera-
tor. (8,10) A major finding in our study was that performing the transseptal puncture was 
accompanied by a higher radiation burden for the patient and the operator compared to 
retrogradely crossing the aortic valve (Figure 2). In our experience with the MNS, crossing 
the aortic valve with the floppy magnetic catheter is fairly easy when using the correct series 
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of consecutive vector movements in combination with temporary reduction of the magnetic 
field strength.
However, total radiation exposure time did not differ significantly in both groups, meaning 
that the difficult positioning of the magnetic catheter in the TA approach discards the gain in 
radiation exposure. As we did not separately measured patient and operator exposure time, 
we can only assume that the physician was exposed to less radiation in TA procedures, being 
placed remotely during the manipulation of the catheter across the aortic valve.
A
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Figure 1. Upper panels: fluoroscopic views in LAO of the ablation catheter at the ablation spot. Panel 
A shows the magnetically navigated catheter (Celsius RMT 4 mm tip) that retrogradely crosses the 
aortic valve and is positioned on the mitral annulus (black arrow). A bipolar catheter was placed in de 
right ventricular apex and a decapolar catheter was positioned in de coronary sinus. Panel B shows an 
EPT Blazer 4mm tip catheter that crosses the interatrial septum and is positioned on the mitral annulus 
(white arrow). Lowers panels: ECG (I, aVF, V1) and intracardiac recordings (distal bipolar and unipolar, 
coronary sinus 1-2) during ventricular pacing directly before application of RF energy.
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Procedural time
Despite the time difference in performing the transseptal puncture and retrogradely crossing 
the aortic valve, total procedure time does not differ significantly in both approaches. Careful 
examination of the time required to perform the different steps in the ablation process shows 
that the time gained by the TA approach seems to be lost by more difficult catheter position-
ing (Figure 2). Even when using the MNS, acquiring a stable catheter position using the TA 
approach is a daunting task. Transseptal positioning times tended to be shorter.
Magnetic navigation system
Like all major technological innovations, installing a MNS comes with a significant cost. The 
MNS hardware, shielding of the electrophysiology lab and the use of specifically designed  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Comparison of fluoroscopy times (upper panel) and procedural 
times  (lower panel) of transseptal and transaortic approach (minutes). 
Cumulative times are presented. Subdivision are 1: time to perform 
electrophysiological study, 2: time to perform transseptal puncture or to 
retrogradely cross the aortic valve, 3: time to first radiofrequency 
application, 4: time to first successful radiofrequency application, 5: 
time to final successful radiofrequency application, 6: total time.  
 
Figure 2. Comparison of fluoroscopy times (upper panel) and procedural times (lower panel) of 
transseptal and transaortic a p oach (min tes). Cumulative times are prese ted. Sub ivision are 1: time 
to perform electrophysiological study, 2: time to perform transseptal puncture or to retrogradely cross 
the aortic valve, 3: time to first radiofrequency application, 4: time to first successful radiofrequency 
application, 5: time to final successful radiofrequency application, 6: total time.
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catheters are the major determinants of the procedural cost. Fortunately the MNS serves 
a broad area of applications, both in the electrophysiological field and in the coronary in-
terventional field. This favours the use of the MNS in high volume invasive centres from an 
economic point of view. However interesting, given the limited number of patients included 
in this trial, it is not possible to perform an analysis of the cost-effectiveness.
limitations
This prospective randomized trial consists of only 22 patients. This relative small number 
of patients does not allow us to perform extensive statistical analysis and also reduces the 
power of the study results. The results discussed in this paper serve as a pilot study, larger 
studies including more patients need to be conducted to confirm the results obtained in our 
study.
CoNCluSIoN
In conclusion, our data suggest that when the MNS is used to perform RF ablation of left 
sided APs the TS and TA approaches are equal in success rate, procedure, patient fluoroscopy 
and ablation time. However, crossing the aortic valve by the MNS is faster and requires 
less fluoroscopy. This has implications for physicians who were not trained for transseptal 
punctures.
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Remote magnetic navigation guided single 
catheter ablation of the slow pathway is 
feasible for the treatment of patients with 
slow-fast AVNRT
Bruno Schwagten MD, Luc Jordaens MD, PhD, FESC, Dominic A.J. Theuns, PhD, 
Marieke Takens, RN, Paul Musters, RN, Tamas Szili-Torok MD, PhD
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ABSTRACT
Background: Ablation of AVNRT is a highly effective procedure both with radiofrequency 
(RF) and cryoenergy. Conventionally, it requires insertion of several diagnostic catheters and 
hospital admission.
Objectives: To test a highly simplified approach using RF ablation with the remote magnetic 
navigation system (MNS) and to compare its safety and efficacy to cryoenergy and manual 
RF ablation.
Methods: in the magnetic navigation (MN) group a single MN quadripolar catheter inserted 
through the internal jugular vein was used to perform ablation. In the cryoenergy group 
(cryo) ablation was done after cryomapping. In the manual RF group (ManRF) ablation was 
done conventionally.
Results: Of 69 eligible patients, 26 patients were treated using MN, 25 with cryo, and 16 
with ManRF. Mean procedural time was 83 ± 25 min (MNS) vs 117 ± 47 (cryo), vs 117 ± 55 
(ManRF)(p<0.01). Physician radiation time was respectively 0.02 ± 0.07, vs 19 ± 17, and 22 
± 23 min (p<0.001). Patient radiation time was significantly reduced for MNS: 10 ± 7 min. 
The duration of applications was comparable for both RF groups: 357 ± 315 s (MNS) vs 266 
± 197 (ManRF). No major adverse events occurred. At 3 months, Holter recordings showed 
no recurrences, and similar PR intervals. During a mean follow-up of 26 ± 5 months, one 
recurrence occurred in each group.
Conclusions: MN guided single catheter approach is a feasible and safe technique in treating 
carefully selected patients with typical AVNRT.
Abbreviations:
AVNRT = atrioventricular nodal re-entry tachycardia
RF = Radiofrequency
MNS = Magnetic Navigation System
CS = Coronary Sinus
RV = Right Ventricle
AV = Atrioventricular
ERP = Effective Refractory Period
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INTRoduCTIoN
Catheter ablation is the preferred therapy for atrioventricular nodal re-entry tachycardia 
(AVNRT), the most common regular supraventricular tachycardia(1). Although it is a highly 
effective treatment modality, with success percentages varying between 95 and 99%,(2) (3) 
conventionally it still requires the insertion of multiple diagnostic catheters into the heart 
both when RF or cryoablation is used. (4) Multiple catheters theoretically augment the risk 
for complications such as venous thrombosis, and perforation of the myocardium. Using 
multiple catheters also is more costly. Venous catheterization using the femoral vein is associ-
ated with haematomas, atrioventriculair (AV) fistulas, pain, vagal reactions, and temporary 
immobilization. Therefore, this procedure is typically performed in the setting of an overnight 
hospital stay. These disadvantages are not addressed by using cryoablation, which in our 
hands is judged as an otherwise safe procedure. (5,6) In order to simplify the procedure, we 
developed an alternative approach involving the use of only one catheter to diagnose and 
treat the AVNRT.
With remote magnetic navigation (NIOBE® Magnetic Navigation System, Stereotaxis, Inc., 
Saint Louis, MO, USA)(MNS) it might be possible to perform an easy, single catheter proce-
dure, approaching the heart from the upper limb or a upper central vein, as a flexible and 
non-traumatic magnetic navigation catheter can be manoeuvred to all sites of interest.
We compared the safety and efficacy of this approach (MN group) to the use of conventional 
cryoablation (cryo) and standard manual RF (ManRF) ablation, in both groups using multiple 
diagnostic catheters. (7) So far, several studies have been conducted demonstrating the 
feasibility of the MNS in catheter ablation of AVNRT. (8,9) This is the first report that proves 
its feasibility and demonstrates further advantages of the MNS on conventional approaches.
MeThodS
We prospectively screened 100 consecutive patients with recurrent narrow QRS-complex 
tachycardia and kept 69 patients with a 12-lead ECG suggestive for AVNRT (Figure 1). 
Patients were enrolled for the MN, cryo or ManRF treatment if they fulfilled following ECG 
criteria: a documented small QRS tachycardia on surface ECG with retrograde P waves in 
the inferior leads no further than 100 milliseconds after the ending of the QRS complex. All 
antiarrhythmic drugs were discontinued for the duration of 5 half-lives. All patients agreed 
to have the single catheter procedure performed as an outpatient treatment or the cryoabla-
tion and ManRF ablation as a conventional treatment, and signed after informed consent a 
treatment agreement. They were assigned to a procedure type in function of the availability 
of the lab.
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In the cryo and the ManRF group a standard electrophysiological study was performed. One 
bipolar catheter, one decapolar and one quadripolar catheter were inserted into the right 
femoral vein and advanced to the right ventricular apex, coronary sinus and His bundle 
position, respectively. Detailed measurements were taken and cryo or ManRF ablation was 
performed if diagnosis of dual AV nodal pathways (AH-jump) and AVNRT was made on the 
basis of standard diagnostic criteria.(5)
For the MN group we introduced a single magnetic navigation quadripolar catheter (Celcius 
RMT 4mm, Biosense-Webster, Diamond Bar, CA, USA) through the internal jugular vein 
under local anaesthesia. This catheter was remotely manoeuvred using the MNS (Figure 2). 
The principles and use of the MNS have already been extensively described. (10) Initially, 
the catheter was introduced into the right atrium (Figure 3). Using vectors to manoeuvre 
towards the lateral wall, a right atrial lateral position was achieved. At this position the atrial 
signal amplitude should be large, and stimulation threshold low. Subsequently, an attempt 
was made to reach the His position. The catheter was placed into this His region providing 
ventricular capture on the distal electrode pairs with wide paced QRS duration, while on 
the proximal pole a clear atrial signal should still be visible. The position of the His bundle 
was tagged on the MNS in the LAO and RAO views, through the fluoroscopic annotation 
option. A yellow dot was continuously displayed on fluoroscopy indicating the His bundle in 
all incidences. Subsequently, the coronary sinus was cannulated using the navigation system. 
All the magnetic vectors of the above mentioned anatomical locations were stored in the 
system. This allowed quick re-navigation of the catheter to a selected position using the 
system’s target navigation option. Images of these positions were stored in two radiological 
views: right anterior oblique (RAO 30°) and left anterior oblique (LAO 30°). After registration 
of the important anatomical locations, programmed stimulation was performed. Incremental 
atrial and RV programmed stimulation and extra stimulus testing determined decremental 
conduction, the anterograde and retrograde effective refractory periods (ERP) of the AV node, 
as well as the Wenckebach point. RV and parahisian stimulation using the distal electrode 
pair at the His position and recording of an atrial signal on the proximal electrode pair was 
performed in order to exclude the presence of retrograde conducting parahisian accessory 
100 patients screened 
69 eligible based on ECG criteria
28 enrolled in single catheter 
procedure 
25 enrolled in cryoablation 
procedure 
2 inconsistent 
diagnostics 
26 underwent 
successful ablation 
25 underwent successful 
ablation 
16 enrolled in standard manual RF 
procedure 
1 unsuccessful 
procedure 
15 underwent 
successful ablation 
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Figure 1. Flow chart of the study design, with the enrolment. 
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Figure 2. Part of the interface of the magnetic navigation system, displaying vector navigation 
and the ability to store magnetic vectors. A cast of the right atrium is displayed in the upper 
right corner, and the yellow arrow indicates the direction of the imposed vector on the 
catheter tip in the RAO and LAO 30 degrees views.  
 
 
 
 
 
 
 
 
 
Figure 2. Part of the interface of the magnetic navigation system, displaying vector navigation and the 
ability to store magnetic vectors. A cast of the right atrium is displayed in the upper right corner, and 
the yellow arrow indicates the direction of the imposed vector on the catheter tip in the RAO and LAO 
30 degrees views.
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Figure 3. Fluoroscopic views (A) of the single catheter respectively in the high right atrium 
(LAO 30), coronary sinus (RAO 30) and His position (LAO 30). Corresponding electrograms 
during sinus rhythm (B) and during ongoing tachycardia (C). 
 
 
 
 
 
 
Figure 3. Fluoroscopic views (A) of the single catheter respectively in the high right atrium (LAO 30), 
coronary sinus (RAO 30) and His position (LAO 30). Corresponding electrograms during sinus rhythm 
(B) and during ongoing tachycardia (C).
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pathways. During pacing from the right atrium an A-QRS jump was searched. Diagnosis of 
dual AV nodal pathways was made on the basis of standard diagnostic criteria modified 
according to the single catheter approach. (11)
Subsequently we tried to induce sustained tachycardia. During ongoing tachycardia the 
catheter was re-navigated using the stored magnetic vectors to the His position, into the CS 
proximal and distal part and subsequently VA measurements were taken (Figure 3). The VA 
time should be less than 90 ms at all of these locations. Based on the findings of the EP study 
the diagnosis of AVNRT was made: if the ventricular and atrial signals appeared almost si-
multaneously and the shortest VA time was measured at the His position, diagnosis of typical 
slow-fast AVNRT with an anterior exit point was made. (11) If sustained tachycardia could not 
be induced, isoproterenol and, if necessary atropine were infused to facilitate tachycardia. 
If any of the above-mentioned tests were not consistent with the diagnosis of AVNRT, the 
procedure was converted into a standard EP study by inserting diagnostic catheters in the 
standard locations in the heart, and ablation was performed according to the diagnosis.
Ablation endpoints
For the 3 groups, the endpoint was non-inducibility of AVNRT. Inducibility of AVNRT was 
tested after each application, and if non-inducible, repeated after a 30 min waiting period.
RF ablation with the MNS
RF catheter ablation in the MN group was performed with the 4-mm, solid-tip, magnetic 
ablation catheter (Celcius RMT 4mm, Biosense-Webster Inc, Diamond Bar, CA, USA) in a 
temperature controlled mode (maximum temperature 55°C, maximum duration 60 seconds, 
maximum 40 W) with the use of a Stockert RF generator. The target was the slow pathway 
guided by a combination of intracardiac electrogram criteria and anatomical landmarks. 
(12) Catheter positioning and handling was performed using the MNS and fluoroscopy. The 
target position was labelled using a hollow white dot on the fluoroscopic images in the 
two aforementioned radiological planes, with also a full white dot on the His bundle as a 
reference (Figure 4). When changing the angle of the fluoroscopy, these markings on the 
fluoroscopy screen moved concordantly. The fluoroscopy image was set at LAO 30°, and the 
navigation started at the His position. The magnetic vector was changed in the same plane 
inferior from the His, providing safe distance from the His bundle. Movement of the catheter 
was continuously monitored and recorded. When an optimal balance of a small fractionated 
A and large V signals was seen (Figure 4), RF energy was applied starting at a low energy 
level. Each application was started with the power set at 10 W and, if AV conduction was 
preserved, the power was progressively increased to 40 W until a maximum of 55°C was 
reached or junctional rhythm appeared. Fluoroscopy was used throughout each application. 
Procedure time was measured from the moment of puncturing the jugular vein in the EP lab 
until the removal of the sheath from the jugular vein, including the 30 min waiting period.
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Cryoablation
Cryoablation was performed using a 4mm tip Freezor 3, catheter (Cryocath Technologies, 
Montreal, Canada) and a CCT2 CryoConsole (Cryocath Technologies, Montreal, Canada). 
Initially, ice mapping was performed by cooling to -30°C for a maximum of 60 s. If a potential 
successful site was identified cryoablation till -75°C was performed. (5)
Manual RF ablation
ManRF ablation was performed using an Alcath Gold FullCircle RF catheter (Biotronik Inc., 
Berlin, Germany) in a temperature controlled mode (maximum temperature 55°C, maximum 
duration 60 seconds, maximum 40 W) with the use of a Stockert RF generator. The target 
was the slow pathway guided by a combination of intracardiac electrogram criteria and 
anatomical landmarks. Catheter positioning was done manually. When an optimal balance 
of a small fractionated A and large V signals were seen and a stable catheter position was at-
tained, RF energy was applied, starting at 10 W. If AV conduction was preserved, the power 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Left side: fluoroscopic view of the ablation spot (LAO) with labeling of the His by a 
white dot. Right side: the corresponding electrogram during sinus rhythm (A), during 
radiofrequency application (B) and during junctional rhythm (C), at the end of the tracing.   
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Figure 4. Left side: fluoroscopic view of the ablation spot (LAO) with labeling of the His by a white 
dot. Right side: the corresponding electrogram during sinus rhythm (A), during radiofrequency 
application (B) and during junctional rhythm (C), at the end of the tracing.
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was progressively increased to 40 W until a maximum of 55°C was reached or junctional 
rhythm appeared. Fluoroscopy was used throughout each application.
Follow-up
Immediately after ablation all patients received a 24 hour Holter monitor. MNS patients were 
discharged on the same day of the procedure. The following day all patients were seen at the 
outpatient clinic and an electrocardiogram and transthoracic echocardiographic examination 
were performed. Three months after the procedure all patients received a new 24 hour 
Holter monitor, were examined at the outpatient clinic and asked about recurrent palpita-
tions. If longstanding palpitations occurred within the follow-up period, a 24 hour Holter 
monitor was performed and an effort was made to make an ECG at the time of complaints.
Statistical analysis
Continuous variables were expressed as mean ± standard deviation, if normally distributed, 
or otherwise by median. The Students t test or analysis of variance was used when appropri-
ate. A Chi-square test was used for categorical data. The level of significance was set at p < 
0.05. All statistics were performed using SPSS (16.0) for Windows (Chicago, Il, USA).
ReSulTS
Patient data
Of 100 patients screened 69 were found to be eligible based on documented ECG criteria. 
Two of the 28 patients enrolled for the single catheter MN approach were excluded due to 
inconsistent diagnostic results. Finally, 26 patients were ablated using the single catheter 
MN approach (Figure 1), 25 were treated using cryoenergy, and 16 with ManRF ablation 
(Table I). The mean age was similar in the 3 groups, with a female majority in the 3 groups. 
The mean number of total antiarrhythmic drugs used before the procedure was 1.0 ± 0.8 
and decreased to 0.2 ± 0.5 for the entire group after the procedure (p<0.001), with only 3, 
respectively 2 and 2 patients in the groups continuing anti-arrhythmic drugs.
Procedure and ablation data
A right sided jugular venous access was achieved in all but 3 patients, in whom the left 
subclavian vein was used. Details of the electrophysiology procedure are shown in Table II. 
The mean procedural time was significantly shorter for MN than for cryo (p=0.002) and for 
ManRF (p=0.008). The mean physician radiation time was 0.02 ± 0.07 min for MN vs 19 ± 
17 for cryo and 22 ± 23 for ManRF (both p<0.001). The mean patient radiation time was 
shorter for MN than for cryo (p=0.01) and ManRF (p=0.02). The mean patient radiation dose 
was 992 ± 759 μGym2 vs 1273 ± 999 (NS) and 958 ± 778 (NS). The median application 
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number in the 3 groups was respectively 9.5; 2 and 3.5. The mean duration of applications 
was comparable for MN and ManRF, while it was longer in the cryo group (p=0.008) .
RF delivery was interrupted in two, respectively one patient in the MNS group because of 
the appearance of first and second degree AV block. The conduction disturbances spontane-
ously resolved within 6 ± 5 minutes. A transient third degree AV block was seen in two 
patients during cryomapping which spontaneously resolved, after 8 seconds and 10 minutes 
respectively. Transient VA block was seen in two patients during application in the ManRF 
group. After interrupting the application, normal AV conduction was seen. Acute success 
was achieved in all patients, except for one in the ManRF group. No major adverse events 
occurred.
Table I. Patient characteristics
MN group Cryo group ManRF group
Number of patients 26 25 16
Male/female (n/n) 8/18 7/18 4/12
Mean age (years) 45 ± 10 51 ± 19 51 ± 15
Weight (kg) 78.8 ± 17.7 73.6 ± 14.9 69 ± 12
Length (m) 1.71 ± 0.10 1.64 ± 0.37 1.70 ± 0.10
Mean duration of symptoms (months) 166 ± 127 109 ± 108 78 ± 72
Mean symptoms/week (n) 1.8 ± 2.2 2.5 ± 2.5 1.8 ± 1.7
Mean number of AAD before procedure (n) 1.0 ± 0.4 0.8 ± 0.4 0.8 ± 0.5
Mean number of AAD after procedure (n) 0.2 ± 0.5 0.2 ± 0.5 0.2 ± 0.4
Number of patient taking AAD after procedure (n) 3 2 2
Underlying heart disease/hypertension (n) 3 4 2
Previous RF ablations (pts) 0 0 0
Table II. Electrophysiology study and ablation results
MN group Cryo group Man RF group
Anterograde jump (≥50ms) 15 (57%) 16 (64%) 12 (75%)
Slow-fast AVNRT 26 (100%) 25 (100%) 16 (100%)
CL tachycardia (ms) 339 ± 51 343 ± 58 344 ± 51
Median application number 8.5 2 3.5
Mean application duration (s) 357 ± 315 605 ± 322 266 ± 197
Occurrence of junctional rhythm 26 (100%) 0 (0%) 16 (100%)
Residual jump after ablation 1 (4%) 3 (12%) 1 (6%)
Non-inducibility 26 (100%) 25 (100%) 15 (94%)
Procedure time (min) 83 ± 25 117 ± 47 117 ± 55
Patient radiaton time (min) 10 ± 7 19 ± 16 22 ± 23
Patient numbers, with % between brackets
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Follow-up data
No major adverse events such as tamponade, high degree AV block or death were observed 
after the procedure. One patient suffered a haematoma in the neck which spontaneously 
resolved after a few weeks. The PR interval and the heart rates before and the day after the 
procedure are given in Table III. No differences were observed between groups, and between 
the two measurements in time.
Table III. Heart rate and PR intervals
MN group Cryo group Man RF group
Heart rate at baseline (bpm) 75 ± 12 70 ± 14 69 ± 11
PR at baseline (ms) 149 ± 25 143 ± 33 155 ± 25
Heart rate after 24 hour (bpm) 75 ± 13 71 ± 13 70 ± 9
PR after 24 hour (ms) 148 ± 25 149 ± 24 153 ± 18
Heart rate after 3 months (bpm) 75 ± 12 78 ± 13 74 ± 9
PR after 3 months (ms) 152 ± 26 142 ± 24 152 ± 27
The heart rates and PR intervals three months after procedure were also comparable. No 
patient had a PR ≥ 220 ms nor significant arrhythmias at the three month Holter.
Mean follow-up was 26 ± 5 months without further documented bradycardia or conduction 
disturbance. Twenty-five (96%) vs 24 (96%) and 14 (93%) patients remained asymptomatic. 
Three patients, one in each group had a recurrence. The patient in the MN group had docu-
mented small complex tachycardia more than 3 months after the index procedure, probably 
AVNRT, but symptoms were no longer disabling. The 2 other patients underwent a redo 
procedure.
dISCuSSIoN
The major finding of this study is that RF ablation for AVNRT using the MNS, with a single 
catheter proves to be feasible.
MNS in AVNRT
Although ablation treatment modalities for AVNRT are highly efficient, with success rates 
ranging up to 95%, a conventional procedure requires the insertion of several diagnostic 
catheters into the heart. (12) These procedures were initially associated with a significant ra-
diation exposure for both patient and investigator, (13) but in recent times radiation exposure 
dropped significantly. (14) This report supports the idea of using the different advantages of 
the advanced MNS technology to simplify and speed up RF ablation and reduce radiation 
exposure in a well-selected group of patients with AVNRT. (8,15)
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Safety
In experienced hands, the incidence of inadvertent high degree heart block is low, with RF 
and cryo. (6,16) Compared to an extremely safe technique such as cryoablation, the single 
catheter approach also did not result in creation of inadvertent heart block, while this was 
temporarily present during the applications, which were interrupted at that moment.
To enhance safety, the position of the His bundle was tagged on the MNS in the LAO and 
RAO views and by means of the fluoroscopic annotation option. This feature makes the 
presence of a His catheter redundant, but this can also be performed with other navigation 
or mapping systems. Catheter stability, precise navigation capabilities and tagging of the 
His on fluoroscopy all contribute to the safety of this procedure. We did not search for slow 
pathway potentials; this might have allowed to tag the slow pathway region as well. Even 
though we observed two transient first degree and one transient second degree heart blocks 
during RF application, no permanent block remained after the procedure. At late follow up, 
where a large variation of arrhythmias may be discovered after AVNRT ablation, no conduc-
tion disturbances were observed. (17)
Advantages of the MNS in the trigonum of Koch
The soft and flexible magnetic navigation catheter permits easy manipulation. The possibility 
of perforating the myocardial wall with the extremely floppy catheter tip is very unlikely. 
Precise target or vector navigation can be achieved with accuracy of up to 1mm or 1 degree. 
A long as the magnetic field is applied the catheter will remain at the desired location, 
irrespective of patients taking deep breaths or even during accelerated junctional rhythm. 
This characteristic of the MNS is particularly important when mapping and ablating in small 
regions such as the triangle of Koch and in direct proximity of the compact AV node and 
His bundle. Additionally, different locations can be stored in the MNS workstation and exact 
re-navigation is accomplished by reapplying these vectors. (18) This feature of the MNS al-
lows us to make the diagnosis of AVNRT quickly and with the use of one single catheter 
which is re-navigated to the right atrial lateral position, the His position and in the ostium 
of the CS. In this study overall procedure time was reduced by 52% to an average of 83 
minutes in comparison to previous reported results and with 29% to conventional RF in this 
study. (10) Patient radiation exposure was reduced by 55% to an average of 10 minutes in 
comparison to the group reported in the same paper, and with a similar amount compared 
to the conventional RF group. (10) In comparison to the cryoablation group overall procedure 
time and patient radiation exposure are also significantly reduced. The decrease in overall 
procedure time is mainly due to the possibility of immediate and precise re-navigation to 
pre-stored positions facilitating diagnostics and therapy. The decrease in radiation exposure 
is supported by recent papers. (19,20)
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Advantages of an upper limb or jugular access
The use of the jugular venous access literally allows the patient to walk in and out of the 
electrophysiology lab. A combination of the aforementioned advantages permits us to treat 
a much higher of patients with AVNRT in the same electrophysiology lab when compared to 
the conventional approach: all patients can be discharged on the day of the procedure. By 
using Doppler-echo techniques, it might have been possible to avoid the subclavian punc-
tures as well, making the overall advantage more clear.
limitations
A possible limitation to the current single catheter approach was the inconsistency in di-
agnostic findings in two patients, in whom a correct diagnosis was impossible with one 
catheter. Further, monitoring VA-conduction from the surface electrocardiograms was very 
difficult, and was potentially the reason of the short lasting block.
CoNCluSIoNS
In conclusion, compared to cryoablation and manual RF catheter navigation, the use of the 
MNS is safe and offers further advantages for ablation of the slow pathway since procedural 
times are shortened, physician’s radiation exposure is virtually zero and radiation exposure 
to the patient is lower. Moreover, this MN procedure can be safely done as an outpatient 
procedure. This is the first comparative study which shows real potential benefit of using the 
magnetic navigation system in AVNRT ablation. The present study also showed that in the 
large majority of patients suspected of AVNRT a complete, fast study can be done with a 
single catheter in this way.
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ABSTRACT
Introduction: Remote magnetic navigated ablation has proven its feasibility in a large group 
of arrhythmias. Until now only scarce data are available on the use for atrial flutter. In this 
study we compared remote magnetic navigation (RMN), using non-irrigated and irrigated tip 
catheters, to manual radiofrequency ablation for ablating typical atrial flutter.
Methods: The 3 study groups consisted of 17 patients treated with RMN 8 mm tip; 14 pa-
tients with RMN irrigated tip; and 24 patients with a manual 8 mm tip. The primary outcome 
was the number of patients in whom bidirectional isthmus block could be obtained with 
≤15 applications. Secondary endpoints were the median number of applications needed, 
the need to switch to a manual irrigated tip catheter, the procedural and fluoroscopy times.
Results: There was no significant difference in the primary endpoint (RMN 8 mm tip group: 
59%, RMN irrigated tip group: 64% and manual group: 83%). The median number of 
applications needed to obtain block was higher in the RMN groups compared to the manual 
group. In 5 patients from the RMN 8 mm tip group, 1 in the RMN irrigated tip group and 1 in 
the manual group, a switch to a manually irrigated tip catheter was performed. There was no 
difference in fluoroscopy time, but procedural time was significant longer in the RMN groups 
compared to the manual group (p=0.03).
Conclusions: The use of magnetic navigation for the ablation of atrial flutter is feasible but 
not superior to a manual approach. There was no difference concerning the primary end-
point of acute success within 15 applications. Overall, more applications were needed and 
procedure times were longer with RMN, however RMN with the irrigating tip is promising.
Keywords: Atrial flutter; remote magnetic navigation; radiofrequency ablation; cavotricuspid 
isthmus
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INTRoduCTIoN
Radiofrequency catheter ablation of the isthmus between the tricuspid annulus and the 
inferior vena cava has become a first-line treatment for patients suffering from recurrent 
atrial flutter 1. Since the introduction of the concept of bidirectional block over the isthmus, 
this method has evolved into a highly effective procedure. New treatment strategies are 
being developed with as major goals to further improve efficiency, efficacy and safety of this 
procedure.
Remote magnetic navigation (RMN) has proven its feasibility in a large group of arrhythmias 
such as atrial fibrillation 2, AV-node re-entry tachycardia 3, congenital heart disease 4 and 
ventricular tachycardia 5. The advantages of RMN are the very precise and accurate naviga-
tion possibilities, the reduced radiation exposure for the operator. The soft catheter makes 
cardiac perforation unlikely. The most often used catheter types, the 8 mm tip and the 
irrigated tip, are also available for RMN.
Nowadays, different strategies to ablate the cavotricuspid isthmus exist: some prefer to drag 
the ablation catheter while ablating; others use a point-by-point approach. Recently a third 
method has been described guided by the maximum voltage over the isthmus, based on the 
pathological observation that the cavotricuspid isthmus is composed of distinct muscular 
bundles, responsible for the electrical conduction 6. The maximum voltage technique aims 
to target only these muscular – electrical conducting – bundles and not the interlaying – non-
conducting - connective tissue. This is achieved by sequentially ablating the highest voltages 
on the isthmus till bidirectional block is reached. This technique was assessed during coronary 
sinus pacing, sinus rhythm and during atrial flutter and proven to be a feasible method 7. 
This technique reduced the number of ablation lesions, the fluoroscopy and the procedure 
times needed to achieve bidirectional isthmus block. The primary aim of this project was to 
assess the feasibility and efficacy of the use of RMN (Stereotaxis, Niobe) in conjunction with 
the maximum voltage technique for ablating the cavotricuspid isthmus. We compared both 
the 8 mm remote magnetic navigated catheter, the irrigated remote magnetic navigated 
catheter with a manual approach using an 8 mm tip catheter.
MeThodS
Patient characteristics
Between May 2007 and March 2010, 55 patients were included in this registry. Only patients 
with a first procedure were included. We excluded patients with congenital heart disease and 
heart transplantation. In total, 31 patients were treated with the aid of RMN: 17 with an 8 
mm tip catheter, and 14 patients with an irrigated tip. The other 24 patients were treated 
with a manual 8 mm tip catheter. The choice whether a patient was treated with RMN or 
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with a manual approach was based on the availability of the RMN room. We started the RMN 
irrigated tip instead of the RMN 8 mm catheter from November 2008 on.
Ablation procedure
The procedures were performed in fasting state, under local anesthesia and light sedation 
with diazepam. Analgesia was given with IV fentanyl. A 20-pole catheter (Inquiry H, Boston 
Scientific) was advanced into the right atrium and positioned around the tricuspid annulus; 
a decapolar catheter (Polaris, Boston Scientific) was positioned in the coronary sinus. All 
patients were ablated while pacing the os of the coronary sinus. All procedures were carried 
out by a junior and senior electrophysiologist. Procedural times were measured from the 
puncture till 30 minutes after the last applications.
Manual group
Ablation in the conventional group was performed with an 8 mm Blazer catheter (Boston 
Scientific, Inc.). The isthmus between the tricuspid valve and the vena cava inferior was 
carefully mapped and the highest peak-to peak bipolar atrial electrograms were searched 
for. Ablation was first directed to the highest potential. If the ablation lesion did not result in 
bidirectional block, the next largest atrial electrogram was subsequently targeted for ablation 
until bidirectional block was present. Catheter settings were 60 s, 60 W, 60ºC. We used 
standard pacing maneuvers to verify bidirectional block. If bidirectional block could not be 
achieved within 15 applications a switch to a cooled-tip catheter was allowed (Thermocool, 
Biosense Webster, settings: 60 s, 35 W, 48ºC, cooling 20 ml/min).
RMN 8 mm tip group
All patients in the magnet group were ablated with the Navistar DS 8 mm catheter (Biosense 
Webster). The cavotricuspid isthmus was mapped with the aid of RMN (Stereotaxis, Niobe) 
and an electro-anatomical mapping system (CARTO, Biosense Webster). This was not used 
for activation mapping, but to tag the ablation line: the highest peak-topeak bipolar elec-
trograms were indicated on the map. Ablation was first directed to the highest potential 
on this map. If the ablation lesion did not result in bidirectional block, the next largest atrial 
electrogram was subsequently targeted for ablation until bidirectional block was present. The 
magnetic navigation system was used to store the vectors into the system which allowed us 
to easily redirect the magnet catheter to the highest atrial electrogram, after the map of the 
cavotricuspid isthmus was made. The settings of the ablation were 60 s, 60 W, 50ºC. If we 
did not succeed in reaching bidirectional block within 15 applications; a switch to a manual 
guided cooled-tip catheter was allowed (Thermocool, Biosense Webster, settings cfr supra).
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RMN irrigated tip group
The same protocol was used as for the RMN 8 mm tip group, but with a Thermocool (Bio-
sense Webster) with 60 s, 55 W, 48ºC., 20 ml cooling.
Endpoints
The primary endpoint was defined as the presence of bidirectional block within 15 applica-
tions. Secondary endpoints were the median number of applications needed to obtain acute 
success, the ablation time, procedural time, fluoroscopy time.
Statistical analysis
Continuous, normally distributed, variables were compared with the ANOVA test and as 
post-hoc test the Fisher exact test. Continuous, not normally distributed variables were 
compared with the non-parametric Kruskal Wallis test. Not normally distributed variables 
are present as median ± interquartile range. A p-value of <0.05 was considered statistically 
significant.
ReSulTS
Patient characteristics
The mean age of the patients was 59 ±10 years [range 25-84 years] and 27% was female. 
Thirty-six percent suffered from AF and 18% from hypertension. Five patients had valvular 
heart disease, 3 patients a pacemaker before ablation, 4 had known ischemic heart disease, 
one patient peripheral vascular disease and 2 patients had a history of transient ischemic 
attack.
Procedural parameters
There was no difference between the different groups concerning the primary endpoint. 
The proportion of patients who could successfully be treated within 15 applications was 
59% for the RMN 8 mm tip group, 64% for the RMN irrigated tip group and 83% for the 
manual group (p=0.19). Patients treated in the magnet group (both 8 mm and irrigated tip) 
needed overall significant more applications to obtain bidirectional block compared to the 
conventional group. The median number of applications was 10 in the RMN 8 mm tip group, 
13 in the RMN irrigated tip group and 8 in the manual group (p=0.03) (Fig. 1). The median 
application time was 570 seconds (RMN 8 mm tip group), 692 seconds (RMN irrigated tip 
group) and 465 seconds (manual group) (p=0.03). Five or less applications were needed in 
12% of the patients in the RMN 8 mm tip group, 7% in the RMN irrigated tip group versus 
17% in the conventional group (p=0.69). In 5 patients from the RMN 8 mm tip group (29%), 
the magnet catheter was switched to a conventional guided cooled-tip catheter. In 2 patients 
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bidirectional block could be achieved after 1 extra application; in another 2 patients after 4 
and 15 extra applications with the cooled-tip catheter, while in 1 patient we could not create 
bidirectional block at all. In 1 patient of the RMN irrigated tip group (8%) there was a switch 
to a conventional irrigated tip catheter. In this patient, 3 extra applications were needed to 
obtain complete isthmus block. In the manual group there was also 1 patient which was 
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Figure 1. Box-plot of the total number of applications needed to achieve bidirectional 
cavotricuspid isthmus block. 
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Figure 2. Graph depicting the percentage of patients in whom bidirectional block could be 
achieved with ≤15 applications, > 15 applications, and after a switch to a manual navigated 
cooled-tip catheter and were no bidirectional block could be obtained. 
 
 
 
 
 
Figure 2. Graph depicting the percentage of patients in whom bidirectional block could be
achieved with ≤15 applications, > 15 applications, and after a switch to a manual navigated
cooled-tip catheter and were no bidirectional block could be obtained.
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switched to an irrigated tip catheter (4%). In this patient 8 extra applications were needed to 
obtain bidirectional block (p=0.04) (Fig. 2).
Procedural times were significantly longer in the magnet group compared to the conven-
tional group: 148 ±44 min (RMN 8 mm tip group) 143 ±40 min (RMN irrigated tip group) 
versus 106 ±53 min (manual group) (p=0.03). There was no difference in fluoroscopy times: 
23 ±12 min (RMN 8 mm tip group), 22 ±7 min (RMN irrigated tip group) and 20 ±11 min 
(p=0.62) (manual group) (Table 1).
There was 1 adverse event, consisting of a false aneurysm in a patient of the RMN irrigated 
tip group.
dISCuSSIoN
The main finding of this study is that for the primary endpoint (success within 15 applica-
tions) there was no difference between the 3 catheters. Secondary endpoints showed that 
more applications were needed with RMN compared to the manual approach, and that 
procedural times were longer. A third finding is that the maximum voltage technique is 
feasible with RMN.
Remote magnetic navigation
RMN proved to be a feasible technique for ablation of the majority of arrhythmias and has 
shown superiority in some difficult arrhythmias, such as in congenital heart disease 4. The 
major advantages are that it is a safe procedure since perforation with a floppy catheter is 
highly unlikely and that the amount of radiation for the operator substantially decreases, as 
he can operate the catheter remote from the patient 8. However, it is not impossible that 
these measures compromise efficacy.
Recently the irrigated tip catheter for RMN was introduced, making the advantages of cath-
eter tip cooling possible in the magnetic environment.
In atrial flutter we did not see a statistical difference in the primary endpoint (success within 
15 applications) compared to manual ablation. Nevertheless, the results with the RMN 8 mm 
tip were disappointing. We needed more applications compared to a conventional approach, 
Table I. Procedural data
Table 1
Manual  navigation
8 mm tip (n=17) irrigated tip (n=14) 8 mm tip (n=24) p-value
Number of applications 10 ±16 13 ±9 8 ±5 0.03
Ablation times (seconds) 570 ±815 692 ±579 465 ±265 0.03
Switch to manual approach 5 1 1 0.04
Procedure time (min.) 148 ±44 143 ±40 106 ±53 0.03
Fluoroscopy time (min.) 23 ±12 22 ±7 20 ±11 0.62
Remote magnetic navigation
Table(s)
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and we needed to switch 5 times to a manual irrigated tip catheter. Our results with the 
RMN irrigated tip catheter were encouraging since fewer switches to a cooled-tip manual 
catheter were needed (5 versus 1). Newer technologies which are emerging such as adjust-
able magnetic field strength might help to achieve even higher acute success rates.
There are several possible explanations for these mixed results. First of all, there are many 
anatomical variants in the cavotricuspid isthmus: the isthmus can vary in length, there may be 
pouch-like recessesses or a prominent Eustachian valve and the angle between the inferior 
vena cava and the isthmus have different degrees 9. Troublesome ablation of atrial flutter 
is associated with a longer cavotricuspid length and with a rectangular angle between the 
isthmus and the vena cava inferior 10. The maximum tissue force which can be applied by 
RMN is less than the average and significantly less than the maximal force which can be 
applied using a standard manual catheter 11. This can make it difficult to overcome some 
anatomical variations and to put the catheter parallel to the isthmus. When the catheter 
is placed more perpendicular than parallel to the tissue, the effective ablated contact area 
will decrease. When comparing lesions from magnetically steered catheters with standard 
manual catheters, the lesions from the former are more round or oval than elongated. The 
likelihood of seeing “brush lesions” as is common with the standard manual catheter is 
substantially less with the magnetically steered catheter. However, this “brush lesions” can 
actually be advantageous in the setting of flutter ablation12.
Particularly, when there is a rectangle between the isthmus and the vena cava inferior, it is 
sometimes difficult to have good wall contact at the transition of the isthmus and the vena 
cava inferior. Especially, an 8 mm magnetic catheter will have disadvantages both when the 
cavotricuspid isthmus is irregular, and when the angle with the vena cava inferior is sharp. 
The use of a RMN 8 mm tip catheter has been described in other studies. Vollmann et al. 
found that acute success rate was a reduced, more applications to obtain isthmus block 
were necessary, with longer procedural times and a reduced long-term success 13. Similar 
results have been presented with acute success ranging from 54% till 89% 14, 15. Only in 
one study a success rate of 100% was reported in a group of 24 patients 10. The use of the 
irrigated tip catheter could improve these results, since it is easier to titrate the energy, and 
as deeper lesions are formed.
The difference in procedural time is partly explained by the use of the electro-anatomical 
mapping system (CARTO) in the RMN group, even when activation was analysed. Since 
the EP recording system can not measure voltages, we needed to use this system to exactly 
measure the highest peak-to peak bipolar atrial electrograms. The combination of CARTO 
and RMN needs additional time for set-up and registering both systems and can explain a 
large part of the extra time needed in the RMN groups.
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Maximum voltage technique
The approach using the maximum voltage technique led to a significant decrease in the 
number of applications compared to former approaches. In this series, we needed a median 
of 8 applications to achieve bidirectional block (conventional manual group). This is far less 
then the average of 23 applications when we created continuous lines as has been published 
before. 16. The procedural time decreased as well in the historical control group from 170 
±48 min to 106 ±53 min, fluoroscopy time from 29 ±15 min till 20 ±11 min 16. The aid of 
magnetic navigation however, did not add to a further decrease in the number of applications 
and fluoroscopy times as initially expected. This might be due as many of these procedures 
were done by in a training program, and because the set-up of the electromagnetic system 
required additional time in the RMN, which was shared with the intervention group.
limitations
Whether a patient was appointed to the magnet group or the conventional group was 
based on the availability of the Stereotaxis room, and not to a randomization system. We 
did not perform angiography of the right atrium in order to assess the characteristics of 
the cavotricuspid isthmus. However, we have no reasons to presume that the distribution 
of the different anatomical variants is different between the 3 groups. Unfortunately, no 
comparison was made with a conventional irrigated tip group.
CoNCluSIoNS
The use of magnetic navigation for the ablation of atrial flutter with the maximum voltage 
technique is feasible but not superior to a manual approach. Overall, more applications are 
needed and procedure times are longer (unfortunately influenced by other equipment in the 
two groups). Nevertheless, with RMN and irrigated tip technology, we required less often 
a switch to manual catheters, which is promising. Hopefully, further improvements in the 
catheter design and the magnetic navigation system such as an adjustable magnetic force 
can make this safe approach also more performing.
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Initial experience with catheter ablation 
using remote magnetic navigation in adults 
with complex congenital heart disease and 
in small children
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ABSTRACT
Background: The improved outcomes and increased availability of surgery for congenital 
heart disease (CHD) over the last three decades have created a small but steadily increasing 
subset of patients with unique needs: children and adults with complex arrhythmias in the 
setting of structural cardiac abnormalities. Radiofrequency catheter ablation (RFCA) in these 
patients, and in small children with normal cardiac anatomy, is effective but challenging. 
An understanding of specific anatomical and electrophysiological characteristics of these 
patients and the technical challenges in addressing them are critical to the success of this 
therapy. Tools specifically designed for intracardiac diagnosis and therapy in anatomically 
complex and/or small hearts remain scarce. Aims: We report single-center results from an 
ongoing registry of all patients with congenital heart disease and all children with complex 
arrhythmias in which the Magnetic Navigation System (MNS) was used. Results: Included 
in this report are 12 patients with CHD in whom 17 tachyarrhythmias were treated, and 
11 pediatric patients with normal cardiac anatomy who each had a single arrhythmia. The 
procedures’ duration and the duration of fluoroscopy time as well as arrhythmia recurrence 
rates were comparable to those found in previous reports of procedures performed in adults 
with structurally normal hearts, and the incidence of complications was quite low.
Discussion: In patients with complex congenital malformations, retrograde mapping of 
the pulmonary venous atrium was feasible, eliminating the need for puncture of the atrial 
septum, or surgically placed baffle in many cases. Moreover, the design of the catheter 
eliminated the need for multiple mapping and ablation catheters.
Conclusion: Our findings suggest that RFCA using the MNS for arrhythmias after surgery for 
congenital heart disease and in pediatric patients is safe and effective.
Key words: magnetic navigation, radiofrequency ablation, congenital heart disease, pediatrics
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INTRoduCTIoN
The improved outcomes and increased availability of surgery for congenital heart disease
(CHD) over the last three decades have created a small but steadily increasing subset of 
patients with unique needs: children and adults with complex arrhythmias in the setting 
of structural cardiac abnormalities. In these patients, arrhythmias may be related to suture 
lines, surgical scars, or myocardial abnormalities secondary to chronic chamber dilatation or 
increased wall stress.1,2,3 In addition, the use of radiofrequency catheter ablation (RFCA) 
has become more common for the treatment of arrhythmias in children with normal hearts. 
RFCA is effective in these patients,4 however, technically challenging. There are few tools 
specifically designed for intracardiac diagnosis and therapy in small and anatomically abnor-
mal hearts. Believing that the use of the remote magnetic navigation system (MNS) could 
overcome some of the technical difficulties encountered in these patients, we evaluated the 
feasibility of its use in our patients with CHD and in small children presenting with complex 
arrhythmias. While the number of patients in our series is relatively small, it is of interest 
given the paucity of published information on the use of MNS in similar patients.
PATIeNTS ANd MeThodS
All children with complex arrhythmias as well as all patients with CHD who were treated at 
our center with RFCA using MNS are included in this report. Information on these patients 
was obtained from an ongoing registry of such patients. The pediatric group consisted of 11 
patients who ranged in age from 5 to 14 years (median = 10 years), in height from 103 to 
161 cm (median = 130 cm), and in weight from 17 to 49 kg (median = 31 kg). The tachyar-
rhythmias treated were atrioventricular node reentry in one, atrial tachyarrhythmias in two, 
left-sided accessory pathways in four, and right-sided accessory pathways in four patients. 
All children had structurally normal hearts. The CHD group included 12 patients ranging in 
age from 16 to 61 years (median = 32.5 years). The underlying heart diseases were surgically 
repaired ventricular septal defect, surgically corrected tetralogy of Fallot, surgically repaired 
atrial septal defect, dextrocardia with anomalous pulmonary veins, pulmonary stenosis status 
postmyectomy, and pulmonary artery homograft each in one patient, transposition of the 
great arteries status post-Mustard’s operation in two patients, and single ventricle status 
post-Fontan’s operation in five patients. Ablation Procedures in Children
All procedures were performed under general anesthesia. A standard diagnostic electro-
physiologic (EP) study was performed. After obtaining femoral venous access, heparin was 
given and diagnostic catheters were positioned in the coronary sinus, at the His bundle 
and in the right ventricular apex. Access to the left side of the heart, when necessary, was 
achieved using either a retrograde or transseptal approach. After standard EP measurements 
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were made, the magnetic-guided catheter (Celsius RMT, 4 mm, Biosense Webster, Diamond 
Bar, CA, USA) was introduced into the heart. The principles and use of the MNS have been 
described in detail previously by our group.5,6 The Niobe MNS (Stereotaxis Inc., St. Louis, 
MO, USA) consisted of two permanent magnets situated on either side of the patient, which 
were computer controlled via a workstation (Navigant, Stereotaxis Inc.) to allow for changes 
in the orientation of a stable magnetic field within the chest of the patient. A combined field 
strength of 0.08 T was produced in navigation mode. As navigation was best performed 
with a fixed table position, this was optimized prior to the start of magnetic navigation. 
When the magnets were positioned next to the patient, only limited angulation of the C-arm 
was possible (~28° in the right and left anterior oblique angulations). Remote catheter ad-
vancement and retraction from the control room were performed using a catheter advancer 
system, CardiodriveTM (Stereotaxis Inc.), positioned on the high anterior thigh. Remote 
control of the fluoroscopy system was also performed from the control room. The ablation 
catheters, with multiple magnets within the distal tip segment, aligned themselves with 
the field produced by the external magnets, allowing effective catheter orientation. The 
remote workstation in conjunction with the Cardiodrive unit allowed precise orientation of 
the catheter by 1° increments and by 1-mm steps in advancement or retraction. The system 
was controlled by joystick or mouse and allowed remote control of the ablation catheter 
from inside the control room. After the magnets were brought in next to the patient, the 
physician was free to leave the room and perform the rest of the procedure from the control 
room. A single nurse remained with the sedated patient to administer drugs, as needed. Vital 
signs were monitored from the control room by the anesthesiologist. The MNS catheter was 
used to determine the mechanism and chamber of origin of the tachyarrhythmia and the ap-
propriate site for ablation; the same 4-mm tip magnetic-guided catheter was used to deliver 
the radiofrequency energy. The procedure was considered complete when the target ar-
rhythmia could no longer be induced. Ablation Procedures in Patients with Congenital Heart 
Disease As in the pediatric patients, vascular access was obtained, heparin was given, and 
a standard diagnostic EP study was performed using both a screw-in electrode (Medtronic 
Inc., Minneapolis, MN, USA), attached to the septal area of the systemic venous atrium in 
most cases, and the magnetic-guided catheter (Navistar RMT DS, 8-mm, Biosense Webster). 
After induction of tachyarrhythmia by programmed stimulation, a voltage and activation 
map was created using the MNS in combination with the CARTO TM navigation system 
(Biosense Webster, Fig. 1). In all patients who had previously undergone Fontan’s procedure 
for treatment of single ventricle-type CHD or Mustard’s procedure for correction of trans-
position of the great arteries, a biatrial voltage and activation map was created. Whenever 
possible, we tried to avoid puncture of a baffle by using the retrograde transaortic approach 
to map the pulmonary venous atrium. In two patients, however, a baffle puncture had to be 
performed due to the presence of a mechanical valve prosthesis. We used transesophageal 
echocardiography in one patient and intracardiac echocardiography in the other, to guide 
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the transseptal puncture with a manually modified Brockenbrough needle. To determine the 
optimal ablation site in patients who had undergone these surgical procedures, we used the 
“no channel—no reentry” strategy. On the detailed CARTO map we could discern, among 
regions of scar tissue, different channels of conductive tissue with potential of becoming a 
substrate for macro-reentrant tachycardia. After identification of the arrhythmia substrate, 
ablation was performed using the same 8-mm tip magnetic-guided catheter. The procedure 
was considered complete when the target arrhythmia was no longer inducible.
Statistical Analysis
All results are descriptive, and are expressed as ranges and median.
ReSulTS
In the pediatric group, the procedures ranged from 80 to 300 minutes in duration (median =
130 minutes), and fluoroscopy time ranged from 2 to 58 minutes (median = 16 minutes). 
Each patient was treated with one to 19 RF applications (median = three applications). All 
procedures were immediately successful, although tachyarrhythmias recurred in two patients 
at 3 and 12 months, respectively. In the CHD group, 17 tachyarrhythmias were treated in 
12 patients, including two cavotricuspid isthmus-dependent flutters, five focal atrial tachyar-
rhythmias, and 10 incisional macro-reentrant tachyarrhythmias. Procedure times ranged 
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Figure 1. Biatrial voltage CARTO maps in a patient with transposition of the great arteries, 
status post-Mustard’s operation (inferior and LAO views). The extremely floppy and 
maneuverable magnetic navigation catheter was used to map both atria, reaching the 
pulmonary venous atrium via an existing interatrial connection (baffle). 
 
 
 
 
Figure 1. Biatrial voltage CARTO maps in a patient with transposition of the great arteries, status 
post-Mustard’s operation (inferior and LAO views). The extremely floppy and maneuverable magnetic 
navigation catheter was used to map both atria, reaching the pulmonary venous atrium via an existing 
interatrial connection (baffle).
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from 120 to 540 minutes (median = 240 minutes), and fluoroscopy time ranged from 12 to 
85 minutes (median = 39.4 minutes). Each patient was treated with two to 105 applications 
(median = 26 applications) of RF energy. Among the 12 patients, 11 were free from inducible 
arrhythmias at the end of the procedure; three had recurrences of arrhythmia at follow-up of 
4–6 months. None of the 23 patients developed pericardial effusion, tamponade, or embolic 
events in association with the procedure. A fever developed following the procedure in one 
patient who was diagnosed with Staphylococcus aureus bacteremia; therapy with antibiotics 
was initiated and the patient recovered without sequelae.
dISCuSSIoN
RFCA of tachyarrhythmias in patients with complex CHD and in small children requires con-
siderable expertise, acquired through both training and practical experience. Although the 
number of such patients is increasing as a result of successful surgical and medical manage-
ment of complex CHD and improved clinical diagnosis, they remain a very small minority 
among patients treated for arrhythmias, making it difficult for most electrophysiologists to 
become expert in their care. Another consequence of their small numbers is that there are 
few if any tools specifically designed for intracardiac diagnosis and treatment of electrophysi-
ologic disorders in very small and/or structurally abnormal hearts.
MNS offers several potential advantages in treating these patients. The MNS catheter is 
floppy and a-traumatic, reducing the risk of perforation, and can easily pass through fenes-
trations associated with previous surgery. It can be passed retrogradely into the pulmonary 
venous atrium via the arterial approach, eliminating the need for transseptal puncture. At 
the same time, the catheter has excellent navigation characteristics, and is quite stable once 
positioned. In many cases, it can be used for complete mapping and RF delivery, eliminating 
the need for multiple catheters with different curvatures. These characteristics should result 
in more accurate and effective transmural lesions, especially when used with 3D imaging 
techniques such as computed tomography, magnetic resonance imaging, and ultrasound.
Our results reflect these advantages. The procedure and fluoroscopy times compare favor-
ably with those reported previously when the MNS was used in adult patients with normal 
hearts.7,8 Immediate success was achieved in nearly all patients and the recurrence rate was 
fairly low. No major complications such as pericardial effusion, cardiac tamponade, or stroke 
occurred. One technical issue noted when using the Navistar RMT DS 8-mm tip catheter was 
frequent char formation on the tip during RF application, impairing energy delivery to the 
tissue, necessitating regular cleaning of the catheter tip after RF application.
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CoNCluSIoN
Our experience suggests that RFCA using MNS for arrhythmias occurring after surgery for
CHD and in pediatric patients is safe and effective. Procedure and fluoroscopy times were 
comparable to those previously reported, and no procedural complication occurred. The 
design of the MNS catheter offers multiple advantages in the treatment of these very chal-
lenging patients.
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ABSTRACT
Background: Transcatheter ablation is an effective method to eliminate the arrhythmogenic 
substrate in symptomatic children with various types of arrhythmias. A reduction in proce-
dure and fluoroscopy time decreases hazardous effects of ablation. The magnetic navigation 
system (MNS) utilizes atraumatic catheters and allows attainment of all targeted regions 
for mapping and treatment. Aim: to compare the efficacy and safety between a manual 
and MNS guided approach for mapping and ablation of arrhythmias in a general pediatric 
arrhythmia population and in a subgroup of young children aged less than 10 years. Results: 
58 pediatric patients (mean age: 12,2 ± 3,2 years) were included into this study. Twenty-nine 
consecutive patients were treated with MNS system, while 29 consecutive patients under-
went conventional manual ablation. There were no demographic differences between the 
groups. Acute success was achieved in 26 out of 29 vs. 27 out of 29 patients (p=NS). Mean 
procedure and fluoroscopy times were comparable in both study groups (168 ± 56 vs. 183 ± 
52, p= NS, 22 ± 59 vs. 30 ± 29, p= NS). In young children (age under 10 years), success rate 
did not differ between the groups (10/11 vs. 6/8, p= NS). However, significant decrease in 
procedure and fluoroscopy times were achieved (139 ± 57 vs. 204 ± 49 min and 13 ± 7 vs. 
31 ± 28 min, respectively, p=0,01 and p=0,04). Conclusion: Our data strongly suggest that 
using the MNS for treating young children is advantageous because it significantly reduces 
procedure and fluoroscopy times without compromising efficacy.
Key Words: Magnetic navigation system, children, ablation, reduction fluoroscopy time
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INTRoduCTIoN
Transcatheter ablation is an effective method for eliminating the arrhythmogenic substrate 
in symptomatic children with various types of tachyarrhythmias 1-4. Safety is without a doubt 
a crucial issue in these young and vulnerable patients. Unfortunately, in small-sized children 
only a limited number of dedicated devices (i.e.: significantly smaller in size and with specially 
designed curves) are available for ablation procedures. Reduction of procedure and fluoros-
copy times decreases hazardous effects of ablation such as complications and the potential 
long-term effects of radiation exposure, such as leukemia and a whole spectrum of solid 
cancers 5 6 7. The magnetic navigation system (Niobe, Stereotaxis, St Louis, MO, USA)(MNS) 
combines several possible advantages: it utilizes atraumatic catheters, with superior naviga-
tion capabilities and allows attainment of all targeted regions for mapping and treatment 
8 9 10. In our study we aimed to compare the efficacy and safety between manual and MNS 
guided approach for the mapping and ablation of tachyarrhythmias in a general pediatric 
population and in a subgroup of young children.
MeThodS
Patients
In our centre patients were recruited from an ongoing registry of all children with complex 
arrhythmias. Patients treated using the MNS were included consecutively into this study 
from the time when the MNS was introduced into our hospital for ablation of paediatric 
patients. All paediatric patients were treated with the MNS from this moment on. A control 
group of manually ablated patients was accumulated in the same consecutive fashion in the 
period directly before the introduction of the MNS. This means that patients with different 
tachyarrhythmias were included into the study and only those with a parahisian substrate 
were excluded. Informed consent was obtained from the parents of the patients who were 
younger than 18 years old. Amiodarone was discontinued for at least 1 month and all other 
antiarrhythmic agents were discontinued for at least 5 half-lives before the procedure. The 
operators were the same for both groups. All procedures were performed under general 
anaesthesia. Data was collected regarding procedural time, use of fluoroscopy, acute suc-
cess and procedure related complications. Procedural time was measured from the time of 
puncturing the vein until the time of removal of the sheaths from the groin, including the 30 
minutes waiting period after a successful ablation.
electrophysiologic assessment
The diagnosis of both dual AV nodal pathways, atrioventricular nodal reentrant tachycardia 
(AVNRT), circle mediated tachycardia (CMT) or atrial tachycardia (AT), was made on the basis 
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of standard diagnostic criteria. The earliest retrograde atrial activation during both tachycardia 
and premature ventricular complexes was registered. Single premature atrial and ventricular 
stimuli were applied during tachycardia while the His bundle was refractory to assess if tachy-
cardia could be reset. This confirmed the presence or absence of an accessory pathway. In 
patients with manifest pre-excitation, the site that showed the earliest ventricular activation 
was identified. If sustained tachycardia could not be induced an infusion of isoprenaline was 
given. In case of an accessory pathway, the final classification was made according to the 
successful ablation site. In patients suspected of having an AT a 3D electroanatomical voltage 
and/or activation map (CARTO, Biosense-Webster Inc, Diamond Bar, CA, USA) was made.
Manual RF ablation
Manual RF catheter ablation was performed using a 4-mm, solid-tip, ablation catheter 
(Biosense-Webster Inc, Diamond Bar, CA, USA) in a temperature controlled mode (maximum 
temperature 55°C, maximum duration 60 seconds, maximum 40 W) with the use of a Stock-
ert RF generator (Biosense-Webster Inc, Diamond Bar, CA, USA).
Magnetic navigation system ablation
Catheter ablation using the MNS was performed using a 4mm tip catheter (Celsius or Navistar 
RMT DS, Biosense-Webster Inc, Diamond Bar, CA, USA) with the use of the same Stockert RF 
generator (Biosense-Webster Inc, Diamond Bar, CA, USA). The principles and use of the MNS 
have already been extensively described previously by our group 8.
Atrioventricular nodal re-entrant tachycardia
In patients with AVNRT our target was elimination of the slow pathway. The ablation was 
guided using a combination of fluoroscopic images and electrograms (EGM). The procedural 
endpoint was defined as non-inducibility of the tachycardia. Inducibility was tested after each 
application. If non-inducible the test was repeated after a 30 min waiting period. Procedure 
time was recorded from the moment of puncturing the femoral vein in the EP lab until the 
removal of the sheath from the femoral vein, including the 30 minute waiting period.
Atrial tachycardia
In patients with an AT a 3D electroanatomical voltage and/or activation map (CARTO, 
Biosense-Webster Inc, Diamond Bar, CA, USA) was created. The procedural endpoint was 
again defined as non-inducibility of the tachycardia. Procedural time was measured in the 
same fashion and also included the 30 minute waiting period.
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Accessory pathway
In patients with a CMT the objective of the ablation was abolition of conduction over the 
accessory pathway. Procedural time was measured in the same fashion and also included the 
30 minute waiting period.
Follow-up
Twenty-four hours after receiving treatment patients were re-evaluated clinically and an 
electrocardiogram and a transthoracic echocardiographic examination were performed.
Statistical analysis
Continuous variables were expressed as mean ± standard deviation, if normally distributed, 
or otherwise by median. The Students t-test or analysis of variance were used when appropri-
ate. A Chi-square test was used for categorical data. The level of significance was set at p < 
0.05. All statistics were performed using SPSS (16.0) for Windows (Chicago, Il, USA).
ReSulTS
Patient data
Fifty-eight pediatric patients (mean age: 12,2 ± 3,2 years) were included into this study. 
Twenty-nine consecutive patients were treated with the MNS system, while 29 consecutive 
patients underwent conventional manual ablation. There were no demographic differences 
between the groups (MNS: age 12,1 ± 3,0, AVNRT: 4, AT: 3, RAP: 10, LAP: 12 pts vs. conven-
tional group: age: 12,3 ± 3,4, AVNRT 7, AT 1, RAP 11, LAP 10, p= NS) (Table I).
Table 1 Patient and procedural data
atrial tachycardia, a 3-dimensional electroanatomic voltage
and/or activation map (CARTO, Biosense-Webster, Dia-
mond Bar, California) was constructed.
Manual RF catheter ablation was performed using a
4-mm, solid-tip, ablation catheter (Biosense-Webster) in a
temperature-controlled mode (maximum temperature 55°C,
maximum duration 60 seconds, maximum energy 40 W)
using a Stockert RF generator (Biosense-Webster).
Catheter ablation using the MNS was performed using a
4-mm tip catheter (Celsius RMT or Navistar RMT, Bio-
sense-Webster) using the same Stockert RF generator (Bio-
sense-Webster). The principles and use of the MNS have
been extensively described previously by our group.8
In patients with atrioventricular nodal re-entrant tachy-
cardia, our target was elimination of the slow pathway. The
ablation was guided using a combination of fluoroscopic
images and electrograms. The procedural end point was
defined as noninducibility of the tachycardia. Inducibility
was tested after each application. If the arrhythmia was
noninducible, the test was repeated after a 30-minute wait-
ing period. The procedure time was recorded from the
moment of puncturing the femoral vein in the electrophys-
iology laboratory until removal of the sheath from the fem-
oral vein, including the 30-minute waiting period.
In patients with atrial tachycardia, a 3-dimensional elec-
troanatomic voltage and/or activation map (CARTO RMT,
Biosense-Webster) was created. The procedural end point
was again defined as noninducibility of the tachycardia. The
procedural time was measured in the same fashion and also
included the 30-minute waiting period.
In patients with circle-mediated tachycardia, the objec-
tive of the ablation was abolition of conduction over the
accessory pathway. The procedural time was measured in
the same fashion and also included the 30-minute waiting
period.
At 24 hours after receiving treatment, the patients were
re-evaluated clinically and an electrocardiogram and trans-
thoracic echocardiographic examination were performed.
Continuous variables are expressed as the mean  SD if
normally distributed, or otherwise by the median. The Stu-
dent t test or analysis of variance was used when appropriate
for continuous variables, and the chi-square test was used to
compare categorical data. The level of significance was set
at p 0.05. All statistical analyses were performed using
Statistical Package for Social Sciences, version 16.0 for
Windows (Chicago, Illinois).
Results
A total of 58 pediatric patients (mean age 12.2  3.2
years) were included in the present study. Of the 58 patients,
29 consecutive patients were treated with the MNS and 29
consecutive patients underwent conventional manual abla-
tion. No demographic differences were present between the
2 groups (Table 1).
Acute success was achieved in 26 of 29 and 27 of 29
patients in the 2 groups (p  NS). The mean procedure and
fluoroscopy times were not different between the 2 study
groups (Table 1). No complications occurred. A subgroup
analysis was performed selecting only young children aged
10 years (Table 2). The success rate did not differ between
the 2 groups (10 of 11 vs 6 of 8, p  NS). However, a
significant decrease in the procedure and fluoroscopy times
was achieved (139  57 vs 204  49 minutes and 13  7
vs 31  28 minutes, p  0.01 and p  0.04, respectively).
Discussion
The major finding of the present study was that using the
MNS in young children is advantageous, because it signif-
icantly reduced the procedure and fluoroscopy times with-
out compromising the safety or efficacy.
Before the introduction of the MNS at our center, we had
developed a longstanding experience in the ablation of ar-
rhythmias in children. Nevertheless, to increase the safety
even more,11 we switched from manual ablation to MNS-
guided ablation for all pediatric patients shortly after the
MNS became available.
To date, dedicated devices designed especially for use in
young children have been very scarce. The different cathe-
ters at our disposal have been developed mainly for use in
adults. When performing an electrophysiology study and
ablation in children, we must be aware not only of the
difference in scale between an adult heart and a pediatric
Table 1
Patient and procedural data
Variable MNS
(n  29)
Manual
(n  29)
Age (years) 12.1  3.0 12.3  3.4
Weight (kg) 28  4.0 30  4.5
Males 14 (48%) 16 (55%)
Atrioventricular nodal re-entrant
tachycardia
4 (14%) 7 (24%)
Atrial tachycardia 3 (10%) 1 (3%)
Right-side accessory pathway 10 (34%) 11 (39%)
Left-side accessory pathway 12 (42%) 10 (34%)
Procedural time (min) 168  56 183  52
Fluoroscopy time (min) 22  59 30  29
Acute success 26 (90%) 27 (93%)
Complications 0 0
Data are presented as mean  SD or numbers (%).
No significant differences were observed between 2 groups.
Table 2
Patient and procedural data of subgroup of young children (aged 10
years)
Variable MNS Manual
Patients (n) 11 (58%) 8 (42%)
Age (years) 8.9  1.0 7.8  3.0
Atrioventricular nodal re-entrant
tachycardia
1 (9%) 0
Atrial tachycardia 3 (27%) 0
Right-sided accessory pathway 5 (45%) 3 (38%)
Left-sided accessory pathway 2 (19%) 5 (62%)
Procedural time (min) 139  57* 204  49*
Fluoroscopy time (min) 13  7† 31  28†
Acute success 10 (91%) 6 (75%)
Complications 0 0
Data are presented as mean  SD or numbers (%).
* p  0.01; † p  0.04.
70 The American Journal of Cardiology (www.ajconline.org)
Bruno BW.indd   155 05-Jan-12   17:36:56 PM
156 Chapter 5
Procedure and ablation data
Acute success was achieved in 26 out of 29 vs. 27 out of 29 pts (p=NS). The mean procedure 
and fluoroscopy times were not different between the study groups (168 ± 56 vs. 183 ± 52, 
p= NS, 22 ± 59 vs. 30 ± 29, p= NS). No complications occurred. A subgroup analysis was 
performed selecting only young children aged less than 10 years (Table II). The success rate 
did not differ between the groups (10/11 vs. 6/8, p= NS). However, a significant decrease in 
procedure and fluoroscopy time was achieved (139 ± 57 vs. 204 ± 49 min and 13 ± 7 vs. 31 
± 28 min, respectively p=0,01 and p=0,04).
Table 2 Patient and procedural data of subgroup of young children (aged 10 years)
atrial tachycardia, a 3-dimensional electroanatomic voltage
and/or activation map (CARTO, Biosense-Webster, Dia-
mond Bar, California) was constructed.
Manual RF catheter ablation was performed using a
4-mm, solid-tip, ablation catheter (Biosense-Webster) in a
temperature-controlled mode (maximum temperature 55°C,
maximum duration 60 seconds, maximum energy 40 W)
using a Stockert RF generator (Biosense-Webster).
Catheter ablation using the MNS was performed using a
4-mm tip catheter (Celsius RMT or Navistar RMT, Bio-
sense-Webster) using the same Stockert RF generator (Bio-
sense-Webster). The principles and use of the MNS have
been extensively described previously by our group.8
In patients with atrioventricular nodal re-entrant tachy-
cardia, our target was elimination of the slow pathway. The
ablation was guided using a combination of fluoroscopic
images and electrograms. The procedural end point was
defined as noninducibility of the tachycardia. Inducibility
was tested after each application. If the arrhythmia was
noninducible, the test was repeated after a 30-minute wait-
ing period. The procedure time was recorded from the
moment of puncturing the femoral vein in the electrophys-
iology laboratory until removal of the sheath from the fem-
oral vein, including the 30-minute waiting period.
In patients with atrial tachycardia, a 3-dimensional elec-
troanatomic voltage and/or activation map (CARTO RMT,
Biosense-Webster) was created. The procedural end point
was again defined as noninducibility of the tachycardia. The
procedural time was measured in the same fashion and also
included the 30-minute waiting period.
In patients with circle-mediated tachycardia, the objec-
tive of the ablation was abolition of conduction over the
accessory pathway. The procedural time was measured in
the same fashion and also included the 30-minute waiting
period.
At 24 hours after receiving treatment, the patients were
re-evaluated clinically and an electrocardiogram and trans-
thoracic echocardiographic examination were performed.
Continuous variables are expressed as the mean  SD if
normally distributed, or otherwise by the median. The Stu-
dent t test or analysis of variance was used when appropriate
for continuous variables, and the chi-square test was used to
compare categorical data. The level of significance was set
at p 0.05. All statistical analyses were performed using
Statistical Package for Social Sciences, version 16.0 for
Windows (Chicago, Illinois).
Results
A total of 58 pediatric patients (mean age 12.2  3.2
years) were included in the present study. Of the 58 patients,
29 consecutive patients were treated with the MNS and 29
consecutive patients underwent conventional manual abla-
tion. No demographic differences were present between the
2 groups (Table 1).
Acute success was achieved in 26 of 29 and 27 of 29
patients in the 2 groups (p  NS). The mean procedure and
fluoroscopy times were not different between the 2 study
groups (Table 1). No complications occurred. A subgroup
analysis was performed selecting only young children aged
10 years (Table 2). The success rate did not differ between
the 2 groups (10 of 11 vs 6 of 8, p  NS). However, a
significant decrease in the procedure and fluoroscopy times
was achieved (139  57 vs 204  49 minutes and 13  7
vs 31  28 minutes, p  0.01 and p  0.04, respectively).
Discussion
The major finding of the present study was that using the
MNS in young children is advantageous, because it signif-
icantly reduced the procedure and fluoroscopy times with-
out compromising the safety or efficacy.
Before the introduction of the MNS at our center, we had
developed a longstanding experience in the ablation of ar-
rhythmias in children. Nevertheless, to increase the safety
even more,11 we switched from manual ablation to MNS-
guided ablation for all pediatric patients shortly after the
MNS became available.
To date, dedicated devices designed especially for use in
young children have been very scarce. The different cathe-
ters at our disposal have been developed mainly for use in
adults. When performing an electrophysiology study and
ablation in children, we must be aware not only of the
difference in scale between an adult heart and a pediatric
Table 1
Patient and procedural data
Variable MNS
(n  29)
Manual
(n  29)
Age (years) 12.1  3.0 12.3  3.4
Weight (kg) 28  4.0 30  4.5
Males 14 (48%) 16 (55%)
Atrioventricular nodal re-entrant
tachycardia
4 (14%) 7 (24%)
Atrial tachycardia 3 (10%) 1 (3%)
Right-side accessory pathway 10 (34%) 11 (39%)
Left-side accessory pathway 12 (42%) 10 (34%)
Procedural time (min) 168  56 183  52
Fluoroscopy time (min) 22  59 30  29
Acute success 26 (90%) 27 (93%)
Complications 0 0
Data are presented as mean  SD or numbers (%).
No significant differences were observed between 2 groups.
Table 2
Patient and procedural data of subgroup of young children (aged 10
years)
Variable MNS Manual
Patients (n) 11 (58%) 8 (42%)
Age (years) 8.9  1.0 7.8  3.0
Atrioventricular nodal re-entrant
tachycardia
1 (9%) 0
Atrial tachycardia 3 (27%) 0
Right-sided accessory pathway 5 (45%) 3 (38%)
Left-sided accessory pathway 2 (19%) 5 (62%)
Procedural time (min) 139  57* 204  49*
Fluoroscopy time (min) 13  7† 31  28†
Acute success 10 (91%) 6 (75%)
Complications 0 0
Data are presented as mean  SD or numbers (%).
* p  0.01; † p  0.04.
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dISCuSSIoN
The major finding of this study is that using the magnetic navigation system in young children 
is advantageous because it significantly reduces procedure and fluoroscopy times without 
compromising efficacy.
The rationale of using the magnetic navigation system
Before the introduction of the MNS at our center, we had already developed a longstand-
ing experience in ablation of arrhythmias in children. Nevertheless, to increase safety even 
more 11, we switched from manual ablation to MNS guided ablation for all pediatric patients 
shortly after the MNS became available.
The lack of dedicated devices for small hearts
Until now, dedicated devices designed especially for use in young children were very scarce. 
The different cathet rs w ich are at our dispositi n have be n developed mainly for use in 
adults. When performing an electrophysiology study and ablation in children, we need to be 
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aware not only of the difference in scale between an adult heart and a paediatric heart, but 
also we need to realize that the morphology is somewhat different in children than in adults. 
For example the position of the ostium of the coronary sinus usually is far more caudal in 
children than in adults. These morphological differences compel us to be even more careful 
in treating these children. Even more so than in adult patients, this gives rise to the need 
to be extra cautious when manipulating these oversized and relatively stiff catheters inside 
the heart. As a consequence it is rather difficult to gain access to certain remote areas 
inside the heart of these young children. When using the magnetic navigation system, it is 
possible to gain access to even the most remote areas in the heart. The floppy magnetically 
steered catheter allows us to navigate freely inside the heart without fear of perforating 
the myocardium (Figure 1). Furthermore it is possible to make several consecutive bends 
in different directions with this extremely steerable catheter. The ease of this unrestricted 
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Figure 1. Different fluoroscopic views of the heart in a 9-year old child. A decapolar catheter 
is positioned in the coronary sinus, one quadripolar catheter is on the His and one is 
positioned in the right ventricular apex. The magnetically steered catheter is retrogradely 
advanced into the left ventricle in order to ablate a left sided accessory pathway. The different 
views depict the extreme flexibility of the magnetically steered catheter. Panel A: tip of the 
catheter is retrogradely advanced  through the aortic valve via the left ventricle and the mitral 
valve into the ostium of the right inferior pulmonary vein. Panel B and C: the catheter can be 
navigated freely in the left ventricle without fear of perforating the myocardium. Panel D to F: 
finally the is positioned on left sided accessory pathway and a successful RF ablation was 
performed. 
 
 
 
Figure 1. Different fluoroscopic views of the heart in a 9-year old child. A decapolar catheter is 
positioned in the coronary sinus, one quadripolar catheter is on the His and one is positioned in 
the right ventricular apex. The magnetically steered catheter is retrogradely advanced into the left 
ventricle in order to ablate a left sided accessory pathway. The different views depict the extreme 
flexibility of the magnetically steered catheter. Panel A: tip of the catheter is retrogradely advanced 
through the aortic valve via the left ventricle and the mitral valve into the ostium of the right inferior 
pulmonary vein. Panel B and C: the catheter can be navigated freely in the left ventricle without fear of 
perforating the myocardium. Panel D to F: finally the is positioned on left sided accessory pathway and 
a successful RF ablation w s performed.
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manoeuvrability is a possible explanation for the decrease in procedural and fluoroscopy 
times in young children.
Radiation hazard/vulnerability in young children
It has indisputably been proved that children are ten times more sensitive than adults to the 
induction of cancer by external radiation exposure 6. Radiation exposure causes an excess 
incidence of leukemia and a whole spectrum of solid cancers. This risk varies dramatically 
with age. Young children are most vulnerable to the effects of radiation. The risk decreases 
with age. Particularly at early ages there seems to be also a gender difference with girls 
being more radiosensitive than boys. Iatrogenic induction of any form of cancer in children is 
without a doubt a major concern. Especially when the detrimental radiation is used to cure 
an in most cases benign disease. So every effort is needed to try to minimize effective radia-
tion doses. Our data suggest that using the MNS for ablation in children and especially young 
children significantly reduces fluoroscopy times without compromising efficacy. Reduction of 
fluoroscopy times seems to be a general finding whenever the MNS is used 12.
Improved safety
Ever since RF catheter ablation established itself as an effective method to eliminate the 
arrhythmogenic substrate in symptomatic children with various types of arrhythmias, the 
challenge remained to avoid ablation-induced complications 13,14. The use of the MNS in 
young children has several possible advantages. First of all our data suggest that using the 
MNS in young children results in shorter procedural and fluoroscopy times. This decreases 
hazardous effects of ablation such as complications and the potential long-term effects of 
radiation exposure in these very young patients. Secondly only a limited number of dedicated 
devices for young children are available for manual ablation procedures , the risk of perforat-
ing the myocardium when using these relatively stiff and oversized manually manipulated 
catheters remains. However, when using the MNS, creating a perforation of the myocardium 
with the floppy magnetically steered catheter is virtually impossible. Furthermore, absolute 
catheter stability during ablation decreases the risk of damaging vital areas of conduction.
Complications
Shorter procedural times when using the MNS decrease the chance for acute complications, 
which is without a doubt a definite advantage. The beneficial effects of reducing fluoroscopy 
times in these young children are not to be noticed acutely. Although there is no absolute 
proof, one can imagine the benefit of reducing the exposure to long periods of radiation of 
these young patients in the long run. Off course also the reduction of radiation exposure of 
the physician is a major step in the right direction. In most of our procedures performed with 
the MNS, the radiation exposure of the physician is virtually zero. The radiation dose caught 
by the physician is limited to the time needed to position the different electrophysiological 
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catheters inside the heart since the rest of the procedure is performed in a remote fashion 
from the workstation.
Cost- efficacy
Surely purchasing the MNS is a huge investment and the limited number of patients in our 
study do not allow us to perform a thorough cost-efficacy evaluation. On one hand ablation 
of tachycardia`s in young children should be preferably done in high volume centres with a 
longstanding experience in this field. The number of these kind of procedures performed 
in these high volume centres and the possibility of using the MNS for numerous other 
procedures could allow this technique to become cost-effective. On the other hand one 
can imagine this technique could lower the threshold to perform radiofrequency catheter 
ablation in young children even in low-volume centres equipped with a MNS, given the 
safety of catheter handling. However, we do not encourage this unless the operator has 
acquired a lot of experience in treating arrhythmias in young children.
Issues to be resolved
Acute success is high in both the manual and the MNS group. Whether these results remain 
in the long run needs to be investigated. Most diagnostic catheters used are still rather stiff 
and relatively large for use in young children. Downsizing of catheters and development of 
more specific tools for the paediatric population could be helpful.
CoNCluSIoN
In conclusion, using the MNS to treat tachyarrhythmias in children is effective and safe in 
comparison to manual RF ablation. But more specifically taking into account our data, we can 
strongly suggest using the MNS for RF catheter ablation in young children as this significantly 
reduces procedure and fluoroscopy times without compromising efficacy.
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Chapter 6
The magnetic navigation system allows 
avoidance of puncturing a baffle during 
ablation of a postincisional macroreentrant 
tachycardia
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ABSTRACT
An 18-year-old female patient with tricuspid atresia, discordant ventriculo-arterial connec-
tions, a total cavo-pulmonary connection, and a Damus-Kaye-Stansel suffered with atrial 
tachycardia. Use of a magnetically navigated catheter made it possible to create an electro-
anatomical map of both atriums using a retrograde approach. It then proved possible to 
ablate successfully the tachycardia in the left atrium thanks to the unique capabilities of the 
magnetic navigation system.
Key words: Arrhythmias; atrial tachycardia; radiofrequency catheter ablation
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INTRoduCTIoN
Even for experienced operators, puncturing a surgically created intra-atrial baffle can be a 
challenging procedure.1–5 The magnetic navigation system, however, offers the advantage 
of using an extremely flexible, steerable, and non-traumatic catheter. 6,7 In this presentation, 
we describe the utility of such a system in structurally and functionally modified hearts.
CASe RePoRT
An 18-year-old female was referred because of multiple recurrences of atrial tachycardia 
2 years after an apparently successful catheter ablation. At birth, she had been diagnosed 
with tricuspid atresia, discordant ventriculo-arterial connections, and aortic coarctation. 
At an initial surgical procedure, the coarctation was corrected and a band placed on the 
pulmonary trunk. After a period of 1 year, a bidirectional Glenn shunt was created, and 
the ventricular septal defect was enlarged. After another 3 years, the pulmonary trunk was 
closed proximally, and the systemic venous atrium was connected directly to the pulmonary 
arteries. She then developed severe mitral valvar insufficiency at the age of 10 years, requir-
ing surgical repair. At the same intervention, a total cavo-pulmonary connection was made 
using an intra-atrial tunnel, connecting the pulmonary trunk end-to-side to the aorta as the 
Damus-Kaye-Stansel procedure (Fig. 1). Subsequently, the patient developed multiple epi-
sodes of atrial tachycardia with a fast ventricular response, leading to near-syncope on many 
occasions, and necessitating frequent electrical cardioversions. Pharmacological treatment 
did not alleviate the symptoms, and caused unacceptable side-effects. An epicardial dual 
chamber pacemaker was implanted because of severe and symptomatic bradycardia. An 
electrophysiological study resulted in mapping and ablation of two scar-related tachycardias 
in the left atrium, using transoesophageal echocardiography to guide puncture of the intra-
atrial baffle. The symptoms recurred 2 years later, and a new electrophysiological study was 
undertaken. Under general anesthesia, we punctured the right femoral artery and vein. A 
screw-in pacing lead (Medtronic, Minneapolis, MN, USA) was inserted into the right femoral 
vein and screwed into the lateral portion of the intra-atrial tunnel. A magnetically steer-
able catheter (Navistar RMT DS 8mm, Biosense-Webster, Diamond Bar, CA, USA) was also 
inserted into the right femoral vein, and the tip was positioned in the intra-atrial tunnel. With 
programmed atrial stimulation, and atrial burstpacing, multiple episodes of non-sustained 
atrial tachycardias could be induced with slightly different cycle lengths, suggesting a com-
plex substrate for the arrhythmia. All tachycardias, nonetheless, had a centrifugal sequence 
of activation, suggestive for an origin in the intra-atrial tunnel. In the light of the history of 
arrhythmias in the left atrium, and using the CARTOTM navigation system (BiosenseWebster, 
Diamond Bar, CA, USA) in combination with the magnetic navigation system (MNS) (Niobe, 
Bruno BW.indd   167 05-Jan-12   17:37:03 PM
168 Chapter 6
Stereotaxis, St. Louis, MO, USA), we were able to create safely a biatrial bipolar activation 
and voltage map (Fig. 2). We mapped the left atrium retrogradely using the femoral arterial 
access, a transseptal approach being deemed undesirable given the previous puncture of the 
baffle. The magnetically navigated catheter was piloted through the aortic arch, through 
the Damus-Kaye-Stansel shunt, into the incomplete morphologically right ventricle, through 
the ventricular septal defect into the morphologically left ventricle, and retrogradely through 
the surgically repaired mitral valve into the left atrium (Fig. 1). The voltage map showed 
high voltages in the intra-atrial tunnel, albeit without any channels or scars. In the left 
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Figure 1. Top: Fluoroscopic images in the left anterior oblique projection of the magnetic 
navigation catheter retrogradely crossing the aortic valve, passing through the incomplete 
right ventricle, via the ventricular septal defect to the left ventricle, retrogradely through the 
mitral valve, and ending in the left atrium. The atrial and ventricular leads of an epicardial 
pacemaker are visible on all images. Bottom: Schematic reproduction of the heart after 
surgical repair. VCS superior caval vein, APD right pulmonary artery, APS left pulmonary 
artery, AAO ascending aorta, APC common pulmonary artery, TUNNEL intraatrial tunnel, 
LA left atrium, RV right ventricle, LV left ventricle, VCI inferior caval vein. 
 
Figure 1. Top: Fluoroscopic images in the left anterior oblique projection of the magnetic navigation 
catheter retrogradely crossing the aortic valve, passing through the incomplete right ventricle, via 
the ventricular septal defect to the left ventricle, retrogradely through the mitral valve, and ending in 
the left atrium. The atrial and ventricular leads of an epicardial pacemaker are visible on all images. 
Bottom: Schematic reproduction of the heart after surgical repair. VCS superior caval vein, APD right 
pulmonary artery, APS left pulmonary artery, AAO ascending aorta, APC common pulmonary artery, 
TUNNEL intraatrial tunnel, LA left atrium, RV right ventricle, LV left ventricle, VCI inferior caval vein.
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atrium, however, we found multiple channels capable of conducting re-entry tachycardia. 
We modified the substrate by creating 2 lines. The first line bisected a channel between the 
septal and lateral parts of the intra-atrial tunnel, while the second line joined the first line 
to the inferior caval vein (Fig. 2). Subsequent to creation of these lines, we were no longer 
able to induce the tachycardia. The patient remained haemodynamically stable during the 
procedure. During the period of follow-up thus far, the patient has suffered only very short 
episodes of palpitations.
dISCuSSIoN
Conventional manually steerable electrophysiological catheters nowadays are designed to 
reach even remote areas in the heart. These catheters, nonetheless, have a relatively stiff 
body, making it very difficult to generate different consecutive bends, and at the same time 
to maintain a stable position for the tip of the catheter. It is virtually impossible to use a 
retrograde approach with a manually steered catheter to ablate an atrial tachycardia, and 
to our knowledge this has never been performed, even in structurally normal hearts. In our 
patient, we were confronted with several challenges to gain access to the left atrium to 
create activation and voltage CARTO maps. Transseptal mapping through the femoral vein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 
Left panel: the biatrial CARTO voltage map shows only large potentials in the left atrium 
(LA), and different channels in the intra-atrial tunnel (IAT). Right panel: detail of CARTO 
voltage map in antero-posterior orientation (AP) of the intra-atrial tunnel with ablation points 
(red dots), with the first ablation line (hollow arrow) bisecting a channel, and the second 
ablation line (solid arrow) joining the first line to the inferior caval vein. 
 
 
 
 
 
 
 
 
 
Figure 2.
Left panel: the biatrial CARTO voltage map shows only large potentials in the left atrium (LA), and 
different channels in the intra-atrial tunnel (IAT). Right panel: detail of CARTO voltage map in antero-
posterior orientation (AP) of the intra-atrial tunnel with ablation points (red dots), with the first 
ablation line (hollow arrow) bisecting a channel, and the second ablation line (solid arrow) joining the 
first line to the inferior caval vein.
Bruno BW.indd   169 05-Jan-12   17:37:03 PM
170 Chapter 6
was undesirable given the difficulties caused by the previous puncture of the atrial baffle. The 
likelihood of a possible cardiac perforation would put the patient at an unacceptable risk. 
A retrograde approach crossing the aortic valve, passing through the Damus-Kaye-Stansel 
shunt into the incomplete right ventricle, through the ventricular septal defect into the left 
ventricle, and retrogradely through the surgically repaired mitral valve into the left atrium 
was out of the question using a conventional manually steerable catheter. The magnetic 
navigation system, on the other hand, offers the opportunity to use extremely flexible and 
steerable catheters. The floppy tip of such catheters makes it possible to generate multiple 
consecutive bends. The soft and flexible nature of the catheter permits safe access to regions 
that are otherwise practically inaccessible. In addition, the chance of perforating the myo-
cardial wall with the extremely floppy tip is very small. Another advantage is that as long as 
the magnetic field is applied, the tip remains stable at the desired position. Hence, we were 
able safely to generate a biatrial map, which provided valuable information about the origin 
of the postincisional macroreentrant tachycardia.
CoNCluSIoN
To our knowledge, this is the first report demonstrating successful retrograde mapping of the 
left atrium in a patient with complex congenital cardiac disease. Our experience, therefore, 
shows that such procedures can safely and effectively be performed, but we would suggest 
that they be attempted only in centers with extensive experience in magnetic navigation of 
congenitally malformed hearts.
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ABSTRACT
Background: Catheter ablation of ventricular tachycardia (VT) remains a challenging task. 
Recent studies support several advantages of the remote magnetic navigation system (MNS) 
(Niobe, Stereotaxis, Inc., Saint Louis, MO, USA) such as procedural safety, catheter manoeu-
vrability, improvements in electroanatomic mapping and reproducibility of catheter position. 
The aim of this study was to compare the acute and late outcome of VT ablation using 
the MNS to ablation using conventional manual techniques (MAN). Methods: Ablation data 
of 113 consecutive patients with ventricular tachycardia treated with catheter ablation at 
our centre were analyzed. MNS was used in combination with the CARTO RMT (Biosense-
Webster Inc., Diamond Bar, CA, USA) system for catheter navigation, mapping and ablation 
for the MNS group. Patients in the manual group (MAN) were manually ablated using either 
the CARTO XP or the EnSite NavX system (St. Jude Medical, St. Paul, MN, USA). Success 
rate, complications, procedure, fluoroscopy and ablation times, and recurrence rates were 
systematically recorded for all patients. Results: Seventy-two patients were included in the 
MNS group and forty-one patients were included in the MAN group. Patient age, gender, 
aetiology, and right ventricular (RV) and left ventricular (LV) VT were equally distributed 
between the two groups. The investigators did not have input into treatment selection (MNS 
vs. MAN). Acute success was achieved in 59 patients in the MNS group (82%) vs. 27 (66%) 
patients in the MAN group (p = 0.046). Procedural time (177 ± 79 vs. 232 ± 99 minutes, p < 
0.001), mean patient fluoroscopy time (27 ± 19 vs. 56 ± 31 min, p < 0.001), and recurrence 
rate (23.7% vs. 44.4%, p = 0.047) were all significantly lower in the MNS group when 
compared to the MAN group. No major complications occurred in the MNS group (0%) 
vs. 1 cardiac tamponade leading to patient demise and 1 significantly damaged ICD lead in 
the MAN group (4.9%, NS). After a mean follow-up of 20 ± 11 vs. 20 ± 10 months (NS), 
VT recurred in 14 pts (23.7%) in the MNS group vs. 12 pts (44.4%) in the MAN group (p = 
0.047). Conclusions: The use of MNS offers major advantages for ablation of VT, including a 
higher acute success rate, reduced procedure time, lowered fluoroscopy exposure and fewer 
complications. Moreover, fewer recurrences of VT were observed in the MNS group.
Key words: ventricular tachycardia, catheter ablation, remote magnetic navigation
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INTRoduCTIoN
Catheter ablation was introduced in clinical electrophysiology in the 1980s[1,2]. In the past 
decades, it has become well established as first line therapy for many types of arrhythmias, 
including ventricular tachycardia (VT)[3]. Further technological developments such as electro-
anatomical mapping, integration of cardiac imaging and improved catheter design have been 
implemented to improve the consistency of the procedural outcome[4-6]. Until recently, all 
of the above mentioned techniques were based on manual navigation of catheters within 
the heart. The innovation of the remote magnetic navigation system (MNS) has offered 
important theoretical advantages in safety due to the atraumatic catheter design and less 
physical stress and radiation exposure for the physician[6-9]. Higher efficacy is also expected 
due to the unrestricted and reproducible catheter movement as well as improved catheter 
stability[7,10,11].
The objective of this prospective study was to evaluate the acute and long-term efficacy of 
MNS for ventricular tachycardia when compared to conventional manual ablation in the 
hands of the same operators at a single center. We hypothesized that the superior navigation 
capabilities of MNS tip delivery would lead to a superior and more consistent outcome with 
an improvement in procedural safety when compared to conventional methods.
MeThodS
Patients
A total of 113 consecutive VT patients were included in this case series (consecutive VT 
patients from January 1, 2008 until August 31, 2010). Seventy-two patients were included 
in the MNS group and forty-one patients were included in the MAN group. Patient age, gen-
der, etiology, and right ventricular (RV) and left ventricular (LV) VT were equally distributed 
between the two groups (p = NS, Table 1).
At our center, we have two separate electrophysiology laboratories: one equipped with the 
MNS system and one without a MNS system. A responsible person assigns individual patients 
to the one of the two laboratories without input from the investigators. Though this study 
was clearly not randomized, our internal policy does afford some of the scientific benefits 
of a formal randomization, as is evident by the homogeneity of the two groups. The reason 
for the lower number of manual ablations is that the electrophysiology laboratory where the 
manual ablations were performed serves as a device lab too, while in the magnetic room only 
ablations are performed.
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Table 1. Comparison of ablation results between MNS and MAN groups.
MNS – 
number
MNS – 
percentage
MAN – 
number
MAN – 
percentage
P-value
Total pts (n=113) 72 pts 41 pts
Ptn age (years) 51±15 49±17 NS
Sex (male) 49 68.1% 33 80.5% NS
Pediatric 2 2.8% 2 4.9% NS
Hospital stay (days) 4.7 7.1 NS
 NSHD-VT 3.5±2.9 4.4±4.5 NS
 SHD-VT 7.4±9.0 9.9±12.1 NS
ASA 40 55.6% 21 51.2% NS
Acenocoumarol 3 4.2% 5 12.2% NS
Amiodarone 7 9.7% 14 34.1% <0.01
Beta-blocker 16 22.2% 14 34,1% NS
RV/LV Distribution
 RV: →
 LV: →
35
37
48.6%
51.4%
16
25
39.0%
61.0%
NS
VT Etiology
 NSHD: →
 SHD: →
49
23
68.1%
31.9%
21
20
51.2%
48.8%
0.046
Retrograde approach LV 32/37 86.5% 21/25 84.0% NS
Overall Acute success 59 81.9% 27 65.9% 0.046
 NSHD-VT 41/49 83.7% 13/21 61.9% 0.049
 SHD-VT 18/23 78.3% 14/20 70.0% NS
Procedural time (minutes) 177±79 232±99 <0.01
 NSHD-VT 151±57 210±96 0.011
 SHD-VT 237±91 250±101 NS
Number of RF applications 17.8±21.5 24.4±24.0 NS
 NSHD-VT 10.2±8.1 12.4±9.3 NS
 SHD-VT 33.3±30.8 34.0±27.8 NS
Application time (seconds) 816±902 1330±1289 0.024
 NSHD-VT 494±402 652±541 NS
 SHD-VT 1540±1254 1636±1412 NS
Fluoroscopy time (minutes) 26.9±19.3 55.9±31.5 <0.001
 NSHD-VT 19.7±11.2 42.3±20.3 <0.001
 SHD-VT 42.5±23.7 68.9±35.1 <0.01
Major complications 0 0% 2 4.9% NS
Follow up (months) 20±11 20±10 NS
Recurrence 14 23.7% 12 44.4% 0.047
 NSHD-VT 7 17.1% 4 30.8% NS
 SHD-VT 7 38.9% 8 57.1% NS
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electrophysiology studies - ablations
The procedures were performed over the entire study duration by the same senior electro-
physiologist group with the assistance of four fellows, trained for both manual catheter 
navigation and for remote MNS ablation. All catheter procedures were performed in ac-
cordance with institutionally approved local medical treatment protocols of the Erasmus MC, 
Thoraxcenter, Rotterdam. Prior written, informed consent for the ablation procedure was 
obtained from all patients. Resting 12-lead ECG, laboratory tests, an x-ray thorax image and 
a two-dimensional echocardiography were acquired from all patients within 48 hours of the 
procedure.
Standard peri-procedural medication protocols were followed in all patients. For planned 
procedures, patients were instructed to stop taking antiarrhythmic drugs for a period of at 
least four half lives prior to undergoing the procedure (except amiodarone). In cases of emer-
gency VT ablation, medication remained unchanged. The procedures were performed during 
a fasting state, using local or general anesthesia. Market-approved diagnostic and ablation 
catheters were used as clinically indicated at the discretion of the operator. Investigators were 
not involved in the decision as to whether a patient was placed in our MNS laboratory or our 
MAN laboratory.
The left heart was accessed via retrograde aortic route or transseptal puncture based on 
the operator’s preference. Generally, left sided ventricular arrhythmias were performed via 
retrograde approach (MNS 32/37, 87%; MAN 21/25, 84%; p = NS, Table 1). The use of a 
three-dimensional mapping system was mandatory in both groups for all patients. Intracar-
diac echocardiography (ICE) was used to guide transseptal punctures in all patients where 
applicable.
Table 1. (continued)
MNS – 
number
MNS – 
percentage
MAN – 
number
MAN – 
percentage
P-value
ICD 22 30.6% 22 53.7% 0.013
 NSHD-VT 5 10.2% 4 19.0% NS
 SHD-VT 17 73.9% 18 90.0% NS
ATP 0.94±2.19 [0-9] 1.18±2.21 [0-8] NS
 NSHD-VT 0.50±1.00 [0-2] 0.50±1.00 [0-2] NS
 SHD-VT 1.08±2.47 [0-9] 1.38±2.47 [0-8] NS
ICD Shock 0.41±0.87 [0-3] 0.88±2.03 [0-7] NS
 NSHD-VT 0.75±0.96 [0-2] 0.50±1.00 [0-2] NS
 SHD-VT 0.31±0.85 [0-3] 1.00±2.27 [0-7] NS
NSHD= non-structural heart disease, RV= right ventricle, LV= left ventricle, SHD= structural heart 
disease, VT= ventricular tachycardia, IHD= ischaemic heart disease, NIHD= non-ischaemic heart disease, 
RF= radiofrequency, ICD= implantable cardioverter defibrillator, ATP= antitachycardia pacing
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For patients with SHD, the procedure started with induction of VT and was followed by de-
tailed mapping of the ventricle in order to localize of the myocardial scars as potential targets 
for catheter ablation. Programmed stimulation was performed using up to triple extrastimuli 
pacing from the right ventricular apex, right ventricular outflow tract or left ventricle. 12-lead 
ECG recordings were obtained for all inducible arrhythmias. If only VF or polymorphic VT 
was inducible the procedure was continued with electroanatomical substrate mapping using 
either the CARTO RMT (Biosense Webster, Inc., Diamond Bar, CA, USA) or the EnSite NavX 
system (St Jude Medical, Inc., St Paul, MN, USA). Bipolar contact electrograms were recorded 
and used to create a 3-dimensional map of the chamber based on the voltage amplitude. Af-
ter creating a substrate map an extensive scar ablation (scar homogenization) was performed 
in all regions where scar tissue was identified. Scar was defined as a low voltage area under 
1.5 mV. However, in order to minimize myocardial damage all lesions were made at the ≤ 1.0 
mV border. In case of a hemodynamically stable VT the operators were allowed the tackle the 
VT by creating an activation map and identifying corridors as a part of the specific VT circuit. 
However, even after successful treatment of that particular VT, eventual scar homogenization 
was mandatory. For patients with idiopathic VTs standard ablation and mapping techniques 
were applied based on operator’s choice. In principle, during hemodynamically stable VTs an 
activation map was created during the VT, usually followed by pace mapping (the site with 
a paced 12-lead QRS morphology identical to an inducible monomorphic VT was assumed 
to be the exit site or the site of origin of that particular VT) for confirmation. In patients 
where the VT was hemodynamically untolerable or was non-sustained, pace mapping was 
performed to identify the origin and/or exit of the tachycardia. If that was possible the VT 
was targeted during ongoing tachycardia in this group. There were no differences between 
treatment strategies in the MNS and manual ablation groups.
Crossover from the magnetic navigation catheter to manual navigation catheter was allowed 
at the discretion of the investigator. Any crossover was counted as an acute failure for the 
MNS group. Crossover from the MAN to the MNS group was not possible due to the fact 
that the MAN procedures were performed in another EP laboratory which was not equipped 
with MNS.
The endpoints of procedural success were defined as follows: if the VT was inducible, non-
inducibility was the endpoint; if only ventricular extrasystoles (VES) were present, then the 
complete abolishment of VES as assessed by 24 hours telemetry was required for acute 
success. The presence of pacemaker (PM) or implantable cardioverter defibrillator (ICD) was 
not considered as a contraindication for MNS guided ablations, which is consistent with 
the product labeling for the MNS. There was a statistically greater percentage of implant-
able devices in the MAN group (22/41, 53.7%) when compared to the MNS group (22/72, 
30.6%, p = 0.013, Table 1).
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MNS-guided ablations
The procedures were performed in the MNS group using the Stereotaxis Niobe Magnetic 
Navigation System (Stereotaxis, Inc., Saint Louis, MO, USA) in an EP lab equipped with a 
Siemens Axiom Artis (Siemens, Erlangen, Germany) fluoroscopy system. All patients were 
treated with the NaviStar RMT ThermoCool catheter (Biosense Webster, Inc., Diamond Bar, 
CA, USA). Electroanatomical mapping was performed using the CARTO RMT (Biosense 
Webster, Inc., Diamond Bar, CA, USA) system.
Manual-guided ablations
The procedures in the MAN group took place in an EP lab equipped with a Siemens Megalix 
(Siemens, Erlangen, Germany) fluoroscopy system. Electroanatomical mapping was per-
formed using the EnSite NavX system (St Jude Medical, Inc., St Paul, MN, USA). The following 
ablation catheters were used: Biosense Webster B, D and F curve Celsius Thermocool, St Jude 
Cool Path Duo.
data collection and analysis
The following parameters were analyzed for both the MNS group and the MAN group: acute 
success rate, fluoroscopy time, procedure time, total RF time, RF applications and complica-
tions. Acute success rate was assessed according to the terms mentioned above. Fluoroscopy 
time was recorded from the fluoroscopy system in each room. Procedure time was defined 
as the interval between subcutaneous injection of lidocaine to the groin and removal of 
catheters from the patient’s body including a 30 minutes waiting time for every case. Any 
adverse event recognized by the operator during the procedure, by the attending cardiologist 
prior to hospital discharge, or by the general physician during follow up was investigated 
by a trained electrophysiologist, and was considered as a complication if the event could be 
related to the procedure. Major complications were defined as pericardial effusion or/and 
tamponade, permanent AV block, PM/ ICD damage requiring device or electrode replace-
ment, stroke, major bleeding, or death. Minor complications were defined as minor bleeding 
(groin hematomas), transient ischemic attack and temporary AV block.
Subgroup analyses were performed for patients with and without structural heart disease 
(SHD and NSHD) and for right-sided versus left-sided ablations.
Follow up
Follow up visits were scheduled for all patients at the outpatient clinic of our department 3 
months following the procedure and for every 3 months thereafter. For patients treated for 
idiopathic VT, 24-hours Holter recordings were scheduled during these clinic visits, while for 
scar-related VT patients the ICD interrogations served as primary source for documentation 
of recurrent arrhythmias. ICD shock and antitachycardia pacing (ATP) is reported as an event 
as well.
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Statistics
All patient data was analyzed using SPSS 15.0 (SPSS Inc., Chicago, IL, USA). Patient demo-
graphic and baseline characteristics were presented as mean ± SD. The two-tailed Student’s 
t-test was used for comparing continuous unpaired samples, assuming unequal variances. 
For categorical variables the χ2 test or Fischer’s exact test was performed. A two-sided p value 
< 0.05 was considered to be statistically significant.
ReSulTS
overall
The two groups were statistically homogeneous when comparing age, gender distribution, 
number of pediatrics, hospital stay, and RV/LV distribution (Table 1). Acute success was 
greater in the MNS group when compared to the MAN group (81.9% vs. 65.9%, p=0.046). 
After unsuccessful endocardial ablation an epicardial approach was considered necessary 
in 31% and 29% of the MNS and MAN procedures, respectively (NS). Patients received 
an ICD in 30.6% in the MNS group and 53.7% in the MAN group (p=0.013). In MNS pts 
the post-procedural amiodarone use was significantly lower than in MAN group (9.7% vs. 
34.1%, p<0.01). Overall, the ablation procedures were shorter and fluoroscopy time was 
reduced in the MNS group: 177±79 vs. 232±99 min (p<0.01) and 27±19 vs. 56±31 min 
(p<0.001), respectively. Between MNS and MAN there was no difference in number of appli-
cations (17.8±21.5 vs. 24.4±24.0, p=NS), although in the MNS group there was significantly 
reduced total ablation time (816±902 vs. 1330±1289 seconds, p=0.024).
NShd-VT
The success rate in the NSHD-VT subgroup was higher in MNS group (83.7% vs. 61.9%, 
p=0.049). For NSHD-VT in the RV and LV, no statistical difference was found between MNS 
and MAN (Table 2). MNS procedures for NSHD-VT were related to decreased procedure times 
(151±57 vs. 210±96 min, p=0.011) and less fluoroscopy use (19.7±11.2 vs. 42.3±20.3 min, 
p<0.001). Number of RF applications and total ablation time were not significant different: 
10.2±8.1 vs. 12.4±9.3 (p=NS) and 494±402 vs. 652±541 seconds (p=NS). In the subgroup 
no difference in ICD implantation is noticed between MNS and MAN pts (Table 1).
Shd-VT
In VT subgroup with SHD acute success did not reach statistical significance (78.3% vs. 
70.0%, p=NS). For the subgroups of SHD-VT no differences were observed in success rates, 
too (Table 2). In the MNS group less fluoroscopy was used compared to the MAN group 
(42.5±23.7 vs. 68.9±35.1 min, p<0.01). No statistical difference was found for procedural 
time (237±91 vs. 250±101 min, p=NS), RF applications (33.3±30.8 vs. 34.0±27.8, p=NS) 
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and ablation time (1540±1254 vs. 1636±1412 min, p=NS). There is no statistical significant 
difference for ICD implantation between both groups (Table 1).
Crossovers
In two MNS procedures the operator switched to a manual ablation catheter. During one 
operation the arterial sheath was dislocated resulting in inguinal bleeding (minor bleeding). 
In another patient the VT focus was closely located to the His bundle and for safety reasons 
cryo-ablation was applied.
Complications
There were no major complications in the MNS group (0%). In the MAN group, one patient 
suffered a cardiac tamponade that ultimately lead to the patient’s demise and one patient 
suffered a significantly damaged ICD lead, thus yielding a major complication rate of 4.9% 
(Figure 1). These complication rates were not significantly different between the two groups. 
In MNS and MAN occurrence of groin hematomas was similar (6% vs. 7%, p=NS). In two 
patients in the MNS group, the ICD switched to magnet mode (asynchronous pacing). 
Neither of these patients was PM dependent, therefore temporary programming allowed 
electro-anatomical mapping without further problems. Of interest, both of these patients 
had an implant that was abdominally placed. No any long term effect on ICD or PM function 
was observed in any patient, including these two magnet mode switched patients.
No other complications were recorded in both groups.
Follow up
Patient follow up was obtained at a mean of 20±11 months in the MNS group and 20±10 
months in the MAN group (p = NS). For the overall MNS group, 14/72 patients had a recur-
rence of their arrhythmia (23.7%) compared to 12/41 patients in the MAN group (44.4%). 
This difference was statistically significant (p = 0.047, Table 1). For the NSHD and SHD sub-
groups, no statistical differences were found for recurrence: 17.1% vs. 30.8% (p=NS) and 
Table 2. Comparison of acute success and recurrence rates between all subgroups within MNS and 
MAN main groups.
Total Pts: N = 113 MNS Acute 
Success
MAN Acute 
Success
P-value MNS 
Recurrence
MAN 
Recurrence
P-value
NSHD-VT
 RV
 LV
26/30 (86,7%)
15/19 (78,9%)
8/13 (61,5%)
5/8 (62,5%)
NS
NS
5/26 (19,2%)
2/15 (13,3%)
2/8 (25%)
2/5 (40%)
NS
NS
SHD-VT
 IHD
 NIHD
15/16 (93,8%)
3/7 (42,9%)
8/12 (66,7%)
6/8 (75%)
NS
NS
7/15 (46,7%)
0/3 (0%)
3/8 (37,5%)
5/6 (83,3%)
NS
0.048
NSHD= non-structural heart disease, RV= right ventricle, LV= left ventricle, SHD= structural heart 
disease, VT= ventricular tachycardia, IHD= ischaemic heart disease, NIHD= non-ischaemic heart disease
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38.9% vs. 57.1% (p=NS), respectively. During follow up, fewer recurrences were observed 
in NIHD pts from the SHD subgroup (Table 2). No differences were found in ATP therapy 
and ICD shocks between the overall groups and the VT subgroups (Table 2). Furthermore, 
post-procedural use of amiodarone in the MNS group was significantly lower than in the 
MAN group (9.7% vs. 34.1%, p=0.002).
dISCuSSIoN
This is the first study which directly compares the efficacy and safety of VT ablation between 
remote magnetic and manual navigation involving statistically equivalent, large-scale patient 
groups and including both idiopathic and scar-related VT patients. The major finding of this 
study is that MNS was found to have a higher rate of acute success for catheter ablation of 
VT. Furthermore, this advantage remained apparent during the follow up, as fewer recur-
rences occurred in the MNS group as compared to the MAN group.
Rationale of MNS for VT ablation
The success of catheter ablation procedures depends on accurate substrate location, fol-
lowed by optimal delivery of energy provided by good tissue contact[12]. Manual navigation 
of catheters in the human ventricles has limitations. Some regions are difficult to reach, 
and compromised catheter positioning may result in insufficient lesion formation[7,10,12]. 
Catheter movement in some positions is accompanied by the risk of major complications, in-
Part 3 Chapter 7 
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cluding pericardial effusion or tamponade[13). Although several pre-defined catheter curves 
were introduced to help appropriate lesion delivery, there are no optimal curves available 
for all subtypes of group of patients such patients with small hearts, patients with complex 
congenital heart defects, or for patients with extremely dilated hearts[14]. The introduction 
and utilization of MNS was aimed to surmount these difficulties. It provides improvement of 
safety by the flexible catheter design, and no pericardial effusion or tamponade was reported 
related to catheter navigation using MNS[6,15-19]. MNS also provides better navigation 
capability, which is not limited by preformed or evolved catheter curves[11,14,20].
In addition, non-fluoroscopic imaging and software-based automated functions such as 
auto-mapping and stored magnetic vectors may allow for reductions in fluoroscopy time to 
both operator and patient[21]. Stored magnetic vectors also make it possible to re-navigate 
to spots previously defined and stored during the procedure[11]. Promising initial results have 
been published concerning these capabilities of the MNS[6, 15,17-19].
Differences in mapping capabilities have also been noted between the MNS and conventional 
methodology. Latcu and colleagues reported on 20 patients with suspected arrhythmogenic 
right ventricular dysplasia who underwent RV mapping with both MNS and MAN techniques. 
Figure 2. 
Postero-inferior CARTO electroanatomical map view of the LV ventricle after MNS guided 
scar homogenization in a patient with electrical storm. The patient had more than 15 VT 
morphologies before the ablation procedure and became non-inducible after the ablation. The 
CARTO contains 958 mapping points (including radiofrequency ablation poin s-red dots). 
The white dots indicate regions with isolated late potentials. The patient became non-
inducible and had no recurrences during the follow-up. 
 
 
 
 
 
 
Figure 2.
Postero-inferior CARTO electroanatomical map view of the LV ventricle after MNS guided scar 
homogenization in a patient with electrical storm. The patient had more than 15 VT morphologies 
before the ablation procedure and became non-inducible after the ablation. The CARTO contains 958 
mapping points (including radiofrequency ablation points-red dots). The white dots indicate regions 
with isolated late potentials. The patient became non-inducible and had no recurrences during the 
follow-up.
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In this series, they reported higher RV volumes and surface areas and fewer, more defined 
low voltage areas and concluded that MNS maps were more accurate than MAN maps[22].
Other authors have shown a reduction in ventricular extrasystolies (VES) when using MNS 
for outflow tract tachycardias. Konstantinidou and colleagues recently published a series 
of 13 RVOT tachycardia patients who were treated with the MNS and concluded that the 
MNS was associated with a very low incidence of catheter-induced VES[23]. Our own group 
published a series of 3 cases with minimal ventricular extrasystolies and precise ablation in 
right ventricular outflow tract tachycardia ablation[7].
Ablation of VT: tip delivery vs. therapy delivery
This is the first larger-scale case-control study to prove superiority of MNS for ablation of 
VT when compared to manual navigation. This is demonstrated in most of the analyzed 
parameters, including acute success rate, procedure and fluoroscopy times, and recurrence 
rate. There are multiple reasons to explain this finding. The MNS guided catheter retains its 
maneuverability even in difficult positions, such as those encountered in cusp-related VT 
and papillary muscle originated VT, where the capabilities of manual navigation are seriously 
limited by the multiple curves of the catheter[7]. The MNS controls the tip of the catheter 
without the need for a predefined curve, which means that the unavoidable curves of the 
catheter do not hinder the positioning of the tip, and good contact can be achieved. This 
consistent contact results in appropriate lesion formation[10].
Acute success rates and recurrences
Based on the theoretical advantages mentioned above, MNS could be superior to manual 
navigation in the analyzed parameters. Reports until now focused more on feasibility rather 
than assessment of efficacy of MNS[24-27]. Our data showed a statistically significant in-
crease in acute success in the MNS when compared to the MAN group. In our study, this 
acute difference lead to an improvement in recurrence rates in patients treated with remote 
magnetic navigation when compared to patients treated with manual methods.
limitations of the study
This study is not a randomized, prospective trial, and the follow up interval was relatively 
short. To address this limitation, we included consecutive patients in both groups and did not 
exclude any patient from our study cohort. Also, at our center, patients are placed into either 
our MNS laboratory or our MAN laboratory by a responsible person who is not involved in 
clinical decision-making. This process effectively allows us to practically compare two dis-
parate treatment groups without major bias, as is confirmed by the homogeneity between 
our two study groups. Furthermore, this study includes all consecutive VT patients from our 
hospital regardless the etiology of the tachycardias. This resulted in an obvious difference in 
the follow up method. For the ICD subgroup the ICD follow up provides extreme accuracy, 
Bruno BW.indd   186 05-Jan-12   17:37:09 PM
Catheter ablation of VT using MNS: a consecutive case-control study 187
C
h
ap
te
r 
7
however, device follow up was not available for the idiopathic group, where Holter ECG 
monitoring served as a primary source for the follow up.
CoNCluSIoNS
In conclusion our data strongly suggest that the MNS offers significant advantages for the 
ablation of both idiopathic and scar-related VT when compared to conventional methods. 
Prospective, randomized studies should be conducted to confirm the conclusions from our 
retrospective case-control study.
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Chapter 8
The magnetic navigation system allows 
safety and high efficacy for ablation of 
arrhythmias
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Luc Jordaens, MD, PhD and Tamas Szili-Torok, MD, PhD
Bruno BW.indd   191 05-Jan-12   17:37:15 PM
Bruno BW.indd   192 05-Jan-12   17:37:15 PM
The MNS allows safety and high efficacy for ablation of arrhythmias 193
C
h
ap
te
r 
8
ABSTRACT
Aims: We aimed to evaluate the safety and long-term efficacy of the magnetic navigation 
system (MNS) in a large number of patients. The MNS has the potential for improving safety 
and efficacy based on atraumatic catheter design and superior navigation capabilities. Meth-
ods and results: In this study, 610 consecutive patients underwent ablation. Patients were 
divided into two age- and sex-matched groups. Ablations were performed either using MNS 
(group MNS, 292) or conventional manual ablation [group manual navigation (MAN), 318]. 
The following parameters were analysed: acute success rate, fluoroscopy time, procedure 
time, complications [major: pericardial tamponade, permanent atrioventricular (AV) block, 
major bleeding, and death; minor: minor bleeding and temporary AV block]. Recurrence 
rate was assessed during follow-up (15+9.5 months). Subgroup analysis was performed for 
the following groups: atrial fibrillation, isthmus dependent and atypical atrial flutter, atrial 
tachycardia, AV nodal re-entrant tachycardia, circus movement tachycardia, and ventricular 
tachycardia (VT). Magnetic navigation system was associated with less major complications 
(0.34 vs. 3.2%, P ¼ 0.01). The total numbers of complications were lower in group MNS 
(4.5 vs. 10%, P ¼ 0.05). Magnetic navigation system was equally effective as MAN in acute 
success rate for overall groups (92 vs. 94%, P ¼ ns). Magnetic navigation system was more 
successful for VTs (93 vs. 72%, P , 0.05). Less fluoroscopy was used in group MNS (30+20 
vs. 35+25 min, P , 0.01). There were no differences in procedure times and recurrence rates 
for the overall groups (168+67 vs. 159+75 min, P ¼ ns; 14 vs. 11%, P ¼ ns; respectively).
Conclusions Our data suggest that the use of MNS improves safety without compromising 
efficiency of ablations. Magnetic navigation system is more effective than manual ablation 
for VTs.
Key words: Arrhythmias, Catheter ablation, Remote magnetic navigation
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INTRoduCTIoN
Catheter ablation was introduced in clinical electrophysiology (EP) in the 1980s.1,2 In past 
decades, it became well established as firstline therapy for many types of arrhythmias, includ-
ing atrioventricular (AV) nodal re-entrant tachycardia (AVNRT), circus movement tachycardia 
(CMT), and cavotricuspid isthmus (CTI)-dependent atrial flutter (AFl), and as therapeutic 
option for the treatment of atrial fibrillation (AFib), atrial tachycardia (AT), and ventricular 
tachycardia (VT).3 Further developments were implemented such as electroanatomical map-
ping, integration of cardiac imaging, and improved catheter design.4,5 Until recently, all of 
the abovementioned techniques were based on manual catheter navigation in the heart. The 
innovation of the remote magnetic navigation system (MNS) offered important theoretical 
advantages in safety due to the atraumatic catheter design and less physical stress and radia-
tion exposure for the physician.6 – 11 Higher efficacy is also expected due to the unrestricted 
and reproducible catheter movement, and improved catheter stability.8,11 – 13 Numerous 
centres reported their initial experiences with MNS confirming its feasibility for ablation 
of most arrhythmias.14 – 23 However, these early reports included only small numbers of 
patients, the follow-up periods were short, and they failed to demonstrate superiority of 
MNS in safety and efficacy. The objective of the present study was to evaluate the safety and 
long-term efficacy of MNS as compared with conventional manual ablation techniques in a 
large number of patients with consistent technique and workflow.
MeThodS
Patients
This study is an ongoing registry of the procedures performed in our clinic. Six hundred 
and ten consecutive patients underwent ablation from January 2008 to March 2010. All 
patients scheduled for EP study and ablation were distributed from the waiting list based 
on availability to the MNS-equipped or the conventional EP laboratory. Accordingly, ablation 
was performed either using MNS (group MNS, 292 patients, age 48+19 years, 166 males) or 
using conventional manual ablation (group MAN, 318 patients, age 52+16 year, 197 males). 
The procedures were performed over the entire study duration by the same senior electro-
physiologist group with the assistance of four fellows, trained for manual catheter navigation 
and for MNS as well. The attending physicians performed MNS and MAN procedures in equal 
distribution.
electrophysiology studies—ablations
Written, informed consent for the ablation procedure was obtained from all patients. Rest-
ing 12-lead electrocardiogram (ECG), and laboratory tests, an X-ray thorax image, and a 
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two-dimensional echocardiography were acquired from all patients within 1 month before 
and within 48 h following the procedure. Local peri-procedural medication protocols were 
followed in all patients. In short, AVNRT, CMT, AT, and elective VT patients were instructed 
to stop taking antiarrhythmic drugs for a period of at least four half-lives prior undergoing 
the procedure. In cases of AFib, AV junction (AVJ) and emergency VT ablation medication 
remained unchanged. The procedures were performed during a fasting state, using local 
or general anaesthesia. Market-approved diagnostic and ablation catheters were used as 
clinically required at the discretion of the operator. The left heart could be accessed via the 
retrograde aortic route or transseptal puncture (TSP) based on the operator’s preference. 
Generally, left-sided ventricular arrhythmias were performed via the retrograde approach 
(MNS 93%, MAN 89%; P ¼ ns), left-sided atrial arrhythmias always via TSP, and left-sided 
accessory pathways distributed between the two methods (MNS 22% TSP, group MAN 20% 
TSP; P ¼ ns). The use of three-dimensional mapping system was allowed in both groups 
if necessary. Intracardiac echocardiography (ICE) was used to guide TSPs in both groups. 
Crossover from the magnetic navigation catheter to manual navigation catheter was allowed 
at the discretion of the investigator, although the crossover counted as an acute failure 
for the MNS group. Crossover from the MAN to the MNS group was not possible due to 
logistical reasons (see below).
The endpoints of procedural success were defined as the elimination of accessory pathway 
conduction for CMT, the elimination of inducibility and no more than single echo beats for 
AVNRT, complete AV block for AVJ ablation, bi-directional isthmus block for CTI dependent 
AFl, and complete electrical pulmonary vein isolation for AFib. For VT patients; if the VT was 
inducible, non-inducibility was the endpoint, if only ventricular extrasystoles (VES) were pres-
ent, then the complete abolishment of VES assessed by 24 h telemetry counted as acute suc-
cess. The presence of a pacemaker (PM) or an implantable cardioverter defibrillator (ICD) was 
not considered as contraindication for MNS-guided ablations. According to an institutional 
protocol for the treatment of patients with AFib, all paroxysmal AFib patients were ablated 
using the cryoballoon technique, the persistent AFib patients were ablated using cryoballoon 
or MNS, and all long-standing persistent (.12 months) AFib patients were ablated using MNS. 
Persistent and long-standing persistent AFib procedures included additional linear ablation in 
the left and/or right atrium. Whenever linear ablation was performed, conduction block was 
mandatory to be proven. Regardless of the type of AFib patients pulmonary vein isolation 
was mandatory in all patients. This was always controlled by a ‘lasso-type’ catheter. Also, 
atypical AFl and AT patients were ablated generally using MNS (50 of 56, 89%).
Magnetic navigation system-guided ablations
The procedures were performed in group MNS using the Stereotaxis Niobe II (Stereotaxis, 
Inc., St Louis, MO, USA) implemented in an EP lab equipped with a Siemens Axiom Artis (Sie-
mens, Erlangen, Germany) fluoroscopy system. The following ablation catheters were used: 
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for AVNRT, CMT and AVJ Celsius RMT (4 mm) (Biosense Webster, Diamond Bar, CA, USA), 
and for AFib NaviStar RMT ThermoCool (Biosense Webster), AFl/AT and VT Navistar RMT DS 
(8 mm), NaviStar RMT ThermoCool (Biosense Webster), or Trignum Flux Gold-tip (Biotronik 
GMBH, Berlin, Germany). The use of an 8 mm tip RMT catheter was associated with a char 
formation in some patients. Therefore, after the thermocool RMT catheter became available 
the 8 mm tip catheter was no longer used. When needed, electroanatomical mapping was 
performed using the CARTO RMT (Biosense Webster) system.
Manual-guided ablations
The procedures in the MAN group took place in an EP lab equipped with a Siemens Megalix 
(Siemens) fluoroscopy system. Electroanatomical mapping was performed using CARTO 
(Biosense Webster) or EnSite (St Jude Medical Inc., St Paul, MN, USA) system. The following 
ablation catheters were used: for AVNRT, CMT, and AVJ Biosense Webster B–D curve 4 or 8 
mm tip (Biosense Webster), for AFib, AFl/AT, and VT Biosense Webster Navistar ThermoCool 
(Biosense Webster). The Artic Front cryoballoon catheters (Medtronic Inc., Minneapolis, MN, 
USA) were used for cryo-isolation of the pulmonary veins; Freezor Max (Medtronic Inc.) 
catheters were used in cases when complete electrical isolation could not be achieved with 
the balloon.
data collection and analysis
The following parameters were analysed both in group MNS and group MAN: acute success 
rate, fluoroscopy time, procedure time, and complications. Acute success rate was assessed 
according to the terms mentioned above. Fluoroscopy time and procedure time (latter began 
with subcutaneous injection application of lidocaine by the physician to the groin and ended 
when catheters were removed from the patient’s body) were recorded in the clinical proce-
dure log and included a 30 min waiting time. Any adverse event recognized by the operator 
during the procedure, by the attending cardiologist prior to hospital discharge, or by the 
general physician during follow-up was investigated by a trained electrophysiologist, and 
was considered as a complication if the event could be related to the procedure. Complica-
tions were categorized as major and minor [major: pericardial effusion or/and tamponade, 
permanent AV block, stroke, major bleeding (requiring blood transfusion or haemoglobin 
serum level drop of .20 g/L) or death; minor: minor bleeding, transient ischaemic attack, and 
temporary AV block.
Subgroup analysis of the above-mentioned parameters was performed for the following 
groups: AFib, AFl, atypical AFL (aAFl)/AT, AVNRT, CMT, AVJ, and VT. The AFib group was 
further divided into the following subgroups: paroxysmal, persistent, and long-standing 
persistent. Because different techniques were used for the treatment of paroxysmal and 
long-standing persistent AFib patients, paroxysmal and long-standing persistent AFib sub-
groups were not compared in efficacy; however, data from these groups were included into 
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the safety comparison (Tables 1 and 2). Patients included into the persistent AFib group were 
comparable (Tables 1 and 2). The VT group was further analysed in subgroups of patients 
with and without structural heart disease (SHD and NSHD).
Follow-up
Follow-up visits were scheduled for all patients at the outpatient clinic of the Department of 
Cardiology, Erasmus MC 3 months following the procedure, and every 3 months thereafter, 
Table 1 Patient demographics
complication if the event could be related to the procedure. Compli-
cations were categorized as major and minor [major: pericardial effu-
sion or/and tamponade, permanent AV block, stroke, major bleeding
(requiring blood transfusion or haemoglobin serum level drop of
.20 g/L) or death; minor: minor bleeding, transient ischaemic attack,
and temporary AV block].
Subgroup analysis of the above-mentioned parameters was per-
formed for the following groups: AFib, AFl, atypical AFL (aAFl)/AT,
AVNRT, CMT, AVJ, and VT. The AFib group was further divided into
the following subgroups: paroxysmal, persistent, and long-standing per-
sistent. Because different techniques were used for the treatment of
paroxysmal and long-standing persistent AFib patients, paroxysmal
and long-standing persistent AFib subgroups were not compared in
efficacy; however, data from these groups were included into the
safety comparison (Tables 1 and 2). Patients included into the persist-
ent AFib group were comparable (Tables 1 and 2). The VT group was
further analysed in subgroups of patients with and without structural
heart disease (SHD and NSHD).
Follow-up
Follow-up visits were scheduled for all patients at the outpatient clinic
of the Department of Cardiology, Erasmus MC 3 months following the
procedure, and every 3 months thereafter, except for CMT, AFl, and
AVNRT patients, when other than the first follow-up visit was sched-
uled only if the symptoms recurred. Atrial fibrillation patients were
more rigorously followed at the AFib clinic of the department, includ-
ing daily transtelephonic rhythm strips.
Statistics
Parameters obtained from the registry were analysed using SPSS 15.0
(SPSS Inc., Chicago, IL, USA). Patient demographic and baseline charac-
teristics were presented as mean+ SD. The two-tailed Student’s t-test
was used for comparing continuous unpaired samples, assuming
unequal variances (age, fluoroscopy time, procedure time, and
follow-up period). For categorical variables the x2 test was performed
(number of patients with different arrhythmias, gender, success rate,
recurrence rate, and number of complications). Two-sided P values
,0.05 were considered significant.
Results
Patients
There were no differences in the gender and age between group
MNS and MAN (Table 1). There were no differences in the
number of patients enrolled into the subgroups based on the diag-
nosed arrhythmias, except for the subgroups mentioned in the
Methods section—paroxysmal and long-standing persistent AFib
and AFL/AT (Table 1). There was no difference in the presence
of PMs or ICDs between the study groups (PM: 4 MNS vs. 6
MAN, P ¼ NS; ICD 20 MNS vs. 21 MAN, P ¼ NS). In, two patients
(both in the VT group, both had abdominal implant) the ICD
switched to magnet mode (asynchronous pacing). None of these
patients were PM dependent; therefore, temporary programming
allowed electro-anatomical mapping without further problems.
No long-term effect on ICD or PM function was observed.
Ablation
Magnetic navigation system was equally effective as MAN in acute
success rate for the overall groups (Table 2). In the subgroups only
VT results were different, where MNS was more successful
(Table 2). The success rate in the NSHD-VT subgroup was
higher in MNS group, whereas the difference in VT subgroup
with SHD did not reach statistical significance (Table 2). For the
other subgroups no differences were observed in success rates
(Table 2).
Crossovers occurred only before the availability of irrigated tip
MNS catheters, whereas one CMT patient and two AFl patients
underwent crossover from MNS catheters (4 mm for CMT,
8 mm for AFl) to manual guided irrigation tip catheters. Following
the crossover all the three patients were ablated successfully.
However, the MNS still proved to be non-inferior for the ablation
of AFl and CMT. Overall, less fluoroscopy was used in group MNS
(Table 3). In the AVNRT and VT subgroups, less fluoroscopy was
used in group MNS, otherwise there were no differences
between the two groups (Table 3). There were no differences in
procedure times between group MNS and MAN. Concerning sub-
groups, procedure times were higher using MNS in AFl, but were
shorter in the VT subgroup.
Complications
The use of MNS was associated with a lower complication rate (4.5
vs. 10%; P ¼ 0.005). Moreover, concerning major complications
the difference was also significant between the two groups (0.34
vs. 3.2%; P ¼ 0.01). One permanent AV block occurred in the
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Patie emographics
Group
MNS
Group
MAN
Total
Number 292 318 610
Age (years) 48+19 52+16 50+18
Gender 166 male
(57%)
197 male
(62%)
363 male
(60%)
AFib 56 (19%) 76 (24%) 132 (22%)
Paroxysmal – 60 (19%) 60 (9.8%)
Persistent 23 (7.9%) 16 (5.0%) 39 (6.4%)
Long-standing
persistent
33 (11%) – 33 (5.4%)
AFl 40 (14%) 84 (26%) 124 (20%)
aAFl/AT 50 (17%) 6 (1.9%) 56 (9.2%)
AVNRT 29 (10%) 70 (22%) 99 (16%)
CMT 55 (19%) 45 (14%) 100 (16%)
AVJ 8 (2.7%) 8 (2.5%) 16 (2.6%)
VT 54 (18%) 29 (9.1%) 83 (14%)
VT-SHD 17 (5.8%) 15 (4.7%) 32 (5.2%)
VT-NSHD 37 (12%) 14 (4.4%) 51 (8.4%)
MNS, magnetic navigation system; MAN, manual navigation; AFib, atrial fibrillation;
AFl, cavotricuspid isthmus-dependent atrial flutter; aAFl, atypical atrial flutter; AT,
atrial tachycardia; AVNRT, atrioventicular nodal re-entrant tachycardia; CMT,
circus movement tachycardia; AVJ, atrioventricular junction; VT, ventricular
tachycardia; SHD, structural heart disease; NSHD, non-structural heart disease.
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Table 2 Ablation results—acute success
MNS and one in the MAN group. The other nine major compli-
cations in the MAN group were either pericardial effusion or peri-
cardial tamponade, whereas no effusion/tamponade occurred in
the MNS group. There was a trend towards lower minor compli-
cations in the MNS group as well, but it did not reach statistical sig-
nificance (4.1 vs. 6.4%; P ¼ ns) (Figure 1). Two temporary AV block
were observed in the MNS group, one in the MAN group, the rest
of the minor complications were femoral bleeding/haematoma in
both groups.
Follow-up
There were no differences in follow-up periods between group
MNS and MAN (15+ 9.5 vs. 14+9.5 months, P ¼ ns). There
were no differences in recurrence rates between group MNS
and MAN in overall (14 vs. 11%, P ¼ ns) or in any of the subgroups
[(AFib persistent 14 vs. 19%) (AFib paroxysmal — vs. 16%) (AFib
long-standing persistent 33 vs. 0%) (aAFL/AT 14 vs. 25%) (AFl 13
vs. 11%) (AVNRT 6.9 vs. 7.4%) (CMT 7.7 vs. 5.2%) (AVJ 0 vs. 0%)
(VT 14vs. 14%), P ¼ ns].
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Abla i resu ts—acu success
Group MNS Group MAN Total P value
All arrhythmias 269/292 (92%) 298/318 (94%) 567/610 (93%) 0.904
AFib 52/56 (93%) 75/76 (99%) 127/132 (96%) 0.083
Paroxysmal – 59/60 (98%) 59/60 (98%) na
Persistent 22/23 (96%) 16/16 (100%) 38/39 (97%) 0.398
Long-sta ding persistent 30/33 (91%) – 30/33 (91%) na
AFl 38/40 (95%) 82/84 (98%) 120/124 (97%) 0.440
aAFl/AT 42/50 (84%) 4/6 (67%) 46/56 (82%) 0.295
AVNRT 29/29 (100%) 68/70 (97%) 97/99 (98%) 0.358
CMT 52/55 (95%) 39/45 (87%) 91/100 (91%) 0.075
AVJ 8/8 (100%) 8/8 (100%) 16/16 (100%) –
VT 50/54 (93%) 21/29 (72%) 71/83 (86%) 0.013
VT-SHD 14/17 (82%) 10/15 (67%) 24/32 (75%) 0.306
VT-NSHD 36/37 (97%) 11/14 (79%) 47/51 (92%) 0.026
MNS, magnetic navigation system; MAN, manual navigation; AFib, atrial fibrillation; AFl, cavotricuspid isthmus-dependent atrial flutter; aAFl, atypical atrial flutter; AT, atrial
tachycardia; AVNRT, atrioventicular nodal re-entrant tachycardia; CMT, circus movement tachycardia; AVJ, atrioventricular junction; VT, ventricular tachycardia; SHD, structural
heart disease; NSHD, non-structural heart disease; na, not applicable.
P values listed were calculated based on a two-sample t-test assuming unequal variances between group MNS and group MAN.
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Table 3 Summary of mean fluoroscopy and procedure times for group MNS and MAN
Fluoroscopy time (min) Procedure time (min)
MNS MAN P value MNS MAN P value
All arrhythmias 30+20 35+25 0.009 168+67 159+75 0.119
AFib 44+17 40+22 0.278 248+59 191+81 0.001
Paroxysmal – 36+19 na – 168+52 na
Persistent 42+15 54+28 0.061 232+41 276+107 0.088
Long-standing persistent 46+19 – na 264+70 – na
AFl 27+13 32+24 0.198 152+44 123+47 0.005
aAFl/AT 37+23 47+20 0.361 188+51 208+53 0.464
AVNRT 12+8.8 25+20 0.001 114+39 136+55 0.068
CMT 28+18 32+27 0.428 134+50 146+57 0.314
AVJ 6.5+2.4 7.7+3.7 0.472 72+7.5 86+21 0.147
VT 27+21 56+31 0.001 166+54 222+97 0.009
MNS, magnetic navigation system; MAN, manual navigation; min, minutes; AFib, atrial fibrillation; AFl, cavotricuspid isthmus-dependent atrial flutter; aAFl, atypical atrial flutter; AT,
atrial tachycardia; AVNRT, atrioventicular nodal re-entrant tachycardia; CMT, circus movement tachycardia; AVJ, atrioventricular junction; VT, ventricular tachycardia; na, not
applicable. P values listed were calculated based on a two-sample t-test assuming unequal variances between group MNS and group MAN.
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except for CMT, AFl, and AVNRT patients, when other than the first follow-up visit was 
scheduled only if the symptoms recurred. Atrial fibrillation patients were more rigorously 
followed at the AFib clinic of the department, including daily transtelephonic rhythm strips.
Statistics
Parameters obtained from the registry were analysed using SPSS 15.0 (SPSS Inc., Chicago, 
IL, USA). Patient demographic and baseline characteristics were presented as mean+SD. The 
two-tailed Student’s t-test was used for comparing continuous unpaired samples, assuming 
unequal variances (age, fluoroscopy time, procedure time, and follow-up period). For cat-
egorical variables the x2 test was performed (number of patients with different arrhythmias, 
gender, success rate, recurrence rate, and number of complications). Two-sided P values 
,0.05 were considered significant.
ReSulTS
Patients
There were no differences in the gender and age between group MNS and MAN (Table 
1). There were no differences in the number of patients enrolled into the subgroups based 
on the diagnosed arrhythmias, except for the subgroups mentioned in the Methods sec-
tion—paroxysmal and long-standing persistent AFib and AFL/AT (Table 1). There was no 
difference in the presence of PMs or ICDs between the study groups (PM: 4 MNS vs. 6 
MAN, P ¼ NS; ICD 20 MNS vs. 21 MAN, P ¼ NS). In, two patients (both in the VT group, 
both had abdominal implant) the ICD switched to magnet mode (asynchronous pacing). 
None of these patients were PM dependent; therefore, temporary programming allowed 
electro-anatomical mapping without further problems. No long-term effect on ICD or PM 
function was observed.
Ablation
Magnetic navigation system was equally effective as MAN in acute success rate for the 
overall groups (Table 2). In the subgroups only VT results were different, where MNS was 
more successful (Table 2). The success rate in the NSHD-VT subgroup was higher in MNS 
group, whereas the difference in VT subgroup with SHD did not reach statistical significance 
(Table 2). For the other subgroups no differences were observed in success rates (Table 2). 
Crossovers occurred only before the availability of irrigated tip MNS catheters, whereas one 
CMT patient and two AFl patients underwent crossover from MNS catheters (4 mm for CMT, 
8 mm for AFl) to manual guided irrigation tip catheters. Following the crossover all the three 
patients were ablated successfully. However, the MNS still proved to be non-inferior for the 
ablation of AFl and CMT. Overall, less fluoroscopy was used in group MNS (Table 3). In the 
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AVNRT and VT subgroups, less fluoroscopy was used in group MNS, otherwise there were no 
differences between the two groups (Table 3). There were no differences in procedure times 
between group MNS and MAN. Concerning subgroups, procedure times were higher using 
MNS in AFl, but were shorter in the VT subgroup.
Complications
The use of MNS was associated with a lower complication rate (4.5 vs. 10%; P ¼ 0.005). 
Moreover, concerning major complications the difference was also significant between the 
two groups (0.34 vs. 3.2%; P ¼ 0.01). One permanent AV block occurred in the MNS and 
one in the MAN group. The other nine major complications in the MAN group were either 
pericardial effusion or pericardial tamponade, whereas no effusion/tamponade occurred in 
the MNS group. There was a trend towards lower minor complications in the MNS group 
as well, but it did not reach statistical significance (4.1 vs. 6.4%; P ¼ ns) (Figure 1). Two 
temporary AV block were observed in the MNS group, one in the MAN group, the rest of the 
minor complications were femoral bleeding/haematoma in both groups.
Follow-up
There were no differences in follow-up periods between group MNS and MAN (15+9.5 vs. 
14+9.5 months, P ¼ ns). There were no differences in recurrence rates between group MNS 
and MAN in overall (14 vs. 11%, P ¼ ns) or in any of the subgroups [(AFib persistent 14 vs. 
19%) (AFib paroxysmal — vs. 16%) (AFib long-standing persistent 33 vs. 0%) (aAFL/AT 14 
vs. 25%) (AFl 13 vs. 11%) (AVNRT 6.9 vs. 7.4%) (CMT 7.7 vs. 5.2%) (AVJ 0 vs. 0%) (VT 14vs. 
14%), P ¼ ns].
Table 3 Summary of mean fluoroscopy and procedure times for group MNS and MAN
MNS and one in the MAN group. The other nine major compli-
cations in the MAN group were either pericardial effusion or peri-
cardial tamponade, whereas no effusion/tamponade occurred in
the MNS group. Th re was a trend to ards lower minor compli-
cations in the MNS group as well, but it did not reach statistical sig-
nificance (4.1 vs. 6.4%; P ¼ ns) (Figure 1). Two temporary AV block
were observed in the MNS group, one in the MAN group, the rest
of the minor complications were femoral bleeding/haematoma in
both groups.
Follow-up
There were no differences in follow-up periods bet een group
MNS and MAN (15+ 9.5 vs. 14+9.5 months, P ¼ ns). There
were no differences in recurrence rates between group MNS
and MAN in overall (14 vs. 11%, P ¼ ns) or in any of the subgroups
[(AFib persistent 14 vs. 19%) (AFib paroxysmal — vs. 16%) (AFib
long-standing persistent 33 vs. 0%) (aAFL/AT 14 vs. 25%) (AFl 13
vs. 11%) (AVNRT 6.9 vs. 7.4%) (CMT 7.7 vs. 5.2%) (AVJ 0 vs. 0%)
(VT 14vs. 14%), P ¼ ns].
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Ablation results—acute success
Group MNS Group MAN Total P value
All arrhythmias 269/292 (92%) 298/318 (94%) 567/610 (93%) 0.904
AFib 52/56 (93%) 75/76 (99%) 127/132 (96%) 0.083
Paroxysmal – 59/60 (98%) 59/60 (98%) na
Persistent 22/23 (96%) 16/16 (100%) 38/39 (97%) 0.398
Long-standing persistent 30/33 (91%) – 30/33 (91%) na
AFl 38/40 (95%) 82/84 (98%) 120/124 (97%) 0.440
aAFl/AT 42/50 (84%) 4/6 (67%) 46/56 (82%) 0.295
AVNRT 29/29 (100%) 68/70 (97%) 97/99 (98%) 0.358
CMT 52/55 (95%) 39/45 (87%) 91/100 (91%) 0.075
AVJ 8/8 (100%) 8/8 (100%) 16/16 (100%) –
VT 50/54 (93%) 21/29 (72%) 71/83 (86%) 0.013
VT-SHD 14/17 (82%) 10/15 (67%) 24/32 (75%) 0.306
VT-NSHD 36/37 (97%) 11/14 (79%) 47/51 (92%) 0.026
MNS, magnetic navigation system; MAN, manual navigation; AFib, atrial fibrillation; AFl, cavotricuspid isthmus-dependent atrial flutter; aAFl, atypical atrial flutter; AT, atrial
tachycardia; AVNRT, atrioventicular nodal re-entrant tachycardia; CMT, circus movement tachycardia; AVJ, atrioventricular junction; VT, ventricular tachycardia; SHD, structural
heart disease; NSHD, non-structural heart disease; na, not applicable.
P values listed were calculated based on a two-sample t-test assuming unequal variances between group MNS and group MAN.
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Table 3 Su r of mean fluorosc py and procedure times for group MNS and AN
Fluoroscopy time (min) Procedure time (min)
MNS MAN P value MNS MAN P value
All arrhythmias 30+20 35+25 0.009 168+67 159+75 0.119
AFib 44+17 40+22 0.278 248+59 191+81 0.001
Paroxysmal – 36+19 na – 168+52 na
Persistent 42+15 54+28 0.061 232+41 276+107 0.088
Long-standing persistent 46+19 – na 264+70 – na
AFl 27+13 32+24 0.198 152+44 123+47 0.005
aAFl/AT 37+23 47+20 0.361 188+51 208+53 0.464
AVNRT 12+8.8 25+20 0.001 114+39 136+55 0.068
CMT 28+18 32+27 0.428 134+50 146+57 0.314
AVJ 6.5+2.4 7.7+3.7 0.472 72+7.5 86+21 0.147
VT 27+21 56+31 0.001 166+54 222+97 0.009
MNS, magnetic navigation system; MAN, manual navigation; min, minutes; AFib, atrial fibrillation; AFl, cavotricuspid isthmus-dependent atrial flutter; aAFl, atypical atrial flutter; AT,
atrial tachycardia; AVNRT, atrioventicular nodal re-entrant tachycardia; CMT, circus movement tachycardia; AVJ, atrioventricular junction; VT, ventricular tachycardia; na, not
applicable. P values listed were calculated based on a two-sample t-test assuming unequal variances between group MNS and group MAN.
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dISCuSSIoN
This is the first study that assesses the efficacy and safety of ablations using MNS vs. manual 
navigation involving statistically equivalent, large-scaled patient groups. Our series includes 
all types of arrhythmias, arising from all four heart chambers. There are three major findings 
of this study. First, MNS proved to be equal to manual ablation not only in acute success 
rate, but for a reasonable follow-up period in a broader aspect of arrhythmias. Second, MNS 
was superior in safety as compared with manual navigation resulting in lower number of 
complications as well as less fluoroscopy times. Third, MNS was found to be better for the 
ablation of VT.
Rationale of using MNS for ablations
The success of catheter ablation procedures depends on accurate substrate location, fol-
lowed by optimal delivery of energy provided by good tissue contact.24 Manual navigation 
of catheters in the human heart has limitations: some regions are difficult to reach, and 
compromised catheter positioning may result in insufficient lesion formation.13,24 Catheter 
movement in some positions is accompanied by the risk of major complications, including 
pericardial effusion or tamponade.7,24 Although several pre-defined catheter curves were 
Discussion
This is the first study t at assesses he efficacy and saf ty of abla-
tions using MNS vs. manual navigation involving statistically equiv-
alent, large-scaled patient groups. Our series includes all types of
arrhythmias, arising from all four heart chambers. There are
three major findings of this study. First, MNS proved to be equal
to manual ablation not only in acute success rate, but for a reason-
able follow-up period in a broade aspect of arrhythmi s. Second,
MNS was superior in safety as compared with manual navigation
resulting in lower number of complications as well as less fluoro-
scopy times. Third, MNS was found to be better for the ablation
of VT.
Rationale of using MNS for ablations
The success of catheter ablation procedures depends on accurate
substrate location, followed by optimal delivery of energy provided
by good tissue contact.24 Manual navigation of catheters in the
human heart has limitations: some regions are difficult to reach,
and compromised catheter positioning may result in insufficient
lesion formation.13,24 Catheter movement in some positions is
accompanied by the risk of major complications, including pericar-
dial effusion or tamponade.7,24 Although several pre-defined cath-
eter curves were introduced to help appropriate lesion delivery,
there are no optimal curves available for the treatment of paedia-
tric patients with small hearts, patients with complex congenital
heart defects, or some type of VTs.25 The introduction and utiliz-
ation of MNS was aimed at surmounting these difficulties. It pro-
vides improvement of safety by the flexible catheter design, and
no pericardial effusion or tamponade was reported related to
catheter navigation using MNS.20 Magnetic navigation system also
provides better navigation capability, which is not limited by pre-
form d r evolved catheter curves.19,25,26 Theoretically, non-
fluoroscopic imaging and recently built-in automated functions
(AutoMap, stored magnetic vectors) allow less fluoroscopy time
(to both operator and patient).18 Stored magnetic vectors also
make it possible to re-navigate to spots defined and stored
during the procedure.26 Promising initial results were published
concerning these above-mentioned issues.22,23,25,27 In our experi-
ence, automated map function was used in all AFib, aAFl/AT and
VT patients undergoing MNS ablation. Manual correction was
performed after automated mapping, which could be completed
in 5–6 min on average.
Acute success rates and recurrences
Based on the theoretical advantages mentioned above, MNS could
be superior to manual navigation in the analysed parameters.
Reports until now focused more on feasibility rather than assess-
ment of efficacy of MNS.10,11,15,17,23,25–30 Contrary to this, we
aimed at comparing large groups of patients treated using MNS
or MAN, with a long follow-up period. We confirm that MNS is
feasible for ablation of different kinds of arrhythmias, and clearly
demonstrate that it provides better safety and uses less fluoro-
scopy than manual navigation (see below). Furthermore, superior-
ity in acute success rate can be achieved in the VT subgroup (see
below).
Certainly, some issues are still to be solved that may play a role
in limiting of MNS. The delivered contact force is unknown relative
to manual catheters in which it had been shown to affect adequate
lesion formation. However, based on the high acute success and
Minor Complications
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Figure 1 Complications Comparison of minor, major, and all complications between magnetic navigation system and manual navigation
groups. Pericardial effusion/tamponade is coloured black. Asterisk indicates P ≤ 0.01.
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 Figure 1 Complications Comparison of minor, major, and all complications between magnetic 
navigation system and manual navigation groups. Pericardial effusion/tamponade is coloured black. 
Asterisk indicates P ≤ 0.01.
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introduced to help appropriate lesion delivery, there are no optimal curves available for the 
treatment of paediatric patients with small hearts, patients with complex congenital heart 
defects, or some type of VTs.25 The introduction and utilization of MNS was aimed at sur-
mounting these difficulties. It provides improvement of safety by the flexible catheter design, 
and no pericardial effusion or tamponade was reported related to catheter navigation using 
MNS.20 Magnetic navigation system also provides better navigation capability, which is not 
limited by preformed or evolved catheter curves.19,25,26 Theoretically, nonfluoroscopic 
imaging and recently built-in automated functions (AutoMap, stored magnetic vectors) allow 
less fluoroscopy time (to both operator and patient).18 Stored magnetic vectors also make it 
possible to re-navigate to spots defined and stored during the procedure.26 Promising initial 
results were published concerning these above-mentioned issues.22,23,25,27 In our experi-
ence, automated map function was used in all AFib, aAFl/AT and VT patients undergoing 
MNS ablation. Manual correction was performed after automated mapping, which could be 
completed in 5–6 min on average.
Acute success rates and recurrences
Based on the theoretical advantages mentioned above, MNS could be superior to manual 
navigation in the analysed parameters. Reports until now focused more on feasibility rather 
than assessment of efficacy of MNS.10,11,15,17,23,25 – 30 Contrary to this, we aimed 
at comparing large groups of patients treated using MNS or MAN, with a long follow-up 
period. We confirm that MNS is feasible for ablation of different kinds of arrhythmias, and 
clearly demonstrate that it provides better safety and uses less fluoroscopy than manual 
navigation (see below). Furthermore, superiority in acute success rate can be achieved in the 
VT subgroup (see below). Certainly, some issues are still to be solved that may play a role 
in limiting of MNS. The delivered contact force is unknown relative to manual catheters in 
which it had been shown to affect adequate lesion formation. However, based on the high 
acute success and low recurrence rates found in all subgroups during the reasonably long 
follow-up period, it does not seem to effect patient outcomes. Preparation of the system 
consumes considerable time (isocentering, registration, merging with CARTO, checking 
magnet movement). However, it does not result in significant prolongation of the procedures 
in overall. Although improvements were made recently, we also lack of fully automated 
functions (no need or automated isocentering; reliable, well-defined automapping) yet.
Crossovers
In our series, we encountered only three patients, where crossover to manual navigation 
became necessary (one CMT and two AFl patients). Although the endpoint could be reached 
using manual navigation in all three cases, no difference was found in general between MNS 
and MAN concerning the acute success rates in these subgroups. Also, it is important to no-
tice that these crossovers happened before the availability of irrigation tip catheters for MNS.
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Safety of ablations
The use of atraumatic, flexible designed ablation catheters combined with magnetic field-
guided navigation resulted in significantly reduced number of complications. No pericardial 
effusion or tamponade was observed in the MNS group, whereas in the MAN group these 
proved to be the most frequent major complications. All TSPs were guided by ICE, and 
none of these complications were related to them. This finding is consistent with previous 
reports, but these reports failed to substantiate it with significant statistical difference. Two 
atrioventricular blocks (AVB) occurred in the MSN group (one in a patient with parahisian AT; 
the risk was discussed with the patient after the diagnosis of the tachycardia was established. 
The other AVB occurred in a patient with AVNRT during an application near the ostium of the 
coronary sinus. In this case, our hypothesis is either an ectopic fast pathway or the occlusion 
of the AVN artery) Concerning minor complications—dominantly minor bleeding related to 
the femoral punctures, we also found somewhat higher number in the MAN group, which 
could be explained by the greater diameter of sheaths used for manual ablation such as cryo-
balloon sheaths and decreased movement of the sheath at the puncture site during remote 
catheter manipulation. The high manoeuvrability and atraumatic design of the MNS-guided 
ablation catheter allows navigation without constant fluoroscopy control, while re-imaging 
is typically required after each repositioning of the manual-guided catheter.18 Furthermore, 
stored MNS vectors also help to navigate the catheter without repeated fluoroscopic pulses. 
As we mentioned in the Methods section, our clinic is an academic centre, and the fel-
lows are taking part of the procedures, including femoral vein and artery punctures, and 
diagnostic catheter positioning. This significantly influences fluoroscopy or procedure times, 
and minor complication rates in both groups. Although our data may seem too high at first 
glance concerning these parameters, they are not really deviated from recently published 
available data.31
Transseptal puncture or retrograde aortic approach
In our centre, standard approach for left-sided VT is retrograde aortic ablation. Also, in case 
of left-sided accessory pathway the retrograde aortic approach is preferred. In our experi-
ence, this method helps to avoid the chance for serious complications (pericardial effusion/
tamponade) and/or the need for expensive diagnostic tools (ICE).
Ablation of ventricular tachycardia
This is the first large-scale study to prove the superiority of MNS for ablation of VT compared 
with manual navigation. This is demonstrated in most of the analysed parameters, such 
as acute success rate, and procedure and fluoroscopy times. There are multiple reasons to 
explain this finding. The MNS-guided catheter retains its manoeuvrability even in difficult 
positions, e.g. in cusp-related VTs, papillary muscle-originated VTs, where the capabilities of 
manual navigation are seriously limited by the multiple curves of the catheter.11 The MNS 
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controls the tip of the catheter, which means that the unavoidable curves of the catheter 
do not hinder the positioning of the tip, and good contact can be achieved, resulting in ap-
propriate lesion formation.13 An MNS-guided catheter has no pre-defined curve, which also 
contributes to the high manoeuvrability. Moreover, catheter stability using MNS is improved 
due to the constant magnetic force directing the tip unchanged during application.13 The 
above-mentioned capabilities are especially beneficial for patients in whom the arrhythmia 
substrate is located in a difficult position (i.e. posteroseptal wall in the right or left ventricular 
outflow tract) or where stability is the major issue (i.e. papillary muscle VTs). Two patients 
had papillary muscle-originated VT, and five patients had aortic cusp VT in the MNS group, 
all the seven patients were ablated successfully. This can explain the difference in success 
rates between the VT subgroups, whereas statistical significance could be only proven for 
the NSHD-VT subgroup.
limitations of the study
Although this registry is not a randomized, prospective trial, there was not any difference 
between the two groups and the assignment of the patients to the groups was independent 
of the operators. However, because of local protocols for the treatment of AFib patients, 
there were no paroxysmal patients treated with the MNS, and there were no long-standing 
persistent AFib patients treated manually. This means that only persistent AFib subgroups 
were comparable, and these groups were not different indeed.
CoNCluSIoNS
In conclusion, the MNS is equal in terms of acute and long-term success rates compared with 
MAN, whereas MNS-guided procedures can be performed with a lower complication rate 
and using less fluoroscopy. For the ablation of VT, MNS is superior to MAN.
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SuMMARy
Electrophysiologists have been performing catheter ablation over almost 30 years with vary-
ing success and complication rates. In this thesis we set out to determine where we stand 
after three decades of electrophysiological evolution.
Radiofrequency (RF) catheter ablation for atrioventricular nodal reentrant tachycardia 
(AVNRT) is highly successful but carries a small risk for inadvertent atrioventricular block 
(AVB). Cryoablation (Cryo) can assess the safety of a target site before energy is delivered. In 
chapter 1 of Part I we have evaluated the long term efficacy and safety of cryothermal abla-
tion in comparison to RF in our series of patients treated between 1999 and 2007 excluding 
patients in former studies. We used for the first time a disease specific questionnaire to assess 
the late outcome. Results showed that overall success rate is comparable in Cryo and RF, even 
after a very long term follow-up, which has never been published before. Furthermore, Cryo 
is a safe technique regarding regarding preservation of atrioventricular conduction in AVNRT 
ablation since not a single permanent AVB occurred in the Cryo group.
The advantages offered by Cryo rely on the unique way of lesion formation. This is discussed 
in chapter 2 of Part I. Cooling the tip of the catheter creates a temperature gradient in the 
tissue. By cooling the catheter tip to no more than minus 30°C for less than 60 seconds, the 
targeted tissue will only temporarily lose its conduction capabilities. However, this ‘functio 
laesa’ is of a transient nature and no permanent damage is done. Once the catheter re-
warms, the tissue regains its full function as if nothing happened. When the optimal ablation 
point is determined in this fashion by ‘cryomapping’, the operator can decide to move on to 
‘cryoablation’ and the catheter tip is cooled to minus 80°C. Again a temperature gradient 
is created inside the tissue that reaches a steady state between 3 and 5 minutes. The cells 
within the proximity of the catheter tip permanently lose their function and an irreversible 
ablation lesion is created. At that time another exceptional characteristic of Cryo is revealed: 
on a cellular level the interior of the cells loses its function, but the exoskeleton remains 
intact. This makes cryolesions less thrombogenic and possibly less pro-arrhythmic in the long 
run. Of course we have to take into account that the quality and size of lesion formation is 
influenced by catheter tip size, application duration and freezing rate.
Recently several new tools have been introduced to perform ablation in a faster, easier and 
hopefully safer way. However, by introducing these new tools we sometimes are faced with 
unexpected disadvantages.
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In chapter 1 of Part II we report on the case of a patient with severe PV stenosis of the left 
superior PV 5 months after pulmonary vein isolation (PVI) using a multipolar over-the-wire 
duty-cycled pulmonary vein ablation catheter (PVAC).
Unlike Cryo, RF application causes cells to disintegrate. This can lead to pulmonary vein 
stenosis whenever RF is applied inside the pulmonary veins (PVs). Despite current techniques 
targeting a more extra-ostial ablation, PV stenosis occurs in 1% to 3% of patients after 
catheter ablation for atrial fibrillation (AF). Although frequently asymptomatic, it can be 
associated with severe respiratory symptoms. Point-by-point catheter ablation remains a 
laborious task, this elicits the need for “single-shot” devices to make AF ablation a more 
straightforward procedure. The PVAC catheter, a multielectrode over-the wire catheter using 
duty-cycled bipolar and unipolar nonirrigated RF energy, has recently provided promising 
results.
We present the first report of significant PV stenosis after PVAC ablation, which can rep-
resent a potential serious drawback of the technique. Due to its over-the wire design, the 
PVAC catheter can easily be torqued in and out of the PVs, inevitably harboring the tendency 
to again more closely approach the PV ostium. This approach may increase the risk for PV 
stenosis, especially when delineation of the PV ostia by a selective PV angiogram is not suf-
ficiently accurate. Furthermore, PVAC ablation is performed in a circular fashion at multiple 
electrodes simultaneously. A circumferential cicatrization close to the PV ostium may lead to 
ostial PV stenosis during the subsequent healing process. We advise to limit the total number 
and/or the number of 2:1 modus applications, to avoid ablations too close to the PV ostium, 
and to improve imaging modalities to accurately delineate the PV ostia as potential ways to 
minimize the risk of PV stenosis.
Continuous innovation seeks to increase success rates and diminish complications. However, 
we cannot influence the preexisting substrate and the risk associated with the `frailty` of the 
individual patient. In chapter 2 of Part II we study the safety, feasibility and success rate of a 
cryoballoon ablation in elderly patients as compared to younger patients. Our data suggest 
a similar serious adverse event (SAE) rate in both groups. However, vascular complications 
occurred more frequently in the elderly and if the patients under general anaesthesia were con-
sidered, the higher age group had significantly more SAE, vascular and other adverse events 
(AE). Success rates were similar in both groups. These data suggest that more attention should 
be paid to avoidance of vascular complications if one decides to invasively treat elderly patients.
Another novelty to speed up and possibly increase efficacy of cryoballoon procedures is the 
Achieve circular mapping catheter (Achieve). The Achieve is introduced through the Cryobal-
loon system. This wire is conceived to combine both the properties of a wire for positioning 
of the Cryoballoon at the antrum of the pulmonary veins and the possibility of continuously 
checking the presence of pulmonary vein potentials throughout the ablation. In chapter 3 of 
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Part II we describe an apparent case of real time disappearance of pulmonary vein potentials 
during Cryoballoon application. Judging by the first results the Achieve circular mapping 
catheter seems to be a useful additional tool in PVI procedures using the Cryoballoon. Es-
pecially in pulmonary veins with late branching, delay and disappearance of pulmonary vein 
potentials can be monitored during cryoablation. However, in pulmonary veins with early 
branching local pulmonary vein potentials are hard to monitor during ablation as the Achieve 
wire is advanced into the branches of the veins by the relatively long tip of the Cryoballoon. If 
the findings on the Achieve circular mapping catheter prove to be consistent in randomized 
trials in comparison to the mapping capabilities of the lasso catheter, this could significantly 
speed up procedures. This also could make procedures safer as it obviates the need for a 
second transseptal puncture and renders the need for switching of the Cryoballoon for the 
lasso catheter superfluous.
One particularly interesting new development is the magnetic navigation system (MNS). 
The MNS consists of two permanent magnets situated on either side of the patient, which 
are computer-controlled via a workstation that allows changing the orientation of a stable 
magnetic field within the chest of the patient. Combined field strength of 0.08 to 0.1 Tesla 
is produced in a navigation mode. From the control room, remote catheter advancement 
and retraction can be performed using a catheter advancer system, positioned on the high 
anterior thigh. Remote control of the fluoroscopy system was also performed from the 
control room. The mapping and ablation catheters are equipped with three small perma-
nent magnets within the distal tip segment that align themselves with the direction of the 
externally controlled magnetic field, allowing effective catheter orientation. By changing the 
orientation of the outer magnets relative to each other, the orientation of the magnetic field 
changes and thereby leads to deflection of the catheter. After the magnets are brought as 
close as possible to the patient, the physician performs the rest of the procedure from the 
control room. A nurse stays with the patient to monitor vital signs and administer drugs 
when required.
In Part III we set out to evaluate the limits of the MNS in different clinical trials. In chapter 
1 of Part III a prospective randomized study was conceived to compare RF catheter ablation 
of left-sided accessory pathways (APs) performed either by a transseptal (TS) or transaortic 
(TA) approach. Twenty-two consecutive patients were randomized to either a TS or a TA 
approach. The MNS was used in all patients for catheter navigation and eventual ablation, 
after the electrophysiologic study confirmed the presence of left-sided APs. Our data show 
that TS and TA approaches are equal in success rate and total procedure, patient fluoroscopy, 
and ablation time when using the MNS for left-sided AP ablation. However, crossing the 
aortic valve with the MNS is faster than completing a TS puncture.
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In chapter 2 of Part III we take testing the limits of the MNS even one step further. We test 
a highly simplified approach using a single RF ablation catheter with the remote magnetic 
navigation system (MNS) to diagnose and treat AVNRT. In the magnetic navigation (MN) 
group a single MN quadripolar catheter inserted through the internal jugular vein is used to 
diagnose AVNRT through electrogram interpretation on different prestored positions of the 
catheter. Subsequently RF ablation is performed. The safety and efficacy of this approach 
was compared to cryoablation and manual RF ablation. Procedural times were shorter in the 
single catheter group and physicians were exposed to virtually no radiation. Success rates 
were similar in all groups. This proves that MN guided single catheter ablation of AVNRT is a 
feasible technique in treating carefully selected patients with typical AVNRT.
New techniques are developed with the intention to overcome limitations we are faced with 
in everyday practice. When evaluating these novelties, we discover there is still some room 
for improvement. Chapter 3 of Part III is dedicated to the use of the MNS in treating atrial 
flutter. In this study we compared MNS, using non-irrigated and irrigated tip catheters, to 
manual RF ablation for ablating typical atrial flutter. The primary outcome was the number of 
patients in whom bidirectional isthmus block could be obtained with ≤15 applications. Sec-
ondary endpoints were the median number of applications needed, the need to switch to a 
manual irrigated tip catheter, the procedural and fluoroscopy times. We found there was no 
significant difference in the primary endpoint. However, the median number of applications 
needed to obtain block was higher in the MNS group compared to the manual group. There 
was no difference in fluoroscopy time, but procedural time was significant longer in the MNS 
group. So, the use of magnetic navigation for the ablation of atrial flutter is feasible but not 
superior to a manual approach. Overall, more applications were needed and procedure times 
were longer with MNS.
A new and very interesting field of interest for using the MNS, are children and adults with 
complex arrhythmias in the setting of structural cardiac abnormalities. The improved outcomes 
and increased availability of surgery for congenital heart disease (CHD) over the last three 
decades have created a small but steadily increasing subset of patients with unique needs. 
RF catheter ablation in these patients, and in small children with normal cardiac anatomy, is 
effective but challenging. An understanding of specific anatomical and electrophysiological 
characteristics of these patients and the technical challenges in addressing them are critical to 
the success of this therapy. Tools specifically designed for intracardiac diagnosis and therapy 
in anatomically complex and/or small hearts remain scarce. In chapter 4 of Part III we report 
single-center results from an ongoing registry of all patients with congenital heart disease 
and all children with complex arrhythmias in which the MNS was used. Included in this report 
are 12 patients with CHD in whom 17 tachyarrhythmias were treated, and 11 pediatric 
patients with normal cardiac anatomy who each had a single arrhythmia. Procedure duration 
Bruno BW.indd   214 05-Jan-12   17:37:22 PM
Overview 215
O
ve
rv
ie
w
and fluoroscopy time as well as arrhythmia recurrence rates were comparable to those found 
in previous reports of procedures performed in adults with structurally normal hearts, and 
the incidence of complications was quite low. In patients with complex congenital malforma-
tions, retrograde mapping of the pulmonary venous atrium was feasible, eliminating the 
need for puncture of the atrial septum, or surgically placed baffle in many cases. Moreover, 
the design of the magnetic catheter eliminated the need for multiple mapping and ablation 
catheters. Our findings suggest that RF catheter ablation using the MNS for arrhythmias after 
surgery for congenital heart disease and in pediatric patients is safe and effective.
More specifically we report in chapter 5 of Part III the use of the MNS in young children (<10 
years old), especially because reduction in procedure and fluoroscopy time could decrease 
the hazardous effects of the ablation procedures. We compared the efficacy and safety 
between a manual and MNS-guided approach in this pediatric arrhythmia population and 
in a subgroup of young children aged <10 years old. Our data have strongly suggested that 
using the MNS for treating young children is advantageous, because it significantly reduced 
the procedure and fluoroscopy times without compromising efficacy.
The capabilities of the MNS are highlighted in chapter 6 of Part III by an exceptional case that 
could only be performed in this way using a MN catheter. An 18-year-old female patient with 
tricuspid atresia, discordant ventriculo-arterial connections, a total cavo-pulmonary connec-
tion, and a Damus-Kaye-Stansel suffered from atrial tachycardia. The extreme flexibility and 
maneuverability of the MN catheter made it possible to create a complete electro-anatomical 
map of both atria and ablate successfully the tachycardia in the left atrium using a retrograde 
approach. Even with the MN catheter shaft being twisted in numerous directions, precise 
catheter tip steerability remained intact and allowed for successful ablation. This would have 
been impossible using manual ablation.
Finally, the MNS has also been introduced for ablation of ventricular tachycardia (VT). In 
chapter 7 of Part III we describe our study that compared the acute and late outcome of 
VT ablation using the MNS to ablation using conventional manual techniques (MAN). Our 
results suggest that the use of MNS offers major advantages for ablation of VT, including a 
higher acute success rate, reduced procedure time, lowered fluoroscopy exposure and fewer 
complications. Moreover, fewer recurrences of VT were observed in the MNS group.
As a final overview and in order to evaluate the overall safety and long-term efficacy of the 
MNS, in chapter 8 of Part III we reviewed all patients treated with the MNS at our center be-
tween January 2008 and March 2010, being 292 consecutive patients in total. Patients were 
divided into two age- and sex-matched groups and were compared to conventional manual 
ablation. Subgroup analysis was performed for the following groups: AF, isthmus dependent 
and atypical atrial flutter, atrial tachycardia, AVNRT, circus movement tachycardia, and VT. 
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MNS was associated with less total and less major complications, it was equally effective in 
acute success rate for overall groups, but more effective than manual ablation for VTs, and 
it used less fluoroscopy. There were no differences in procedure times and recurrence rates 
for the overall groups. So we are confident that the use of MNS improves safety without 
compromising efficiency of ablations.
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Conclusion
When considering current literature and our contribution to it through these papers, faster, 
safer and better catheter ablation should indeed be followed by a question mark: not only 
for the mere sequence of these three adjectives, but also for the question if they all apply to 
current practice in electrophysiology.
With respect to the arrangement of those three words, we personally conclude that safety 
remains the critical determinant in the majority of patients treated for cardiac arrhythmias. 
Cryotherapy for AVNRT has undoubtedly proven to be the safest approach in treating this 
non-lethal arrhythmia without creating permanent atrioventricular block. Also in atrial fibril-
lation, cryoballoon therapy has earned its merits when the adequate patients are selected. 
But the new technique that is mostly linked to safety issues is without a doubt the magnetic 
navigation system. We are convinced that this association is appropriate and using remote 
magnetic catheter navigation is advantageous. New companies also investing in this concept 
only reinforce the belief that there is a future for magnetic navigation.
In order to improve both efficacy and speed a thorough knowledge of pathophysiology 
is paramount. Although a great deal of groundbreaking work has already been done, we 
are far from completely understanding complex arrhythmias. And despite the outside world 
pushing to increase numbers, we should try to keep focusing on uncovering the origin and 
progression of several arrhythmias.
To our knowledge, the key to success in invasively treating patients with cardiac arrhythmias 
lies in an approach tailored to the individual patient and flexible in balancing safety, success 
and speed. Different tools are already at our disposal and many more are being developed 
and tested. Fortunately, we have only just embarked on this tremendously innovative journey.
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Besluit
Wanneer we de huidige literatuur bekijken en tevens de boodschap van de verschillende ar-
tikels in deze thesis in acht nemen, kunnen we niet anders dan besluiten dat het vraagteken 
achter ‘faster, safer and better catheter ablation’ er met recht en reden staat. Niet alleen de 
volgorde van deze drie woorden dient in vraag te worden gesteld, maar we moeten onszelf 
ook afvragen of deze drie termen allemaal van toepassing zijn op de manier waarop we 
electrofysiologie vandaag bedrijven.
Wat de volgorde van de woorden betreft, zijn wij ervan overtuigd dat veiligheid primordiaal 
is. Zo heeft vriestherapie onomstotelijk bewezen de veiligst mogelijke behandeling te zijn 
voor AVNRT gezien het risico op het creëren van een totaal atrioventriculair block quasi 
onbestaand is. Bij het behandelen van goed geselecteerde patiënten met voorkamerfibrillatie 
heeft de vriesballon ongetwijfeld ook zijn sporen verdiend. Maar wanneer het om nieuwe 
technieken gaat die ontwikkeld zijn met het oog op het veiliger maken van ablaties, dan 
spant het magnetisch navigatie systeem zondermeer de kroon. Omdat we zelf de veiligheid 
van de patiënt hoog in het vaandel dragen, zijn we absoluut voorstander om het magnetisch 
navigatie systeem zoveel mogelijk in de dagdagelijkse praktijk te gebruiken. Ons geloof in 
de toekomst van dit systeem wordt enkel nog maar versterkt door dat er momenteel nog 
andere systemen ontwikkeld worden die stoelen op hetzelfde mechanisme van magnetische 
navigatie.
Als we bovenop de veiligheid ook de efficiëntie en de snelheid van ablatieprocedures wil-
len verhogen, is het belangrijk om het ontstaan van de verschillende ritmestoornissen te 
bestuderen. In de voorbije decennia is er al heel wat baanbrekend werk verricht op dit vlak, 
maar we kunnen nog niet stellen dat we vandaag het precieze mechanisme van de meer in-
gewikkelde ritmestoornissen volledig doorgronden. Het zou zinvol zijn om, in plaats van toe 
te geven aan de externe prestatiedruk om het aantal ablaties gestadig op te drijven, eerder 
onze aandacht toe te spitsen op het ontrafelen van de oorsprong en natuurlijke evolutie van 
ritmestoornissen.
Wij geloven dat de sleutel tot het succesvol invasief behandelen van ritmestoornissen ligt in 
een behandeling die op maat gemaakt is voor iedere patiënt afzonderlijk en die een perfect 
evenwicht biedt tussen veiligheid, efficiëntie en snelheid. We beschikken reeds over een heel 
arsenaal van hulpmiddelen hiervoor en quasi onophoudelijk worden er nieuwe ontwikkeld. 
En we mogen de toekomst met een gerust hart tegemoet zien, want deze ongelofelijk span-
nende en innoverende tocht is nog maar net begonnen.
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It does not come as a surprise that, after having finished this thesis, it is important to dedicate 
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A major contribution was made by the Belgian and Dutch railway system. This ingenious 
system allowed me to travel from my home to Rotterdam central station in approximately 
2,5 hours…when I was lucky, that is. Here is the theory behind this endeavor: I would get up 
at 05.00am to leave the house at 05.30am. I would cycle towards the train station and catch 
the first train towards Antwerp central station at 05.45am. This train would reach its destina-
tion at 06.15am where I would have plenty of time to wait for the international train towards 
Rotterdam leaving hourly, at 5 minutes before the hour sharp. This direct connection would 
take about 60 minutes, so I should reach Rotterdam around 08.00am. There I would find my 
second bicycle and I would happily arrive at the Erasmus Medical Center around 08.20am 
(which is about 15 minutes late for the ‘overdracht’ of the cardiology department – which 
is attended by all cardiologists from the EMC without exception – a kind of punctuality that 
made me extremely popular amongst certain colleagues…).
The same ritual would take place every night in order to catch the train in Rotterdam central 
station, also leaving hourly, at 5 minutes before the hour sharp. This required a little more 
skills since I had to take into account the time to get changed, leave the hospital (unnoticed, 
preferably) and cycle (usually against a strong headwind) towards the station. I had to make 
sure to arrive in time because I needed another 5 minutes to allow me to walk from the 
bicycle storage location towards the train platform. Again, I would reach the front door of 
my house 2,5 hours later…in the ideal setting.
This fairly simple plan, however, contains a rather large amount of ‘would’s’ and it was 
conceived without taking into account the unlimited number of variables provided by our 
friends at the railway department. I will not go into detail because this would lead us to far, 
but I would like to express my gratitude towards the Belgian and Dutch railway system using 
a simple example.
Punctuality. It seems virtually impossible to run the railway company with trains arriving and 
departing at their preset time. Either the tracks are too hot during summer or too cold during 
winter and this delays the trains. If leaves are on the track during autumn or if heavy rain 
wets them during spring, the trains are delayed. Sometimes a train would simply not show 
up (without any reason) and passengers needed to wait another hour until the next train 
arrived. The 40-year old locomotives broke down with the regularity of a Swiss watch, the 
railway staff had its monthly strikes and one time we even ended up in a traffic jam caused by 
several other trains (!!). By consequence, the preset timing of the travel plan could not always 
be guaranteed and this resorted in me arriving late at work on multiple occasions. Mostly 
this was due to the brilliant organization of the railway system, but once in a blue moon this 
was linked to me not answering my wake-up call. So I would like to thank the railway system 
for readily providing me every day with an generally accepted (even by most of my Dutch 
colleagues) excuse to arrive late at work.
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Another important contribution was made by the person (whose name I will not disclose 
in writing) that made me aware of an important flaw in the security system of the EMC’s 
parking facilities. During the last months of my fellowship, I ultimately switched from train to 
car or motorcycle to make the journey to Rotterdam and back. During the daytime, I parked 
on the premises of the EMC. This was charged by the hour and I realized soon enough that 
stalling my vehicle would cost me a small fortune every month. However, it seemed that the 
entrance of the emergency department had an unmanned barrier that opened automatically 
when approached both when entering and exiting the parking. Timing was crucial when 
performing the escape maneuver: one first had to be sure that no ambulances were on their 
way in as there was only a single driving lane, secondly the U-turn to get on this lane had 
to be made in one time in order not to lose precious time while being monitored by several 
cameras and finally it was of the utmost importance that the guards were patrolling the 
other side of the facilities. This last hurdle was sometimes hard to take and this prompted a 
guard jumping from behind a pillar in front of my car on several occasions. This usually only 
caused a delay of about half an hour before another attempt to escape the parking could be 
made. So again, my special thanks to my informant!
Finally I would very much like to thank the communication department for opening my 
window on the world, even long after I had already left the EMC.
Apart from this madness, I will make sure that those people who genuinely contributed to 
the thesis will be thanked appropriately and from the heart.
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